Adipogenesis in Rodent Skin, The Dermal Adipose Layer: What Signals Adipocyte Development in the Lower Dermis? by DAVIES, OLIVIA,STEPHANIE,EVELYN
Durham E-Theses
Adipogenesis in Rodent Skin, The Dermal Adipose
Layer: What Signals Adipocyte Development in the
Lower Dermis?
DAVIES, OLIVIA,STEPHANIE,EVELYN
How to cite:
DAVIES, OLIVIA,STEPHANIE,EVELYN (2015) Adipogenesis in Rodent Skin, The Dermal Adipose Layer:
What Signals Adipocyte Development in the Lower Dermis?, Durham theses, Durham University. Available
at Durham E-Theses Online: http://etheses.dur.ac.uk/11156/
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or
charge, for personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in Durham E-Theses
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full Durham E-Theses policy for further details.
Academic Support Oﬃce, Durham University, University Oﬃce, Old Elvet, Durham DH1 3HP
e-mail: e-theses.admin@dur.ac.uk Tel: +44 0191 334 6107
http://etheses.dur.ac.uk
2
 
 
 
 
 
 
 
 
 
Adipogenesis in Rodent Skin, The 
Dermal Adipose Layer:  
What Signals Adipocyte 
Development in the Lower Dermis? 
 
 
 
 
Olivia Stephanie Evelyn Davies 
 
MSCR Biological Sciences 
 
School of Biological and Biomedical Sciences 
Durham University 
 
2014 
 
 
 
 
 
 
 
 
 
	   2	  
Research into adipogenesis has become increasingly more fundamental as 
our understanding of diabetes and obesity develops. Adipose tissue (fat) exists in 
many depots throughout the body. While widely known that there is a 
subcutaneous adipose depot beneath the skin, more recently a separate dermal 
adipose layer, within the lower dermis of rodent skin, has been found. However, 
the developmental origins and timings of adipogenesis in this dermal layer are not 
well characterised. This thesis aims to study adipogenesis within this layer, by 
creating an in vivo-like model and investigating signalling pathway effects.  
Firstly, the hypothesis of an inhibition signal from the upper dermis and the 
role of the G0/G1 switch gene 2 (G0S2) in the dermal adipose tissue was explored. 
Experiments showed G0S2 expression in the lower dermis during development. 
PPARγ  has been shown as the main regulator of adipogenesis, together with 
C/EBPα . The potential role of PPARγ  in early adipogenesis was investigated, using 
immunofluorescence analysis. 
Microarray analysis studies previously showed molecular differences 
between in vitro and in vivo, therefore model systems, more closely related to in 
vivo conditions, are necessary. An organ culture and a cell culture model were 
developed. The cell culture model, using 3D cell spheres, proved most useful to 
investigate signalling in adipocyte development. The EGF/EGFR, TGFβ/BMP and 
KGF/KGFR pathways were studied, by supplementing cultures with an activator 
or inhibitor of the receptor of each pathway. Differential levels of oil red O 
staining and therefore adipocyte formation, were observed.  
In conclusion, this work was found to suggest commitment of the cells to the 
adipocyte lineage begins earlier, than from when microarray data was collected. 
While not conclusive, it provides an insight and direction for further studies, in 
terms of PPARγ  and potential adipogenic inhibition signals in the upper dermis, as 
well as a model system. 
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1.1. The Skin  
 
Skin is a vital organ that constitutes the outer layer of the body and plays several 
crucial roles including those involved in insulation and protection from the external 
environment (Igarashi et al. 2005; Millar 2005). Mammalian skin has many essential 
similarities between species. In simple terms, from the outside in, the skin is composed 
of, an epidermis and a dermis (Figure 1.1). Underneath the dermis is a layer which is 
termed the subcutis or hypodermis and which is primarily adipose tissue and therefore 
often known as the subcutaneous layer. These defined layers are in fact divided into 
many sub-layers in which the cell morphology differs (Figure 1.1). A dermal-epidermal 
junction also exists between the epidermis and dermis. 
 
 
 
 
 
 
 
 
 
 
 
 
The skin is associated with many different tissues including those of vascular 
and nervous origin (Kanitakis 2002) (Figure 1.2). The skin also has a number of 
appendages including hair follicles and sebaceous glands (pilosebaceous units) and 
apocrine and eccrine sweat glands, which differ in their distributions across the body. 
For example, in some regions, including the palms of human skin, skin is glabrous and 
does not have any hair follicles (Montagna 1974; McGrath et al. 2004).  
 
 
Figure 1.1: Schematic of the layers within the skin. The skin is divided into the epidermis, dermis 
and basement membrane, but within them are further sub-layers. The direction of keratinocyte 
movement is labelled. (Adapted from McGrath et al. 2004; McGrath et al. 2008; Wojciechowicz 2012) 
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1.1.1. Epidermis 
The epidermis and its associated appendages are of ectodermal origin in 
embryogenesis (Kanitakis 2002). The main cellular component of the epidermis is 
composed of keratinocytes, which differentiate as they move through the skin from the 
inner to the outer layer of the epidermis where they become flattened cornified 
corneocytes, thus the epidermis is continuously self-renewing. The basal layer contains 
the stem cell population. Cells are shed at the skin surface by desquamation and new 
cells are generated from a stem cell population at the basal layer (Bouwstra et al. 2003; 
Moore and Lemischka 2006). The epidermis is subdivided into a number of layers 
(Figure 1.1). The stratum corneum is the outermost layer and therefore the main 
protective barrier (Bouwstra et al. 2003). Cells in the layers beneath move up through 
the epidermis, as annotated in Figure 1.1. Keratinocytes contain many structural 
proteins, including keratin filaments, and lipids. These fibrous proteins increase in 
number as the keratinocytes move through the epidermis in the differentiation process 
and make up the majority of the cytoskeleton (Downing 1992). Each layer can be 
distinguished by the morphology and differentiation state of the keratinocytes, 
molecularly shown by changes in cytokeratin expression (Franssen et al. 2004). 
As well as keratinocytes, there are other cell types present including Langerhans 
cells, melanocytes and Merkel cells (Kanitakis 2002). Intercellular junctions, including 
gap and adherens junctions as well as desmosomes, allow cell-to-cell contact 
throughout the epidermis (Kanitakis 2002). This is fundamental to maintaining the 
Figure 1.2: Morphology of the skin. Schematic of the skin (Adapted from MacNeal 2014) compared 
with Haematoxylin and Eosin staining of 7 day old mouse back skin conducted during this project. 
Follicles protrude into the adipose (fat) layer.  
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structure until the stratum corneum where the desmosomes have been permitted to 
degrade prior to exfoliation from the surface (Downing 1992).  During the 
differentiation of the keratinocytes, they develop many membrane-bound lamellar 
bodies, composed mainly of lipids, which are later secreted to form intercellular 
lamellae (Downing 1992; Bouwstra et al. 2003). As well as a number of lamellar 
proteins, the epidermis has a high lipid content, from phospholipids to ceramides and 
cholesterol; The majority of which are part of the stratum corneum (Downing 1992; 
Bouwstra et al. 2003). These play a significant role in making the epidermal barrier 
impermeable to water. 
 
1.1.2. Dermal-Epidermal Junction 
 At the dermal-epidermal junction (DEJ) is the basement membrane zone (BMZ), 
a specialized structure containing multiple extracellular matrix components including 
collagen fibres, secreted by basal keratinocytes and dermal fibroblasts (Kanitakis 2002). 
This junction is important for adhering the epidermis to the dermis and is also involved 
in the exchange of metabolites between the two. Crucially it is also involved in the 
interactive signalling between the dermis and epidermis. Anchoring fibrils are present to 
join the two layers (Burkhard and Ruppert 1981; Kanitakis 2002). 
  
1.1.3. Dermis 
 The dermis is an elastic connective tissue layer of mesodermal origin, which 
provides mechanical support for the skin (Kanitakis 2002; Bouwstra et al. 2003). Its 
cellular content consists mainly of fibroblasts and in addition dendrocytes and mast 
cells are also present. The spindle-shaped fibroblasts synthesise all the extracellular 
fibres present in the dermis (Kanitakis 2002). Structurally dermis can be defined as a 
fibrous collagen network populated with relatively few cells. Meshworks of collagen 
and elastic fibres create the dermis, making the skin both durable and mobile. The 
dermis also contains a number of nerves, blood vessels and lymphatics (Montagna 
1974) and houses the epithelial skin appendages.  
 
1.2. The Adipose Organ  
The adipose organ not only acts as energy storage, insulation and protection but 
also the body’s largest endocrine organ, influencing cells and tissues across the body 
(Gesta et al. 2007; Poulos et al. 2009). Adipose tissue, commonly known as fat, is made 
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up of several different cell types: mainly adipocytes, but also endothelial cells, blood 
cells, fibroblasts and macrophages (Rosen et al. 1999). The organ is made up of 
anatomically distinct depots including subcutaneous and visceral (Cinti 2007) and 
crucially its structure and functions differ between locations. For example, visceral 
adipose tissue is involved in increased risk of insulin resistance, while the subcutaneous 
adipose tissue is not (Rosen and MacDougald 2006). In accordance with this, gene 
expression also varies between depots (Gesta et al. 2007). 
Adipocytes and adipose tissue play important roles in obesity and diabetes, 
through adipocyte hypertrophy and adipocyte recruitment (Wang et al. 2006). Research 
into adipogenesis has grown in response to the current obesity epidemic (Gesta et al. 
2007; Billon et al. 2008). Obesity being an increase in adipocyte number and size 
whereby a balance between energy intake and expenditure does not exist (Gesta et al. 
2007; Billon et al. 2008). Obesity can cause insulin resistance and has been found to be 
a major causal factor of many diseases, including type 2 diabetes, cardiovascular 
disease and some cancers (Gesta et al. 2007). A better understanding of adipogenesis 
may therefore be beneficial to the treatment and prevention of obesity and associated 
diseases.  
 
1.2.1. Adipocytes 
The main cellular component of adipose tissue is adipocytes. The proteins e.g. 
adipokines that these cells secrete are important for many functions, including blood 
pressure, energy balance and angiogenesis (Lau et al. 2005; Rosen and MacDougald 
2006; Lefterova and Lazar 2009). Mature adipocytes are able to store and synthesise a 
high quantity of lipids and rapidly release them (Rosen and MacDougald 2006). These 
cells differ from other cells that can carry lipids, in that they contain large lipid droplets 
contained within perilipin (Greenberg et al. 1991; Gesta et al. 2007). Leptin is a 
hormone secreted by mature white adipocytes thought to be involved in regulating fat 
mass and energy balance (Gregoire et al. 1998; Martin et al. 1998).  
Two main types of adipocyte can characterize mature adipose tissues. White adipocytes 
contribute to white adipose tissue (WAT) and brown adipocytes to brown adipose tissue 
(BAT), though tissues are not necessarily solely one or the other (Avram et al. 2005). 
WAT and BAT have opposite functions (Billon et al. 2008). White adipose cells 
contain a single lipid droplet (Spiegelman 2013). Brown adipocytes have a lower lipid 
content but more mitochondria for their involvement in heat dissipation during 
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thermogenesis (energy usage) and their importance in preventing hypothermia 
(Spiegelman 2013) while WAT is involved in excess energy storage (Rosen and 
MacDougald 2006; Billon et al. 2008; Farmer 2008; Lefterova and Lazar 2009). BAT 
decreases in volume after birth (Gesta et al. 2007). There are more brown adipocytes in 
rodents than in humans for the burning of energy (Gray et al. 2006).  
It was originally thought that depots of adipose tissue were exclusively white or 
brown, but it was discovered that many of them comprise of a mix of both white and 
brown adipocytes in both rodents and humans (Gray et al. 2006). One suggested reason 
for the introduction of brown adipocytes into white depots is to prevent obesity (Gray et 
al. 2006). The brown adipocytes that develop in white adipose tissue are not of the same 
origin as original brown fat (Seale et al. 2008; Spiegelman 2013). Thus brown 
adipocytes can be defined as; classical brown adipocytes, whereas beige adipose cells 
which develop in white depots are often referred to as brite cells (Petrovic et al. 2010). 
The gene expression profiles of these adipocytes are, for the best part, the same. 
However, certain genes e.g. uncoupling protein-1 (UCP-1) are only expressed by one 
type, in this case brown adipocytes and it is involved in heat dissipation (Gray et al. 
2006; Spiegelman 2013). Brown adipocytes are distributed in the interscapular region 
and develop earlier in foetal development than white adipocytes, which develop 
neonatally in rodents and during midgestation in humans (Gesta et al. 2007).  
 
1.2.2. Origins of Adipose Tissue 
Despite the interest in adipose tissue and its potential for therapeutic 
applications, relatively little is actually known about their origins. They are thought to 
develop from mesenchymal stem cells (MSCs) and before that from mesoderm (Billon 
et al. 2008). MSCs can differentiate into adipocytes, osteoblasts, chondrocytes and 
connective tissue (Figure 1.3). However, due to the precursor cells (preadipocytes) not 
presenting any morphological changes and the lack of definitive cell-specific markers, 
the lineage of MSCs towards adipocytes is yet to be clearly defined (Billon et al. 2008). 
The fact that adipocytes exist in separate adipose tissue depots, which exhibit different 
developmental gene expression profiles (Gesta et al. 2006), suggests they may be of 
differing developmental origin (Billon et al. 2008). Likewise, the variation in gene 
expression may be related to the differing metabolic functions of the individual fat 
depots. For example, adipose tissue in the breasts and thighs is more sensitive to sex 
hormones than other adipose tissue depots (Billon et al. 2008). Are there separate types 
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of preadipocytes for distinct adipose depots?  
It has been suggested that adipocytes may arise from neuroectoderm and neural 
crest as the neural crest stem cells generated had adipogenic potential in culture (Billon 
et al. 2007; Takashima et al. 2007; Billon et al. 2008). In vivo it has been found that 
only cephalic adipose depots arise from neural crest, which further suggests that adipose 
tissues come from different origins, but when do these cells become committed to 
adipocyte lineages and do their functions differ? It may be that only specific depots are 
linked to obesity and associated diseases (Gesta et al. 2007; Billon et al. 2008). One 
hindrance to our understanding of the lineage of different adipose depots is therefore the 
relative lack of specific markers (Billon et al. 2008) There are now some markers 
associated with adipogenesis e.g. CD24, however early adipogenic markers are less well 
characterised (Rodeheffer et al. 2008). 
It has been suggested that developmental genes and those involved in pattern 
formation including Hox genes may be important in the isolated development of 
different adipose depots, e.g. HoxA5, HoxA4 and HoxC8 are more highly expressed in 
intraabdominal adipocytes while HoxA10 and HoxC9 are more highly expressed in 
subcutaneous adipocytes (Gesta et al. 2006; Gesta et al. 2007). 
Atit et al. (2006) investigated the developmental origin of mouse skin dermis 
and traced the lineage suggesting that interscapular fat and dermis arise from the same 
origin in the dermomyotome. Muscle also can develop from this dermomyotome, i.e. if 
muscle formation is inhibited, adipocytes will be produced. It was thought that these 
brown and white adipocytes developed from the same mesenchymal progenitor, but 
now some research shows otherwise. Seale et al. (2008) used lineage-tracing studies to 
find that white and brown adipocytes develop from different origins. For example, 
brown fat and skeletal muscle arise from the same lineage white fat does not. 
Driskell et al. (2013) found that by embryonic day 18.5 (e18.5), the upper 
dermis and lower dermis had become separate. The fibroblasts present were originating 
from two different lineages. The upper dermis and the dermal papilla from one and the 
lower dermis, reticular fibroblasts and preadipocytes from the other (Driskell et al. 
2013). This suggests that at some point before e18.5, the upper dermis was responsible 
for hair follicle formation and the lower dermis for adipogenesis. 
 
1.2.3. Adipogenesis  
Adipogenesis is the development of lipid-containing adipocytes from their 
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precursor cells (Gregoire et al. 1998). Mesenchymal stem cells develop into 
preadipocytes that have become committed. These then differentiate into adipocytes 
(Rosen and MacDougald 2006; Billon et al. 2008). Four stages are involved in this 
second process; growth arrest, mitotic clonal expansion, early differentiation and 
terminal differentiation as shown in Figure 1.3 (Gesta et al. 2007). The need for the 
mitotic clonal expansion step is controversial as some say differentiation occurs without 
it. Some describe adipogenesis more simply as a two-step process; determination 
followed by terminal differentiation (Rosen and MacDougald 2006). Determination, 
similar to early differentiation is the stage at which the stem cell becomes committed to 
a preadipocyte. Terminal differentiation is the process by which preadipocytes become 
mature adipocytes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: The Stages in Adipocyte Differentiation. Several key molecular events that occur are shown 
on the right. Time periods are represented by vertical lines. Two key transcription factor families, PPAR 
and C/EBP are highlighted (red circles). A mature adipocyte contains a high lipid content. Adapted from 
Gregoire et al. 1998. 
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Adipocyte development occurs during embryogenesis and continues postnatally 
(Mandrup and Lane 1997). While fat in terms of adipocytes is not visible in the early 
stages of embryonic development morphologically, changes in gene expression have 
started to occur, though the exact timing of these changes is largely unknown. There are 
a number of transcription factors and genes involved in adipogenesis, crucially PPARγ 
(Peroxisome Proliferator Activated Receptor gamma) and the CEBP (CCAAT enhancer 
binding protein) family (Figure 1.3). What is understood of their roles will be discussed 
later (see sections 2.1 and 3.1). The study of these expression patterns is significant to 
understanding the mechanism by which adipogenesis occurs.  
It has been found that there are many in vivo versus in vitro differences, 
particularly in early adipogenesis when cells become committed preadipocytes (Rosen 
and MacDougald 2006). There is thought to be a bout of cell division before 
differentiation occurs as shown in the 3T3 cell lines (Rosen and MacDougald 2006). 
 
1.3. Hair Follicle Involvement 
 
Mouse skin develops alongside hair follicle formation. Hair follicles are 
structures that contain both epithelial and dermal elements. The epithelial root sheaths 
exist around the hair shaft and the dermal cells form the dermal papilla important for 
continuous hair growth (Sperling 1991; Millar 2002). Hair follicle formation begins in 
embryogenesis and involves signalling between epithelium and mesenchyme to 
orchestrate the development and differentiation into the component parts of a hair 
follicle (Hardy 1992; Millar 2002). The signalling was discovered relatively early in 
developmental studies by experiments recombining epidermis and dermis from mouse 
and chick skin at different embryonic stages (Millar 2002).  
Hair follicle initiation is triggered by a signal from the mesenchyme (“first 
dermal signal”) and starts with thickening in the basal layer of the epidermis forming 
the hair placode (Hardy 1992; Botchkarev and Sharov 2004). The cells orientate and 
their adhesion changes (Nanba et al. 2000; Tumbar et al. 2003; Botchkarev and Sharov 
2004). With a signal from the epithelial placode, underneath this thickening in the 
epidermis, dermal cells become locally denser and cluster in preparation to form the 
follicular papilla or dermal papilla (Paus et al. 1999; Botchkarev and Sharov 2004). 
This is called the dermal condensate which produces a “second dermal signal” allowing 
the epithelial placode cells to proliferate into the dermis and encase the developing 
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dermal papilla (Millar 2002). The epithelial cells then signal to each other to proliferate 
and differentiate to form the inner root sheath and hair shaft (Millar 1999; Millar 2002).  
There are different types of hair follicles. In mice, the guard/primary hair 
follicles are induced between e14.5 and e16.5. Secondary hair follicles (awl, auchene 
and zig-zag) are induced from e16.5 to postnatal day 0.5 (0.5dN) (Sundberg and Hogan 
1994). 
There is developing interest in the relationship hair follicles play with 
developing fat cells (Hausman and Martin 1982; Wojciechowicz et al. 2008). Fat in the 
lower dermis develops close to the lower region of the hair follicles and adipogenesis 
initiation occurs after downgrowth of the follicles (Hausman et al. 1981). When the hair 
follicles are actively growing during anagen the fat layer is at its thickest stage, which 
suggests that there is an interaction involved (Wojciechowicz et al. 2013). Hausman et 
al. (1981) suggested that the cells required for adipogenesis were transported down 
from the upper dermis with the development of the hair follicles, thus inferring a 
developmental relationship between the two processes. A recent study by 
Wojciechowicz et al. (2013) suggests differently that the cells in the lower dermis prior 
to birth become the dermal fat layer as opposed to preadipocytes being transported with 
the follicles. Both studies still find an association between lipid and hair follicle 
development, thus their signalling and molecular regulation may be linked. It may be 
that many of the factors associated with hair follicle growth could play a role in 
adipogenesis and vice versa (Wojciechowicz et al. 2008; Festa et al. 2011) 
A developed hair follicle continues to cycle through stages of hair growth 
throughout postnatal life. There are three main phases. The first being anagen, during 
which signals between the epithelial cells and the dermal cells lead to the development 
of the hair matrix which differentiates into the inner root sheath and the hair shaft 
(Oliver and Jahoda 1988; Taylor et al. 2000; Oshima et al. 2001; Millar 2002). This is 
followed by catagen where the lower parts of the follicle undergo apoptosis and then 
telogen where the follicle is in a resting phase prior to a new growth cycle (Millar 
2002). There is also another phase called exogen which is known as the “shedding 
phase” The hair follicles are also capable of responding to androgens at different stages, 
e.g. causing beard hair follicles in adolescent males to become larger (Millar 2002).       
There are two stem cell populations within in the skin; one at the basal layer and 
the other within the outer root sheath of the hair follicles. The latter regenerates the hair 
and sebaceous glands (Moore and Lemischka 2006). 
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1.4. The Dermal Adipose Layer 
 
Most work into adipogenesis has been conducted using in vitro cell lines e.g. 
3T3 cells and the differentiation differences specific to certain depots are not clearly 
classified (Rosen and MacDougald 2006). During the embryonic stages of development 
the dermis splits into distinctly separate regions, referred to as the upper and lower 
dermis. These can be distinguished by the development of adipose tissue, which only 
occurs in the lower dermis, visible as the white layer in Figure 1.4. The adipocytes 
develop around the base of the follicles (Hausman et al.1981). It was previously found 
that embryonic adipocyte precursor cells in the lower dermis could be labelled with 
C/EBPα, which suggested that fat might be developing there (Wojciechowicz et al. 
2008).  
It is known that within the subcutaneous adipose tissue beneath mouse skin there 
exist many layers. The dermal layer is not always considered separate from the 
underlying subcutaneous layers; however, in mice they are divided by a muscle layer – 
the panniculus carnosus (Cinti 2007; Schmidt and Horsley 2012; Wojciechowicz et al. 
2013). Jahoda’s lab has recently found this dermal fat layer to be of a separate 
developmental origin from that of the underlying subcutaneous adipose layer early on 
during embryonic development thus suggesting that these are in fact two separate 
depots. Skin from embryonic day 14/14.5 was then transplanted under the kidney 
capsule showing that fat can develop without subcutaneous tissue influences 
(Wojciechowicz et al. 2013). 
Figure 1.4: Skin structure in a postnatal mouse. Sections were stained with Haematoxylin and 
counterstained with Eosin. Image of a 28 day mouse (left) shows the fat layer of the lower dermis 
clearly as the white area (Adapted from Millar 2005) The right side is a comparison from a 17 day 
mouse where the adipocytes are stained red with oil red O (Adapted from Wojciechowicz et al. 
2013) Scale bar 30µm. 
 
 
. 
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1.5. Blood Vessels  
 
Blood vessels are present in the dermis and subcutaneous layer of the skin and 
are available to provide the skin with nutrients and to remove waste. They also are 
important in preventing dramatic changes to body temperature by vasodilation and 
vasoconstriction (MacNeal 2014). Vasodilation occurs when the vessels dilate and 
move near the surface of the skin to allow heat to be lost and vasoconstriction involves 
the narrowing of the vessels, which also move deeper into the skin to limit heat loss 
from the skin’s surface. They can be seen represented in the skin in figure 1.2. 
Blood vessel formation, also known as vasculogenesis or angiogenesis, starts 
before and also occurs alongside adipogenesis, during which it has been suggested that 
the developing preadipocytes and capillaries interact (Fukumura et al. 2003; Hausman 
and Richardson 2004; Hausman and Hausman 2006; Wang et al. 2006). A study using 
PPARγ negative construct showed that when angiogenesis was inhibited, adipogenesis 
was also inhibited (Gurnell et al. 2000; Hausman and Hausman 2006).  Hausman et al. 
(1981) suggested a link between hair follicles, adipocytes and capillaries. 
 
1.6. Molecular Involvement 
  
 A complex array of factors regulates the development of adipocytes from 
mesenchymal stem cells (MSCs). These include transcription factors and intermediates 
from a number of signalling pathways (Rosen and MacDougald 2006; Chapter 5). There 
are two main families of factors involvement in adipogenesis. The CCAAT enhancer 
binding protein (C/EBP) family and the peroxisome proliferator activated receptor 
(PPAR) family (Figure 1.3).  These are discussed in further detail in Chapters 2 and 3.  
Microarrays also suggest there are other factors which contribute and may be 
important markers of adipogenesis. Markers are important for tracking the development 
and location of cells and therefore further understanding developmental processes, e.g. 
adipogenesis. Several markers of mature adipocytes have been discovered in mouse 
skin. These include C/EBPα, FABP4, PPARγ, adiponectin and adipsin (Birsoy et al. 
2011; Wojciechowicz et al. 2013). However, little is understood about the formation of 
adipocytes in rodents and therefore the origin of adipose tissue in the skin. With the 
discovery of a dermal adipose layer separated from the subcutaneous adipose layer, 
there is increased interest in the origins of different adipose depots and the timings of 
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development. In order to determine the origin of these dermal adipocytes and the timing 
of events, early markers are important. A marker of pre-adipocyte tissue could allow us 
to follow the development more closely. 
 Wojciechowicz et al. (2008) found that cells in the lower dermis were labelled 
with C/EBPα before birth around e17 to e18 in preadipocyte cells (Wojciechowicz et al. 
2008). Fatty acid binding protein 4 (FABP4) expression was studied in mouse skin with 
the earliest labelling in the lower dermis being found at e16 and increasing between e17 
and e19 (Wojciechowicz et al. 2013). mRNA expression of FABP4 using RT-PCR on 
laser captured tissue was significantly higher in the lower dermis. FABP4 shows the 
usefulness of markers in the study of development. It was expressed in the lower dermis 
before the accumulation of lipids and therefore shows there is already a developmental 
difference between the upper and lower dermis.  
 
1.7. Studying development using Rodents 
 
 There are numerous reasons why in many instances the laboratory mouse is a 
suitable animal model for research into adipogenesis. In comparison with other animal 
models used in research, e.g. pigs (Hausman and Richardson 2004), mice breed quickly 
with a high success rate and their small size enables mice to be more easily maintained. 
They share many similarities with human development and have been widely used in 
many research fields thus suitable techniques and protocols have already been 
established. Knockout and transgenic mouse models have been fundamental in 
establishing the significance of a number of genes in development. Conditional 
knockouts using a system specific promoter can enable studies on one developmental 
system, however, development is complex and in vitro methods are also still used. 
Although not perfect, in many respects mouse skin is very similar to human skin and 
therefore represents a suitable and accessible experimental model for much scientific 
research. In this project an in-vivo like method using mouse back skin and in vitro 
culture methods was used.   
The gestational period is around 21 days in a laboratory mouse (CD1 or FVB). 
Work on mouse back hair by Wojciechowicz et al. (2013) has shown that the first wave 
of follicles (guard hairs) start to form at e14.5 which is followed by the second wave 
(awl and auchene hairs) at e16.5. The zigzag hairs then develop at e18.5 
(Wojciechowicz et al. 2013). Terminal adipocytes were found around the base of the 
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guard hairs at e18.5 although unevenly distributed along the anterior-posterior axis 
(Wojciechowicz et al. 2013). Only one or two days after birth were adipocytes distinctly 
visible throughout a lower dermal layer and this layer continued to thicken alongside the 
developing hair follicles. 
 
1.8. Why study Adipogenesis? Obesity and related disorders  
 
There are a number of different metabolic disorders, which are due to metabolic 
imbalance. These include lipodystrophy or obesity, which can in turn result in 
hyperglycaemia, hyperlipidemia, insulin resistance and diabetes and that can be caused 
by both genetic and environmental defects (Camp et al. 2002; Trayhurn 2005; Gesta et 
al. 2006; Lefterova and Lazar 2009). Adipogenesis is not as well defined as other 
developmental processes, but as research develops, its role is understood to be of 
increasing importance. Further understanding of adipogenesis and the roles of 
adipocytes will certainly further our knowledge of the causes of diabetes and obesity in 
order to optimally treat these diseases (Camp et al. 2002).  
Obesity is a growing worldwide concern and is on the rise, resulting in growing 
interest in adipogenesis (Gesta et al. 2006; Siersbæk et al. 2012; Spiegelman 2013). 
Obesity is both increased adipocyte number (hyperplasia) and increased adipocyte size 
(hypertrophy) (Couillard et al. 2000; Camp et al. 2002) also known as, ‘an imbalance 
between energy intake and energy expenditure’ (Billon et al. 2008). Healthy levels of 
excess fat are stored mainly in adipocytes, whereas when an individual is obese, large 
amounts of fat are stored in other tissues because the levels are too high to be stored in 
adipose tissue (Camp et al. 2002). This build up of fat in other tissues, including 
muscle, liver and pancreatic tissue may be a possible cause of obesity-related type 2 
diabetes mellitus (Unger 2002; Camp et al. 2002). The location of the excess fat 
deposits determines the level of risk in getting these metabolic disorders (Gesta et al. 
2006). 
Now named as playing a fundamental role in metabolism, adipose tissue is 
considered a target for novel therapies for the treatment of obesity and related metabolic 
disorders including diabetes and atherosclerosis (Camp et al. 2002). In adult mice, BAT 
secretes less cytokines and adipokines compared with WAT. Lefterova and Lazar 
(2009) suggest that changing adipocytes from white to brown might be a method of 
treating obesity as brown adipocytes are also involved in lipid oxidation (Farmer 2008).  
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The quantification of adipogenesis is much less detailed in relation to other 
developmental systems. In general there is still a great deal to be understood in terms of 
development of fat, in particular the recently detected dermal fat layer and early 
adipogenesis (initiation). Microarray data has suggested a number of factors to be 
upregulated during the process and some variation from that known from in vitro 
studies (Soukas et al. 2001). However, whether these are specific to fat development or 
indirectly involved via hair follicle or blood vessel development is yet to be 
determined? 
It is clear that a significant number of signalling pathways and molecules 
influence adipogenesis and cause transcriptional events to occur, many of which are still 
being discovered. PPARγ and C/EBPα are just two of many factors involved. Not only 
are transcription factors involved but there is also the potential for the involvement of 
microRNAs, hair follicles and the development of blood vessels (angiogenesis).  
 
1.9. Thesis Aims 
 
From the recent knowledge of the existence of a distinct adipose depot in the 
lower dermis of the skin separate from the subcutaneous compartment, the focus of this 
study was on this dermal adipose layer and to further our knowledge on adipogenesis in 
rodent back skin. More specifically, the work aimed to investigate the developmental 
question of when the cells become committed to becoming adipocytes in rodents and 
what causes these cells to become committed. Why is it only the lower dermal cells that 
undergo adipogenesis?  
Chapter 2 followed on from the work carried out by Wojciechowicz (2013) in 
the host laboratory. She produced microarray data of the upper and lower dermis of 
mouse back skin. This chapter aimed to analyse further what can be found out about the 
molecular basis of adipogenesis in the dermal adipose layer. The expression of one gene 
previously implicated in adipogenesis (G0/G1 switch gene 2), flagged up in these 
microarrays was also investigated. 
Late adipogenesis involving the differentiation of adipocytes is well defined 
compared with early adipogenesis (Gesta et al. 2006). The genetics of how many and in 
which way the stem cells become committed to the adipocyte lineage is not as well 
classified, thus need to look earlier to see at which stage influence development. One 
major factor widely recognised as crucial to adipogenesis in vitro and in vivo is PPARγ. 
	   33	  
The PPAR receptors are now considered important therapeutic targets. They are key in 
the regulation of adipogenesis and the lipid balance. Therefore, by looking in detail at 
the roles of these receptors, efficient treatments for metabolic disease is a viable option 
(Evans et al. 2004). There is still much speculation into the role PPARγ plays in early 
adipogenesis, because there are differences between in vitro and in vivo studies. Chapter 
3 aimed to further elicit the importance of PPARγ in early adipogenesis in expression 
studies. 
As the dermal adipose layer is recent in discovery, this project focused on 
developing our understanding of this layer in rodents. It can be difficult to study the 
effects of many molecules via overexpression and knockout studies because these often 
have lethal effects. Studies involving conditional ablation may be difficult if specific 
promoters are not known. There is therefore a need for in vivo-like models to be created. 
A major part of this project involved the development of a suitable model system to 
study adipogenesis (Chapter 4). The overall aim was to investigate the role of key 
signalling pathways in dermal adipogenesis (Chapter 5). To do this an experimental 
model was required; this model system was then used to investigate the signalling 
pathway question. 
It is also important to investigate how signalling from developing skin or hair 
follicles stimulates the production of dermal fat. It is not yet known why it is only the 
lower dermis and not the upper dermis that develops into fat and at what point the lower 
dermal cells become committed to the adipocyte lineage? The microarray data used in 
chapter 2 was in fact from e17 to e19. However, it is thought that adipocytes start to 
develop even earlier (Wojciechowicz et al. 2013; Driskell et al. 2013). The work in 
chapters 4 and 5 looked at developing a suitable model system at e16.5 and conducting 
signalling pathway analysis at this age. The main hypothesis was therefore that 
commitment to the adipocyte lineage starts earlier than e17 and so more influence on 
the development of adipocytes should be observed earlier than e17. FABP4 labelling of 
the lower dermis has suggested that it has already separated from the upper dermis by 
e16, though it may be that differences develop even earlier in association with hair 
follicle initiation. E14.5 3-dimensional culture was also investigated to determine 
whether there were differences between e14.5 and e16.5 and adipogenesis starts earlier.  
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2.1. Introduction 
 
           Many stages of development, in particular those that occur earlier, are not visible 
morphological changes, but instead occur at the molecular level, i.e. gene expression. 
There are a number of different genes, which correspond to a complex network of 
responses, involved in adipogenesis. The basic process involves fibroblast-like 
preadipocytes differentiating into adipocytes containing lipid-droplets and this involves 
a transcriptional cascade (Lefterova and Lazar 2009; Siersbæk et al. 2012) A complex 
array of factors regulate the development of adipocytes. The genetic reprogramming in 
adipogenesis includes a number of transcription factors, and is also affected by 
hormones, cytokines and nutrients (Fève 2005). Several signalling pathways have been 
implicated in adipogenesis including the BMP pathway and the EGF/EGFR pathway 
(Chapter 5).  
Throughout research into adipogenesis, some genes have been recognised as the 
main regulatory genes. Those crucial to adipogenesis and referred to as the master 
regulators include CCAAT/enhancer-binding proteins (C/EBPs) and the nuclear 
receptor, peroxisome proliferator-activated receptor gamma (PPARγ) (Gregoire et al. 
1998; Farmer 2006). There are also other factors that have been found important more 
recently, including Krüppel –like factors (KLFs) (Banerjee et al. 2003; Birsoy et al. 
2008; Siersbæk et al. 2012), Krox20 (Chen et al. 2005), Wingless, INT-1 proteins 
(Wnts) and cell-cycle proteins (Lefterova and Lazar 2009). Siersbæk et al. (2012) show 
the existence of hotspots in the chromatin where several transcription factors bind, 
which suggests that the factors talk to each other and influence each other’s behaviour. 
For example, KLF4 and Krox20 interact with each other (Lefterova and Lazar 2009). 
There are two main waves of transcriptional activity in adipogenesis (Siersbæk 
et al. 2012). The first wave is thought to involve early factors including C/EBPβ/δ, 
KLFs, cAMP response element binding protein (CREB), early growth response 2 
(Krox20) and sterol regulatory element binding protein 1c (SREBP-1c) (Siersbæk et al. 
2012). The second wave fundamentally involves PPARγ and C/EBPα (Siersbæk et al. 
2012).  
 
2.1.1. Late Adipogenesis 
 Late adipogenesis is better characterised than early adipogenesis. PPARγ2 is 
expressed late in adipogenesis. First C/EBPβ binds to PPARγ binding sites and this 
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could mean that it aids the binding of PPARγ (Siersbæk et al. 2011; Siersbæk et al. 
2012). Many hotspots of transcription factors exist close to the PPARγ, which suggests 
the involvement of many pathways in inducing PPARγ (Siersbæk et al. 2011; Siersbæk 
et al. 2012). PPARγ is discussed further in Chapter 3. C/EBPβ as well as being 
expressed during early adipogenesis, is also present in mature adipocytes (Lefterova et 
al. 2008; Siersbæk et al. 2012). C/EBPα/β or PPARγ in mature adipocytes are required 
for the maintenance of adipogenic genes  (Lefterova et al. 2008) and they interact with 
each other. PPARγ and C/EBPα activate adipogenic genes, which enables the terminal 
differentiation of adipocytes (Fève 2005). 
 
2.1.2. Microarrays 
There are many techniques used to look at the role of certain genes throughout 
development. These include the use of in vitro preadipocyte cell lines and mesenchyme-
derived precursor cells as well as knockout mouse models (Farmer 2006). 
 Most of the research into the molecular basis of adipogenesis has been 
investigated using in vitro cell lines or primary cell cultures (Siersbæk et al. 2012). 
However, more recently in vivo-type studies, ‘global approaches’ have been deemed 
necessary to confirm the molecular mechanisms, because there are microarray 
differences between in vivo and in vitro (Wojciechowicz 2012). Much interaction 
between transcription factors has shown the integration of signalling pathways 
(Siersbæk et al. 2012).  
Microarrays have been conducted for a number of different tissue types. They 
are a way of finding out with factors are expressed during a developmental process. 
Wojciechowicz (2012) in the Jahoda lab produced microarrays from the dermis to study 
fat development in the skin. These were from embryonic day 17 (e17), e18 and e19. 
While analysis was conducted on the lower dermis to observe those genes that were 
significantly upregulated and hence might be important in adipogenesis, little was 
looked at in terms of the upper dermis. Do preadipocytes become committed via a 
positive or negative signal, i.e. are certain fat-related genes switched off in the upper 
dermis or are certain fat-related genes switched on in the lower dermis? As well as this, 
the microarrays could now be taken back earlier, because it is considered adipogenesis 
starts earlier. 
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Expression profiling through microarray analysis has aided the discovery of 
many factors involved in adipogenesis (Soukas et al. 2001; Farmer 2006). Krox20 
(Egr2), being one such early factor is involved in C/EBPβ activation (Farmer 2006). 
 
2.1.3. The C/EBP Family 
The CCAAT enhancer binding protein family includes C/EBPα, -β and -δ. 
Mouse models showed the importance of these genes in adipogenesis (Wang et al. 
1995). Abnormal fat development occurs when C/EBP genes have been deleted. For 
example, homozygous deletion of C/EBPα in mice resulted in lipid accumulation 
failure in adipocytes and decreased expression of the adipose tissue marker, UCP-1 
(Wang et al. 1995). Members of the C/EBP family not only play a role in embryonic 
development but also in the maintenance of mature adipocytes. 
Knocking out C/EBPα in the whole body leads to early fatality of the newborn 
mice (Wang et al. 1995; Lefterova and Lazar 2009). However, when rescued, there was 
still no WAT, but BAT is present. Removing C/EBPα in adult mice caused a reduction 
in WAT (Mandrup and Lane 1997; Wu et al. 1999; Yang et al. 2005; Lefterova and 
Lazar 2009). It is more important for WAT formation, compared with BAT (Linhart et 
al. 2001; Farmer 2006). Many promoters of adipocyte-specific genes have binding sites 
for C/EBPα (Mandrup and Lane 1997). C/EBPα is needed for adipocyte differentiation 
as shown when its anti-sense RNA was expressed in 3T3-L1 preadipocyte cells (Lin and 
Lane 1992; Mandrup and Lane 1997). This resulted in the prevention of differentiation 
and also the blocking of its own expression, which suggests C/EBPα may also be 
required for maintenance of the differentiated state (Mandrup and Lane 1997). C/EBPα 
is also thought to induce the arrest of mitotic activity of the preadipocytes, while 
C/EBPβ and C/EBPδ are expressed in the dividing cells (Mandrup and Lane 1997). 
C/EBPβ has a higher adipogenic potential than C/EBPδ (Mandrup and Lane 1997). 
C/EBPβ and C/EBPδ are thought to be transcriptional activators, which act earlier in the 
developmental process than C/EBPα (Lefterova and Lazar 2009). CEBPα involved in 
terminal differentiation of adipocytes (Gerhold et al. 2002). C/EBPβ is needed to induce 
PPARγ and C/EBPα (Farmer 2006; Lefterova and Lazar 2009). CEBPs also have a later 
role maintaining mature adipocytes (Darlington et al. 1998). 
C/EBPβ is involved in adipogenesis both in vivo and in vitro (Siersbæk et al. 
2012). Profiling of C/EBPβ binding shows that before differentiation is induced it binds 
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with many chromatin regions, thus it may actually be involved early in preadipocytes 
(Siersbæk et al. 2011; Siersbæk et al. 2012).  
Using a mouse model which does not have C/EBPβ, Tanaka et al. (1997) have 
shown that the embryonic fibroblast cells have decreased adipogenic capabilities and 
those cells derived from C/EBPβ and -δ double knockouts are unable to differentiate 
into mature adipocytes (Fève 2005). 
 
2.1.4. The PPAR Family 
Three main subtypes exist within the peroxisome proliferator-activated receptor 
family. PPARγ, PPARα and PPARδ, also known as PPARβ exhibit high similarity in 
their amino acid sequences (Kliewer et al. 1995; Mandrup and Lane 1997). These 
receptors bind with retinoid X receptors (RXRs) to PPAR responsive elements (PPREs) 
(Mandrup and Lane 1997; Michalik et al. 2002). 
The nuclear receptor, PPARγ has been found to be necessary for adipogenesis 
both in early differentiation and later maintenance of mature adipocytes (Rosen et al. 
1999; Gesta et al. 2007) and this in particular is looked further in chapter 3. 
Thiazolinedone (TZD) drugs used to treat diabetes target PPARγ (Lehman et al. 1995; 
Mandrup and Lane 1997; Lefterova et al. 2008). Out of the three subtypes, PPARγ is 
the most adipogenic-specific, highly expressed in adipose tissue and rarely found to be 
expressed in other tissues, as shown by ectopic expression in NIH 3T3 cells (Brun et al. 
1996; Mandrup and Lane 1997). The fundamental value of PPARγ is true of both in 
vitro and in vivo studies (Farmer 2006). 
PPARα and PPARβ/δ are also thought to some extent to play a role in 
adipogenesis (Evans et al. 2004), though in vivo they are distributed differently and 
expressed to different degrees by activation of different ligands (Mandrup and Lane 
1997). PPARδ is expressed in adipose tissue, though precisely when is unclear 
(Mandrup and Lane 1997). PPARα is more highly expressed in brown adipose tissue 
than white adipose tissue (Kliewer et al. 1995, Mandrup and Lane 1997). 
PPARγ is thought to control and trigger the expression of many adipose-related 
genes. Development of brown fat requires a number of extra molecular factors. These 
include peroxisome proliferator-activated receptor γ coactivator 1 (PGC1) and PRDM16 
(Spiegelman 2013). Also uncoupling protein 1 (UCP1) is crucial to brown fat 
development. Its expression causes increased energy expenditure of brown adipocytes 
(Gray et al. 2006). UCP1 expression is regulated by PPARs as well as other important 
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regulators, including CEBP family members. The PPARs associate with a PPAR 
response element in the promoter of UCP1 (Sears et al. 1996; Gray et al. 2006).  
 
It is also important to note that PPARγ interacts with the C/EBP family during 
adipogenesis. PPARγ and C/EBPα are considered the master regulators of adipogenesis 
(Rosen et al. 2002; Farmer 2006). While C/EBPα cannot work alone without PPARγ, 
PPARγ can allow adipocyte development in the absence of C/EBPα (Rosen et al. 1999; 
Farmer 2006). Together PPARγ is expressed upstream of C/EBPα but downstream of 
CEBPβ. There is a degree of colocalization between C/EBPα and PPARγ and 60% of 
genes upregulated in adipogenesis are bound by both factor (Lefterova et al. 2008; 
Lefterova and Lazar 2009). PPARγ expression can recover adipogenesis in C/EBPα-
deficient MEFs (Rosen et al. 2002; Lefterova and Lazar 2009). The exact role and 
interaction between these major regulators is largely unknown. It could be a question of 
compensation, because of the importance of adipose tissue to survival. 
C/EBPα and PPARγ interact with each other during development. While the 
knockout animals are embryonic lethal, heterozygous PPARγ knockouts show reduced 
C/EBPα expression and C/EBPα null mice show reduced PPARγ expression (Barak et 
al. 1999; Wu et al. 1999; Fève 2005). However, while overexpressing PPARγ2 in 
C/EBPα null embryonic fibroblast cells can re-establish adipogenesis, opposingly 
overexpressing C/EBPα in PPARγ null embryonic fibroblasts cannot (Wu et al. 1999; 
Rosen et al. 2002; Fève 2005). Fève (2005) suggests that PPARγ2 may therefore be key 
while C/EBPα may just be required to maintain PPARγ2 expression, but they are both 
essential. 
C/EBPβ and C/EBPδ are first expressed after hormonal induction (Cao et al. 
1991; Farmer 2006; Mandrup and Lane 1997). It is then thought that C/EBPα and 
PPARγ are activated. C/EBPα then maintains its own expression allowing the continued 
expression of many adipogenic genes needed in terminally differentiated adipocytes 
(Mandrup and Lane 1997). As well as this, PPARγ also interacts with C/EBPα to 
activate each other’s expression (Wu et al. 1999; Farmer 2006). 
Many experiments have shown conflicting results. For example mice that don’t 
express C/EBPβ and C/EBPδ still express C/EBPα and PPARγ but adipose tissue 
formation is incapable of developing correctly (Tanaka et al. 1997). This may be 
because of the importance of C/EBPα and PPARγ in adipogenesis that alternative 
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means of activating them can occur when C/EBPβ and C/EBPδ activity has been 
inhibited (Farmer 2006).  
 
2.1.5. Cell Cycle Proteins  
 It is thought that proliferation occurs prior to differentiation, since cells are 
induced to conduct adipogenesis when they are in a state of confluency (Farmer 2006). 
This is known as the mitotic clonal expansion step. When the proliferation step is 
inhibited, adipogenesis cannot occur which suggests it is necessary for the activation of 
adipogenic genes (Tang et al. 2003; Farmer 2006). After this the cell-cycle arrests. G0 
to G1 cell cycle switch due to contact inhibition (Otto and Lane 2005; Lefterova and 
Lazar 2009).  
Cell cycle proteins implicated in adipogenesis include D-type cyclins, cyclin-
dependent kinases 4 and 6 (Cdk4/6), retinoblastoma family (Rb), p107 and p130 
(Farmer 2006). The E2F family is highly recognised for its role in adipogenesis as cell 
cycle proteins (Farmer 2006). Krox20 has also been implicated in the reintroduction of 
preadipocytes into the cell cycle (Farmer 2006). 
 
2.1.6. KLFs 
KLFs are zinc-finger transcription factors whose functions include both stimulatory and 
inhibitory functions (Lefterova and Lazar 2009). For example, KLF6 and KLF15 are 
also involved in inducing adipogenesis (Li et al. 2005; Mori et al. 2005; Farmer 2006; 
Lefterova and Lazar 2009). Contrastingly, KLF2 suppresses adipogenesis (Wu et al. 
2005; Famer 2006). This was found when KLF2 was overexpressed in 3T3-L1 cells 
(Wu et al. 2005; Lefterova and Lazar 2009). 
 These KLFs also interact with PPARγ and C/EBP family members. KLF4 
important early on in differentiation transactivates C/EBPβ (Birsoy et al. 2008; 
Lefterova and Lazar 2009). C/EBPβ and C/EBPδ act together with KLF5 on the 
PPARγ2 promoter and mice with KLF5 knocked out exhibit adipose tissue deficiency 
(Oishi et al. 2005; Farmer 2006; Lefterova and Lazar 2009). KLF15 also acts alongside 
the CEBP family with C/EBPα (Mori et al. 2005; Lefterova and Lazar 2009). 
 
2.1.7. G0-G1 Switch Gene 2 
The G0/G1 switch gene 2 (G0S2) has been implicated in adipogenesis. It 
directly inhibits the lipolytic enzyme, adipose triglyceride lipase (ATGL) (Yang et al. 
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2010; Heckmann et al. 2013) and is thought to be inhibiting proliferation and holding 
the stem cells quiescent (Heckmann et al. 2013), acting as a tumour suppressor gene. In 
mouse 3T3-L1 and human SGBS (Simpson-Golabi-Behmel syndrome) preadipocytes, 
G0S2 mRNA and protein expression increased as cell growth ceases prior to terminal 
differentiation of preadipocytes (Zandbergen et al. 2005; Heckmann et al. 2013). The 
SGBS cell line, originating from an SGBS patient’s adipose tissue, alongside mouse 
3T3 cells are useful tools in the study of adipogenesis (Fischer-Posovszky et al. 2008).  
G0S2 was found influenced by bone morphogenetic protein 2 (Bmp2) in mouse 
embryos (Bachner et al. 1998; Heckman et al. 2013).   
Jahoda’s laboratory previously flagged up G0S2 expression in the adipose 
microarrays as a potential marker of adipocyte development. G0S2 mRNA expression 
was found in both the upper and lower dermis (Wojciechowiz et al. 2013). At e18.5, 
G0S2 expression is limited to brown and white adipose tissue and also later in adult 
adipose tissue (Cristillo et al. 1997; Zandbergen et al. 2005; Heckmann et al. 2013). 
This chapter aimed to investigate in more detail the role of G0S2. It is unclear whether 
G0S2 actively prevents cell cycle continuation.  
Transactivation, gel shift and chromatin immunoprecipitation assays show that 
G0S2 is a direct target of PPARγ (Zandbergen et al. 2005). Thus if it is found to be 
crucial to adipogenesis, it could be a useful marker of PPARγ activity and late adipocyte 
development.  
 
2.1.8. Other Factors 
There are significant number of transcription factors involved in adipogenesis; 
not just those discussed above but also many others. These include aP2, Hsl, 
glucocorticoids, STAT proteins and also clock proteins, e.g. brain and muscle amt-like 
protein 1 (Bmal1), sterol regulatory element-binding transcription factor 1 (SREBP1) 
and Rev-erba (Lefterova and Lazar 2009; Siersbæk et al. 2011). Ectopically expressing 
a dominant negative of SREBP-1c inhibits preadipocyte differentiation and conversely 
overexpressing SREBP-1c leads to increased adipogenesis (Kim and Spiegelman 1996; 
Farmer 2006).  
Glucocorticoids are clearly important in inducing adipogenesis in vitro, but their 
roles in vivo still remain vague (Siersbæk et al. 2011). STAT5A and glucocorticoid 
receptor (GR) are present in many of the same chromatin regions (Siersbæk et al. 2011) 
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Expressing STAT5A leads to adipocyte differentiation and activation of PPARγ in 
fibroblasts not originally adipogenic (Floyd and Stephens 2003; Farmer 2006). 
There are a number of known inhibitory factors of adipogenesis, which are 
increasingly suppressed during differentiation (Farmer 2006). For example, the 
forkhead transcription factor, FoxO1. This is suppressed by insulin, which also induces 
SREBP-1c activity (Farmer 2006). Some of the KLFs as mentioned in section 2.1.6, e.g. 
KLF2 also have an inhibitory effect on adipogenesis. Interferon-regulatory factors 
(IRFs) e.g. IRF3 and IRF4 suppress differentiation (Eguchi et al. 2008; Lefterova and 
Lazar 2009) as well as GATA-binding proteins 2 and 2, which also prevent terminal 
differentiation of preadipocytes (Rosen and MacDougald 2006; Lefterova and Lazar 
2009). 
Microarray data showed that the molecular mechanisms of adipogenesis are 
complex. As well as these, extracellular signals including growth factors can influence 
adipogenesis including bone morphogenetic proteins (BMPs) and fibroblast growth 
factors (FGFs), many of which are discussed in chapter 5 on signalling pathways. 
 
A lot of research has been conducted recently into the control of adipogenesis in 
terms of preadipocyte differentiation into terminal adipocytes. Thus, much more is 
understood about the molecular mechanisms of late adipogenesis in comparison with 
early adipogenesis from the commitment of stem cells. It has also been considered that 
different fat depots develop in different ways, which is why it is important to study each 
depot. In this case, the focus is on the newly identified dermal fat layer, which is 
separate from the subcutaneous fat layer beneath the skin.  
This chapter aimed to elucidate further the dermal adipose layer in terms of the 
molecular mechanisms involved. Genespring was used to produce microarrays of the 
upper dermis to investigate the potential of any inhibitors of adipogenesis. The 
microarrays were already analysed for the lower dermis to investigate the normal 
adipogenic pathway, but whether the upper dermis microarrays showed any potential 
influences on the adipogenic process was never investigated. 
The G0/G1 switch gene 2 (G0S2) present in the arrays list was also investigated 
by immunofluorescence analysis. This was to look at the role and expression of (at the 
time) a relatively under-investigated gene involved in adipogenic differentiation in the 
novel adipogenic depot in mouse skin dermis. 
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2.2. Materials and Methods 
 
2.2.1 Microarray Analysis 
 
2.2.1.1 Use of GeneSpring® GX11.0 Software to generate Upper Dermis Microarray 
Data 
The microarray samples were prepared by Kamila Wojciechowicz at Durham 
University (UK) and Mouse Genechips 430 2.0 (Affymetrix) were used to generate the 
data. Three different embryonic ages were used: e17, e18 and e19 and three samples of 
the upper dermis from each age (Table 2.1). 
 
Table 2.1: Upper Dermis Samples used from the Array Data for the 3 Different 
Embryonic Ages 
Embryonic age 17 18 19 
KW1 K1 K1I 
KW3 K3 K1II Samples 
KW5 K5 E1-19 
 
GeneSpring was used to normalise the data and create a comparison of the 
samples from the three different ages by ANOVA. 
The workload type was selected as ‘Biological Significance’ and then the data 
was loaded. 3 parameters were selected by time point e17, e18 and e19 and the 
statistical test chosen was the Analysis of Variance (ANOVA). To select significant 
genes, the p-value was set at 0.05. These significant genes were then filtered on a fold 
change of 2. 3 microarray lists were created comparing the upper dermis at e17 against 
e18 and e19 and also comparing e18 with e19.  
 
2.2.1.2. GEDI Analysis 
The Gene Expression Dynamics Expector (GEDI) (Version 2.1) was used to analyse 
expression profiles. The generated comparison lists were used to input into GEDI. 
Normalised not raw values were generated and imported into an Excel Document 
(Microsoft). It was then modified for use in GEDI (Figure 2.1). Cell A1 contained 
‘⎬Static’, B1 ‘DESC’ and D1 showed the total number of data sets ‘45101’. What was 
compared was entered in E1, ‘E17vsE18vsE19’ and A2 contained ‘⎬$’. ‘DESC’ 
replaced gene symbol in B2. Probe set IDs and the corresponding fold changes were 
entered under these headings, as shown in Figure 2.1. 
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The document was then saved as a text file and input into GEDI which produced 25 x 
26 square grids based on trends. 
 
2.2.2. Immunofluorescence Analysis of G0S2 
G0S2 was investigated in mouse back skin, both embryonic (e14.5, e16.5 and 
e18.5) and postnatal (0-3 hours, 1-day and 3-days), obtained from mice from timed 
matings as described in section 3.2.2.1. 
 Skin cut from the back of each specimen was rolled or orientated flat and put 
into Tissue-Tek® O.C.T.™ compound (Sakura, Agar Scientific, Netherlands), then snap 
frozen in liquid nitrogen and kept at −80°C. Skin sections (7 µm), were cut on a cryostat 
(LEICA CM 3050S) and attached to ColorFrost®Plus slides (Thermo Shandon Ltd, 
Cheshire, UK). The slides were dried for 2 hours at room temperature, and then used for 
immunofluorescence staining.  
 Slides were fixed in 4% PFA (Appendix I) for 15 minutes, rinsed in PBS 
(Appendix I) and then permeabilised in 0.2% Triton-X for 15 minutes. The slides were 
then washed again in PBS for 3 minutes and blocked in 10% donkey serum for 1 hour. 3 
x 5 minutes washes were conducted in PBS before the slides were incubated overnight 
at 4°C with the primary antibody against G0S2 (1:100, rabbit polyclonal from 
Proteintech). 3 x 5 minutes washes were conducted and then the slides were incubated 
with a fluorescent secondary donkey anti-rabbit antibody (1:500) for 1 hour at room 
temperature. 3 more PBS washes were conducted and then the slides were mounted in 
vectashield and coverslipped and stored in the dark at 4°C. All the incubation steps 
were conducted in the dark in a humidity chamber.  
 
2.3. Results 
 
2.3.1. Microarray Analysis 
Data from three samples of 3 different ages from the upper dermis was inputted 
into GeneSpring to produce 3 different microarray lists. Under 2-fold there was a high 
Figure 2.1: Screenshot to show the formatting for GEDi analysis 
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number of results produced. E17 compared with E18 produced 2526 results, E17 
compared with E19 produced 3203 results and E18 compared with E19 produced 173 
results. This was significantly lower by E19. The data was input into GEDI to 
investigate clusters. There was variability found in samples from the same age, e.g. for 
e17, 2 GEDI maps looked similar but the third was different (Figure 2.2). This was 
unreliable because the data sets produced different results. Therefore, one data set from 
each age was removed and the data was re-entered into GEDi (Figure 2.3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Removing one from each, showed more similar clusters. These were then used 
to observe a cluster, early in e17. There were more genes expressed between e17 and 
e18 and more similarities between e18 and e19.  
 
Figure 2.2: Analysis of Microarray Data of the Upper Dermis using GEDI. 3 different 
ages shown and 3 samples from each. GEDI maps, showing clusters of upregulation and 
downregulation in 25 by 26 grids.  
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Upon analysing the microarray lists, a few genes were flagged up. For example, 
SPARC-like 1. This gene was present in the lower right corner of the GEDI maps, 
where it is clear the expression changes from blue to red, high to low (Figure 2.3). This 
was downregulated significantly 5.31 fold change between e17 and e18 and more so 
7.22 fold change by e19 from e17, suggesting early involvement. Osteoglycin and 
Calmodulin 1 were also down regulated from e17 and e19 (Table 2.2). Serine racemase 
conversely is unregulated more than 10 fold between e17 and e19.  
 
Table 2.2: Four genes expressed more than 2 fold in upper dermis microarrays 
Gene Title  Gene Symbol FC e17 vs e18 FC e18 vs e19 FC e17 vs e19 
SPARC like 1 SPARCl1 -5.308625 - -7.2157235 
Serine racemase Srr 4.7332816 2.1253738 10.126023 
Osteoglycin Ogn -3.4252784 -3.1587124 -10.819469 
Calmodulin 1 Cal1 -5.282315 - -4.6968126 
‘-‘ represents downregulation 
 
2.3.2. G0/G1 Switch Gene 2 (G0S2) 
 
2.3.2.1. Postnatal Mouse Back Skin 
 The antibody was a sample, kindly donated by Proteintech, Europe which was 
tested first in postnatal mouse skin, to observe the working capability of the antibody 
and the presence of G0S2 in the skin. After 0 to 3 hours, the skin showed labelling of 
Figure 2.3: Analysis of Microarray Data of the Upper Dermis using GEDI. 3 different 
ages shown and 2 samples from each. GEDI maps, showing clusters of upregulation and 
downregulation in 25 by 26 grids.  
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G0S2 in the skin dermis, under the base of the follicles, where adipocytes form (Figure 
2.4). The labelling of G0S2 was speckled through the cells. 
 
 
 
 
 
After 1 day (1dN), newborn mouse back skin showed positive labelling of 
G0S2, particularly around the base of the hair follicles (Figure 2.5E), but also there was 
a degree of positive labelling in the upper dermis (Figure 2.5C). A similar distribution 
was also seen in 3-day mouse back skin with a few cells labelled in the upper dermis, 
but also still present around the follicles (Figure 2.6). Negative controls were conducted 
by omitting the G0S2 antibody incubation step, but still incubating with the fluorescent 
secondary antibody to show, if present, the level background fluorescence. 
Figure 2.4: Analysis of G0S2 (Proteintech) expression in 0-3 hour newborn mouse back 
skin. Sections cut at 7µm, stained with an antibody against G0S2 and counterstained with 
DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of G0S2. (A,B) Magnified cells show speckled labelling Fluorescent 
images were taken using a Zeiss Axio Imager M1. Base of hair follicles labelled (arrows). 
(A,B) scale bar = 12µm. (C,D) scale bar = 40µm.   
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Figure 2.5: Analysis of G0S2 (Proteintech) expression in 1-day newborn mouse back 
skin. Sections cut at 7µm, stained with an antibody against G0S2 and counterstained with 
DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of G0S2. (A,B) Controls showing no fluorescently labelled G0S2 
expression. (C-E) labelled using G0S2 primary antibody. Inset shows a magnified image of 
the positive G0S2 labelling in cells.  Hair follicles in the skin labelled, demonstrating their 
position (arrows). Fluorescent images were taken using a Zeiss Axio Imager M1. (A-D) scale 
bar = 40µm. (E) scale bar = 15µm. 
 
 
. 
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Figure 2.6: Analysis of G0S2 (Proteintech) expression in 3-day newborn mouse back 
skin. Sections cut at 7µm, stained with an antibody against G0S2 and counterstained with 
DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of G0S2. (A-C) Controls showing no fluorescently labelled G0S2 
expression. (D-F) labelled using G0S2 primary antibody. Positive G0S2 expression 
highlighted (white squares). Fluorescent images were taken using a Zeiss Axio Imager M1. 
(A-E) scale bar = 40µm. (F) scale bar = 15µm.  
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2.3.2.2. Embryonic Mouse Back Skin 
 Going back to embryonic day 18.5, G0S2 was expressed in the developing 
embryonic skin (Figure 2.7). 
 
 
 
 
 
 
Figure 2.7: Analysis of G0S2 (Proteintech) expression in 18.5-day embryonic mouse back 
skin. Sections cut at 7µm, stained with an antibody against G0S2 and counterstained with 
DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of G0S2. (A) Control showing no fluorescently labelled G0S2 
expression. (B-E) labelled using G0S2 primary antibody. G0S2 labelled cells shown (arrows). 
Fluorescent images were taken using a Zeiss Axio Imager M1. (A-D) scale bar = 40µm. (E) 
scale bar = 15µm.  
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 In comparison with the background staining shown in the negative controls, 
there were some G0S2 labelled cells present in the lower dermis of the skin at e18.5 
(Figures 2.7B and C). However, earlier in e16.5 (Figure 2.8) and also e14.5 (Figure 
2.9), there were no positively labelled cells for G0S2 detected, which suggested, it acted 
from around e18.5.  
Figure 2.9: Analysis of G0S2 (Proteintech) expression in 14.5-day embryonic mouse back 
skin. Sections cut at 7µm, stained with an antibody against G0S2 and counterstained with 
DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of G0S2. (A) Control showing no fluorescently labelled G0S2 
expression. (B) labelled using G0S2 primary antibody. Fluorescent images were taken using a 
Zeiss Axio Imager M1. Scale bar = 40µm. 
 
 
. 
Figure 2.8: Analysis of G0S2 (Proteintech) expression in 16.5-day embryonic mouse back 
skin. Sections cut at 7µm, stained with an antibody against G0S2 and counterstained with 
DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of G0S2. (A) Control showing no fluorescently labelled G0S2 
expression. (B) labelled using G0S2 primary antibody. Fluorescent images were taken using a 
Zeiss Axio Imager M1. Scale bar = 40µm. 
 
 
. 
	   52	  
2.4. Discussion 
 
2.4.1. Microarray Analysis 
 Microarray analysis was previously conducted to investigate the lower dermis 
and compare the upper and lower dermis (Wojciechowicz 2012), but microarray lists 
were not created to look at a comparison across the ages in solely the upper dermis. 
There were significantly more highly expressed genes between e17 and e18 and e17 to 
e19 compared with between e18 and e19. This suggests that most of the signalling that 
occurs in development of the upper dermis takes place earlier, around e17, potentially 
e16 or even e14 though dermis microarrays had not been developed this early.  
 GEDI analysis showed that there were differences in the expression profiles 
within the upper dermis at one age. Either this makes the data sets unreliable or it could 
show that the expression varies in different areas of the upper dermis. For example, 
there may be different genes detected near the epidermis in comparison with near the 
lower dermis as different cells are developing. It could also be that the sample point is 
where a developing follicle is and so the expression profiles are more related to the 
developing follicle than interfollicular dermal cells. 
The thought is that in actual fact, because the depots and more recently the 
dermal adipose layer have been found of different developmental origins that gene 
expression may in fact differ between depots. Macotela et al. (2012) found that when 
adipocyte precursor cells were taken from different depots, both subcutaneous and 
visceral, they had contrasting patterns of gene expression. It may be important to 
characterise gene expression for each depot. This chapter aimed to characterise potential 
inhibitory adipogenic signals of the upper dermis in relation to the dermal adipose 
depot. 
 Four genes of interest were selected that showed significant differences in 
expression across the three ages in the upper dermis. SPARC (Secreted protein, acidic, 
cysteine-rich) like 1 (SPARCl1) was found to be significantly downregulated between 
e17 and e18 and further by e19. It could be suggested that this gene is required to inhibit 
adipogenesis in the upper dermis before the cells differentiate. Like SPARC, its name 
suggests that it may also be associated with inhibiting adipogenesis. Liu and colleagues 
(2014) found that SPARCl1 was expressed in the Visceral Stromal-Vascular Fraction 
(SVF) and therefore expressed visceral, but not subcutaneous. Perhaps it is also 
expressed in the dermis, but not the subcutaneous adipose tissue, separating its 
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functioning in the skin. This may be a signal of inhibition in the upper dermis. This is 
an interesting idea, but one that requires experimentation to observe what occurs in the 
upper dermis when SPARCl1 expression is removed, e.g. by a knockout mouse model. 
Potentially it is already expressed before e17. 
 Comparatively, serine racemase was upregulated between e17 and e19. Serine 
racemase is involved in the regulation of insulin and glucagon release and therefore 
Type 2 diabetes (Tsai et al. 2010). This regulation may be associated with its 
upregulation in the upper dermis later than adipocytes are suggested to develop, thus it 
may be maintaining upper dermal cells in a non-adipogenic state. As more adipogenic 
signals start to influence the dermis, e.g. C/EBPα around e18, this serine racemase 
becomes more highly expressed in the upper dermis to prevent adipocyte differentiation 
from occurring. Chapter 4 shows that dermal cells are capable of differentiating into 
adipocytes in cell spheres from as early as e14.5, so perhaps the upper dermis requires 
an inhibition of the adipogenesis signal. If serine racemase expression was removed 
from the upper dermis would it lead to adipogenesis throughout the dermis or would 
overexpression in the lower dermis inhibit adipocyte formation? These are foundations 
for interesting experiments in relation to serine racemase. For example, to test this 
hypothesis, serine racemase could be downregulated or inhibited in the upper dermis. 
Most of the research found links serine racemase with diabetes but not adipogenesis, so 
this could be an interesting avenue to explore. 
Osteoglycin was downregulated in the microarrays between e17 and e19. 
Insenser et al. (2012) found that osteoglycin expression was increased in obese patients, 
which suggests osteoglycin stimulates or maintains adipocyte formation. The 
downregulation and therefore decrease of osteoglycin in the upper dermis, where no 
adipose tissue develops correlates with this results found by Insenser et al. (2012). 
There is a reduction in positively associated adipocyte factors in the upper dermis 
around the time adipogenesis is occurring. Further work could look at overexpressing 
osteoglycin in the upper dermis to observe if adipocytes can form.   
Calmodulin 1 was also found to exhibit reduced expression between e17 and 
e19. Graves et al. (1985) found that the adipocyte insulin receptor has a calmodulin 
binding domain. Insulin receptor defects are thought to be associated with obesity, 
though the link in humans is not well characterised (Hotamisligil et al. 1995). However, 
a factor associated with insulin could be linked with adipogenesis in the skin, therefore 
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changes in expression of calmodulin 1 in the skin dermis could be an interesting avenue 
to explore, in terms of the regulation of dermal adipogenesis. 
An understanding of the expression profiles of adipocyte development may not 
only help further our understanding of what is involved in adipogenesis, but also might 
enable the identification of some pre-adipocyte markers to help with the study, with the 
aid of earlier microarray studies as well. 
 
2.4.2. G0S2 
G0S2 was found expressed in the dermis in the microarrays and also by 
immunofluorescence staining. G0S2 was not found significantly expressed in the upper 
dermis microarrays, suggesting its importance in the lower dermis development and 
therefore, adipogenesis. Expression in the skin dermis from e18.5 and further in 
postnatal mouse skin was found, which matches that found by Wojciechowicz (2012). It 
was detected in the lower dermis and around the base of the follicles where adipocytes 
develop. This proved positive for the association of G0S2 with adipogenesis, however, 
it was not found to be an early signal. The labelling of G0S2 was speckled in the cells. 
This was similar to that found by Yang et al. (2010).  
At the time that this project was conducted, relatively little was known by way 
of the role of G0S2 in adipogenesis. However, more recently it has been strongly 
implicated in adipogenesis. It has been determined to have an in vivo role, as well as in 
vitro (Choi et al. 2014). Choi et al. (2014) showed that G0S2 knockout mice developed 
with reduced adipose mass. It was found important from mitotic clonal expansion right 
through to terminal differentiation (Choi et al. 2014) and this correlates with the 
findings that G0S2 was expressed in the later ages (section 2.3.2). In pigs, G0S2 was 
found to increase over the course of adipogenesis both in vitro and in vivo (Ahn et al. 
2013). This corresponds with the result that there was more strong antibody labelling in 
the postnatal skin (section 2.3.2). G0S2 is therefore important for adipogenesis and is 
controlled by PPARγ (Choi et al. 2014), which is highly implicated in adipogenesis. 
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CHAPTER 3 
PPARγ: What does it really do? 
In Vitro and In Vivo 
Immunofluorescence Analysis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   56	  
3.1. Introduction 
 
3.1.1. Structure and Function of PPARγ  
 Peroxisome proliferator-activated receptor gamma (PPARγ) is a member of the 
nuclear hormone receptor superfamily and is a ligand-activated transcription factor 
(Mandrup and Lane 1997; Michalik et al. 2002; Lehrke and Lazar 2005; Lefterova and 
Lazar 2009). There are other PPARs, including PPARβ/δ and PPARα. PPARβ/δ has 
been found to be upregulated in the early stages of adipogenesis and is required to 
initiate PPARγ and other genes in the process. PPARγ has four main domains: the DNA 
binding domain (C domain), the ligand-binding domain (E/F domain), the hinge region 
(D domain) and the N-terminal domain (A/B domain) (Michalik et al. 2002). The E/F 
domain is involved in the ligand-dependent receptor function, while the A/B domain is 
involved in the ligand-independent receptor function (Michalik et al. 2002).  
Two PPARγ protein isoforms exist, named PPARγ1 and PPARγ2. The majority 
of PPARγ2 protein is specific purely to adipocytes (Zhu et al. 1995). While both 
isoforms are involved in adipogenesis, PPARγ2 is more dominant (Zhang et al. 2004). 
There are many endogenous ligands of PPARγ, including the prostaglandin PGJ2 and 
members of the 5-HETE family, e.g. 5-oxo-HETE (O’Flaherty et al. 2005). Though 
there are many ligands that have been found in vitro, not all of them have yet to be 
found of importance in vivo (Bishop-Bailey and Wray 2003; Lefterova and Lazar 2009). 
Upon ligand to receptor binding, a conformational change causes the co-
repressor to be released and opens up a docking site for the co-activator (Tontonoz and 
Spiegelman 2008; Lefterova and Lazar 2009). This triggers the expression of target 
genes, which contain PPAR responsive elements (PPRE) (Michalik et al. 2002). PPARγ 
dimerizes with retinoid X receptors (RXRs) (Gerhold et al. 2002; Michalik et al. 2002). 
While it is widely known that PPARγ is important in adipogenesis, which genes it 
targets are partly unrecognised. Some include the LEP gene encoding Leptin, 
Lipoprotein lipase (Schoonjans et al. 1996), G0/G1 switch gene 2 (Zandbergen et al. 
2005; see Chapter 2) and the UCP2 and CD36 genes (Matsusue et al. 2003). Expression 
profiling during differentiation suggests that many genes are regulated by PPARγ, 
though the mechanisms are largely unknown. (Perera et al. 2006; Lefterova et al 2008). 
Therefore regulation of gene expression by PPARγ is not fully understood. It is 
important to understand how the transcriptional activity of PPARγ works to clarify its 
role in adipogenesis. 
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PPARγ has been found to be involved in lipid accumulation and adipogenesis. 
As well as this, PPARγ plays a role in a number of different processes. These include 
macrophage maturation, inflammation control and many functions of mature 
adipocytes, including insulin sensitivity and lipid metabolism (Barak et al. 1999; 
Lefterova et al. 2008). The gene is becoming increasingly more important due to its 
association with syndrome X and diabetes. Thus it is implicated in obesity, which is 
becoming an increasingly large problem amongst the population. Humans with PPARγ 
dominant negative mutations show lipodystrophy, insulin resistance and hypertension, 
which implicate PPARγ in diabetes (Gray et al. 2006). 
 PPARγ interacts with several coregulators, which include the coactivator PGC-
1a which helps activate a number of transcription factors during adipogenesis, including 
nuclear respiratory factor 1 (NRF-1) (Lin et al. 2005; Farmer 2006). The p160 
coregulators also associate with PPARγ and lead to modifications of the chromatin 
(Farmer 2006). Some factors also act as corepressors. Yu et al. (2005) showed that by 
RNAi knockdown of two factors SMRT and NcoR, PPARγ target genes are expressed 
more, suggesting that these factors work with PPARγ activity to repress it (Picard et al. 
2004; Farmer 2006). 
The three PPARs are distributed differently throughout the adult body with the 
majority of PPARα and PPARγ in the liver and adipose tissue (Evans et al. 2004). 
PPARβ/δ is expressed throughout the body (Evans et al. 2004). In rodents, PPARγ 
expression is limited to BAT by day 18.5 of gestation and to the central nervous system 
from day 13.5 to 15.5 (Michalik et al. 2002).  
 
3.1.2. The Master Regulator of Adipogenesis  
PPARγ has long been recognised as one of the master regulators of adipogenesis 
along with CCAAT/enhancer-binding proteins (C/EBP) (Lefterova and Lazar 2009). It 
is thought to be involved in all stages of adipogenesis: the commitment of 
preadipocytes, the differentiation into adipocytes and the survival and maintenance of 
terminal adipocytes (Rotman et al. 2006). It has been shown to be both necessary and 
sufficient for differentiation of white and brown adipocytes (Tontonoz et al. 1994; 
Rosen et al. 2002; Gray et al. 2006; Tontonoz and Spiegelman 2008; Lefterova et al. 
2008; Lefterova and Lazar 2009). As described in chapter 2, members of the C/EBP 
family (C/EBPα and C/EBPδ) interact with PPARγ in adipogenesis (Wu et al. 1996). 
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Research using adipocyte cell lines, e.g. the 3T3-L1 cell line, have been used to 
investigate the functions of PPARγ in adipogenesis (Tang et al. 2003; Lefterova and 
Lazar 2009). PPARγ activators induce 3T3-L1 preadipocytes to differentiate (Chawla 
and Lazar 1994). Not only have 3T3-L1 cells been used to show that PPARγ is a main 
regulator, but also what affects PPARγ expression. How PPARγ is controlled has been 
determined by supplying the cells in culture with various factors and monitoring PPARγ 
transcriptional activity. For example, PKA stimulators were found to inhibit PPARγ 
expression, while thiazolidinedione (TZD) induced it (Gerhold et al. 2002; Watanabe et 
al. 2003).  
Inducing expression of PPARγ can lead to the formation of adipocytes from 
cells that are not normally adipogenic (Tontonoz et al. 1994; Mandrup and Lane 1997). 
For example, Hu et al. (1995) showed that myoblasts cultured with PPARγ accumulate 
lipids and express markers indicative of adipocytes, therefore undergoing 
transdifferentiation (Gerhold et al. 2002). The presence of PPARγ agonist rosiglitazone 
can cause the cells to all differentiate into adipocytes and decrease osteoblast formation 
(Ali et al. 2005: Rotman et al. 2006). While these gain-of-function experiments are 
useful to understanding the function of PPARγ they do not show whether it is indeed 
necessary for adipogenesis, thus loss-of-function experiments are also beneficial (Rosen 
et al. 1999). 
Mouse models have been used to show the importance of PPARγ in vivo as well 
as in vitro. However, as with many of the loss-of-function/knockout mouse models 
involved in the study of adipogenesis, in the absence of PPARγ the mice are embryonic 
lethal (Barak et al. 1999; Gray et al. 2006). Barak et al. (1999) generated PPARγ-
deficient mice whereby the mutation caused the knockout of both the DNA binding and 
ligand binding functions. No homozygous null embryos survived past the 
midembryonic stage (Miles et al. 1999; Rosen et al. 1999), whereas the heterozygotes 
could survive, thus chimeric methods were more insightful. It was found that embryonic 
stem cells (ESCs) that don’t express PPARγ are incapable of developing into 
adipocytes.  
Gray et al. (2006) used a dominant-negative PPARγ mouse model, called P465L 
PPARγ, generated by homologous recombination. The mice had normal levels of 
adipose tissue, though under closer inspection their brown adipocytes had one large 
lipid droplet. White adipose tissue, while appearing normal recruited less brown 
adipocytes and there was less UCP1 expression (Gray et al. 2006). PPARγ in this case 
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is thought to have more of an effect on brown adipocytes than white adipocytes. It was 
also possible to ablate specifically PPARγ2, which decreased the lipid content of brown 
adipocytes (Zhang et al. 2004).  
PPARγ2 was specifically knocked down with homologous recombination in 
white adipose tissue (Koutnikova et al. 2003). Those homozygous (PPARγhyp/hyp) mice 
that survive after birth are severely lipodystrophic with virtually no WAT. In response 
PPARγ1 mRNA was found to increase. Homozygous mice appeared normal at birth, but 
post-natally the lack of PPARγ2 affected WAT development, though it did not appear to 
impede BAT development. Muscle compensates metabolically so the lipodystrophy is 
only temporarily detrimental to those homozygous mice that survive. Zhang et al. 
(2004) also found that PPARγ2-/- mice were able to survive but less WAT had 
developed and the adipocytes were smaller in size, fewer lipids had accumulated and 
they exhibited reduced expression of adipogenic genes. Compared with the wild-type 
mice there was no difference in the weight of BAT depots, liver, spleen or heart.  
PPARγ also has a role in the maintenance of mature adipocytes (Imai et al. 
2004; Zhang et al. 2004), since knocking out PPARγ after adipose tissue formation 
causes the loss of fat over time as well as hyperlipidemia (He et al. 2003; Evans et al. 
2004). PPARγ has therefore been found to function in both adipocyte differentiation and 
maintenance. Koutnikova et al. (2003) also found this to be the case.  
 
3.1.3. Recent Hypotheses   
While the current hypothesis is that PPARγ is crucial to adipogenesis, its exact 
role and timing of involved in different adipose depots in vivo is unclear. In microarray 
analysis of embryonic dermis, the Jahoda group found mRNA expression of PPARγ in 
vivo between e17 and e18 in mouse skin, but not the differential expression that might 
have been expected between the upper and lower dermis. Wojciechowicz (2012) in 
Jahoda’s lab used immunofluorescent analysis to look at the expression of PPARγ in 
embryonic mouse back skin. However, it was not detected in the lower dermis, where 
the dermal fat layer has been found to develop. Several explanations were suggested; 
one that the epitopes for the PPARγ protein in the skin dermis were obscured so the 
antibodies couldn’t bind. Secondly, that the PPARγ protein is not present in the lower 
dermis at the time points analysed (e17, e18 and e19). Thirdly, while PPARγ may be 
crucial to the regulation of the early stages of adipogenesis in other fat depots, this may 
not be the case for the dermal fat layer: Its development may be regulated differently. 
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Fourthly, the antibodies used may not have been appropriate for back skin and therefore 
showed non-specific staining or background staining (Wojciechowiz 2012). Another 
possibility is that while the gene is being expressed the protein is not being produced, or 
not accumulating in the nucleus. Perhaps in skin the importance of PPARγ rests in 
adipocyte differentiation and maintenance and less so at initiation and lineage 
commitment. Vernochet et al. (2002) suggested that in cell culture the media may cause 
the commitment of cells to the adipogenic lineage and in fact PPARγ only then has a 
role in differentiation post commitment (Rotman et al. 2006). PPARγ was found not to 
be required for lineage commitment and the establishment of brown adipocytes, but 
necessary for their development (Barak et al. 1999). Since this gene is widely 
recognised for its involvement in inducing adipogenesis (see above), it is important to 
look closely at its expression in developing skin by accurate and reliable means. 
To address these questions over the role of PPARγ in the formation of the 
dermal fat layer, a positive control is required to clarify that the antibodies used are 
effective and reliable. In this chapter, several different PPARγ antibodies were tested in 
vitro using the 3T3-F442A cell line. PPARγ expression is expressed in 3T3 cell nuclei 
42-60 hours after they have been induced to differentiate down the adipogenic lineage 
(Morrison and Farmer 1999; Wojciechowicz 2012). Immunofluorescent analysis using 
an anti-PPARγ antibody is an appropriate method to determine whether staining is 
localised to the nucleus and thus PPARγ is being expressed. Both induced and non-
induced cells were stained for PPARγ. While the timings in vitro are well understood, 
they are less clear in vivo. After the uncertainties and questions raised by the work of 
Wojciechowicz (2012) the aim of this chapter was to unequivocally describe the 
expression of PPARγ during development of the dermal fat layer. Here in vivo PPARγ 
expression was studied in skin from embryonic day 14.5 to 5 day newborn mice. 
Dermal cell spheres were also created to look at PPARγ expression solely in developing 
dermal cells taken from embryonic day 14.5 mouse back skin.  
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3.2. Materials and Methods 
 
3.2.1. In Vitro Analysis – The 3T3 F442A Cell Line 
 
3.2.1.1. Preadipocyte Cell Culture and Maintenance 
Cryofrozen 3T3-F442A cells (kindly donated by Adina Mihai, Durham 
University) were rapidly defrosted in a water bath. The cells were brought up in 12ml of 
pre-warmed 3T3 cell media (Appendix II) in a T75 flask and incubated at 37°C in 10% 
CO2.  
After 24 hours, the media was poured off and the T75 rinsed with sterile PBS to 
remove excess media. 10ml of a solution of trypsin (0.25%) in EDTA (Gibco) was 
added before the flask was returned to the incubator for several minutes until the cells 
detached. Then trypsinization was stopped by adding another 10 ml 3T3 cell media 
before transferring the suspension to a 15ml centrifuge tube (Falcon) prior to 
centrifugation at 1000rpm for 5 minutes (Hermle Z400 Bench top centrifuge). The cell 
pellet was resuspended in 1ml fresh 3T3 cell media and the cells were counted. The 
cells were seeded at 60-70% confluence in 6 well plates. Some wells contained sterile 
coverslips for the cells to adhere to prior to immunofluorescence staining. The 
coverslips had been soaked in acid ethanol for 24 hours and washed twice in Phosphate 
buffered saline (PBS: Appendix I) before being transferred to 35ml dishes. The plates 
were returned to the incubator at 37°C in 10% CO2. 
 
 3.2.1.2. Inducing Adipogenesis 
Two days after the cells had reached confluence, the cells were stimulated with 
differentiation medium (Appendix II) to induce adipocyte formation. One plate was not 
supplied with differentiation media but was allowed to continue growing in normal 3T3 
cell media as a non-induced control.  
After 2 days one induced and one non-induced 6 well plate was taken out of 
culture for PPARγ immunofluorescence analysis. The other plate was left in culture to 
develop into adipocytes to ensure the differentiation process would be successful at 
producing fat.  
After a further 24 hours the culture medium was changed to insulin media 
(Appendix II). These cells were incubated for another 2 days at 37°C in 5% CO2. The 
media was then changed back to the 3T3 cell media for another 10 days.  
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3.2.1.3. Oil red O Analysis of 3T3 F442A Cells 
After 10 days, oil red O analysis was conducted to determine whether the 
adipocyte differentiation had occurred. The cells were washed in PBS and then fixed in 
calcium formal (Appendix I) for 10 minutes. The wells were then immediately stained 
or stored in PBS at 4°C prior to staining.  
 An incubation with 60% isopropanol was followed by 10 minutes with a 
working solution of oil red O. A short wash in 60% isopropanol was then used to 
remove any excess oil red O followed by two careful washes in PBS. The cells were 
then stored in PBS at 4°C before pictures were taken. 
 
3.2.1.4. PPARγ  Immunofluorescence Analysis in Vitro 
Immunofluorescent staining of PPARγ was carried out on cells after 2 days of 
incubation with differentiation media and also non-induced 3T3 cells after 2 days. Five 
different PPARγ antibodies were used (Table 3.1). 
Table 3.1: Summary of primary antibodies and conditions used for immunofluorescent 
staining in vitro 
Antibody/ 
Factor Name Manufacturer 
Raised 
in 
Clonality 
(P/M*) Dilution Fixation 
Blocking 
serum 
PPARγ-2 Affinity Bioreagents Rabbit P 1:500 Acetone Donkey 
PPARγ (B-5) 
(sc-271392) Santa Cruz Mouse M 1:100 Acetone Goat 
PPARγ (E-8) 
(sc-7273) Santa Cruz Mouse M 1:100 Acetone Goat 
Anti- PPARγ 
(ab19481) Abcam Rabbit P 1:100 PFA Donkey 
Acetone Anti- PPARγ 
(AHP1461) Abd Serotec Rabbit P 1:50 PFA 
Donkey 
* P - polyclonal; M – monoclonal 
Acetone/PFA – Slides were fixed in either ice-cold acetone or 4% paraformaldehyde 
 
Table 3.2: Details of the corresponding secondary antibodies used for immunofluorescent 
staining 
Secondary Antibody Manufacturer Dilution 
Donkey anti rabbit 
(FITC) 
AlexaFluorR 488 Invitrogen 1:500 
Goat anti mouse 
(FITC) 
AlexaFluorR 488 Invitrogen 1:500 
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Cells were grown on square coverslips, therefore, staining was conducted in the 
wells, making sure during each wash, coverslips were washed underneath. Coverslips 
were first washed twice in 1x phosphate buffered saline (PBS-appendix 1) for 2 minutes 
to remove all media prior to fixation. Cells were fixed in either ice-cold acetone for 10 
minutes or 4% paraformaldehyde (PFA – Appendix I) for 15 minutes (see table 3.1). 
Cells that were to be incubated with the anti-PPARγ antibody from Abd Serotec were 
fixed with both acetone and PFA, because this antibody had not been tested on frozen 
sections. Coverslips fixed in acetone were then allowed to dry before being rinsed in 
PBS, while coverslips fixed in PFA were rinsed in PBS, then permeabilised with 0.5% 
Triton-X for 5 minutes, and then rinsed again in PBS. Cells were then blocked with 
20% donkey serum (Sigma, MO, USA) or goat serum (Sigma, MO, USA) in PBS for 30 
minutes (see table 3.1). The wells were then washed for two minutes in PBS and cells 
then incubated with the primary antibodies (Table 3.1) in 1% donkey or goat 
serum/PBS overnight at 4°C.  
The wells were washed three times in PBS for 5 minutes and incubated with a 
corresponding secondary antibody (Table 3.2) for 1 hour at room temperature. 4′,6-
diamidine-2′-phenylindole dihydrochloride (DAPI) (KPL, Maryland, USA) was added 
for 3 minutes at a dilution of 1:1000. Incubations were carried out in the dark to prevent 
the coverslips from drying out and the fluorescence fading. Three more 5-minute PBS 
washes were conducted before mounting the coverslips onto blank slides in anti-fade 
Mowiol. Slides were kept at 4°C in the dark. Immunofluorescence analysis was 
performed on a Zeiss Axio Imager M1 microscope with Volocity software.  
For each type of fixation, blocking step and secondary antibody, negative 
controls were performed, where cells were not exposed to the primary antibodies, but 
incubated with 1% donkey (or goat) serum/PBS. They were exposed to the same 
corresponding secondary antibodies to determine if there was any non-specific staining. 
Other controls were conducted using the 3T3 cells that had not been induced to 
differentiate.  
 
3.2.2. In Vitro Analysis – Dermal Cell Spheres 
 
3.2.2.1. Origin, Maintenance and Breeding of Rodents  
Back skin from 14.5-day embryonic mice was taken from mice of the FVB 
strain from the Durham University Life Sciences Support Unit (LSSU). They were kept 
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at 21°C, 55% humidity on a 12 hour light/dark cycle. They were fed on the Harlan 
Teklad 2013 Rodent Maintenance diet and watered ad libitum.   
Vaginal plug analysis was used to obtain skin from embryos at the specific age. 
The presence of a vaginal plug the morning after breeding pairs had been kept together 
was used as an indication of a successful mating and the embryos were noted at 0.5 days 
gestation at this point. Animals were killed using CO2/cervical dislocation. Back skin 
was microdissected from embryonic mice  (see section 3.2.3.2). 
 
3.2.2.2. Production of Single Cell Suspensions from Mouse Dermis 
 Skin pieces obtained from foetal mouse back skin were put in a 6% 
Pancreatin/5% Trypsin cocktail in Earle’s solution (1:1:2, Appendix III) at 4ºC for 90 
minutes. Fine tweezers were then used to carefully prise apart the dermis from the 
epidermis. Dermal pieces were transferred to sterile Earle’s solution before being 
incubated in a warm working solution of DNase I (Sigma)/Collagenase II (Sigma) 
(Appendix III) at 37C for 15-20 minutes.  Mechanical dissociation was carried out with 
a 1ml pipette to form a single cell suspension of the dermis. The suspension was diluted 
with 2ml of 10% FBS-MEM and filtered through a cell filter (Fisher), before being 
centrifuged at 1000rpm for 5 minutes. The supernatant was carefully poured off leaving 
a cell pellet, which was resuspended in 1ml of 10% FBS / MEM. 
  
3.2.2.3. Preparing 3-dimensional Spheres in Culture 
 Spheres were created by pipetting 10µl drops containing 6000 cells onto the 
petri dish lids, evenly spaced and not too close to the edge. 25ml of sterile distilled H20 
was put into each petri dish and the drops were suspended over this to prevent them 
from drying out. Petri dishes containing 25ml of sterile distilled H20 but no spheres 
were placed above and below before being transferred to the incubator (37C, 5% CO2). 
See Chapter 4, figure 4.5 for diagram of 3D culture set up. 
 
3.2.2.4. Obtaining 3-dimensional Spheres for Analysis 
 After two days the dermal cells had aggregated and formed spheres. 10-15 
spheres were collected and snap frozen in liquid nitrogen suspended in Tissue-Tek® 
O.C.T.™ compound (Sakura, Agar Scientific, Netherlands), before being stored at -
80C. This was repeated each day for 5 days and two blocks were frozen down each day.  
Spheres collected were therefore from e14.5 plus 2, 3, 4, 5, and 6 days. 
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Sections were cut from each sample time point at 7um on a cryostat (LEICA CM 
3050S) and then allowed to dry for 2 hours at room temperature.  
 
3.2.2.5. PPARγ  Immunofluorescence Analysis of e14.5 Spheres 
 Three of the PPARγ antibodies were used; Santa Cruz E-8, Abcam and Abd 
Serotec. The Affinity Bioreagents PPARγ-2 antibody was not used due to limiting 
quantities. The slides were stained as described in section 3.2.1.3 and negative controls 
incubated with only the secondary antibodies and not the primary PPARγ antibodies 
were conducted alongside for each replicate. 
 
3.2.2.6. Oil red O Analysis of e14.5 Spheres 
 Oil red O staining was conducted on the spheres after 2, 3, 4, 5 and 6 days. 
Sections (10µm) were cut from the frozen spheres on a cryostat (LEICA CM 3050S) 
and attached to ColorFrost®Plus slides (Thermo Shandon Ltd, Cheshire, UK). Slides 
were left to dry at room temperature for 1hour 30 minutes and then washed in PBS (3x 
5 minutes) followed by fixation in calcium formal (Appendix I) for 1 hour. They were 
then incubated with 60% isopropanol (Sigma) for 15 minutes and stained with a 
working solution of oil red O (Appendix I) for 15 minutes. Slides were briefly washed 
in 60% isopropanol to remove excess oil red O and then rinsed in water. They were 
counterstained by dipping each slide in Shandon instant haematoxylin (Thermo 
Scientific, Cheshire, UK) and then rinsed in water. Slides were mounted in pre-warmed 
glycergel (DakoCytomation Inc. California, USA) and coverslipped. Images were taken 
on a Zeiss Axio Imager (M1) microscope using Volocity software. 
 
3.2.3. In Vivo Analysis – Rodent Back Skin 
 
3.2.3.2 Preparation of Skin Sections 
 Rodents were maintained and timed matings obtained as described in section 
3.2.2.1, and back skin was obtained from mouse embryos at e14.5, e16.5, e18.5 and 
from newborn mice after 1, 2, 3 and 5 days (Table 3.2). Additional skin samples were 
taken from an 18.5 day-old embryonic rat, of the Lister black hooded strain, also 
provided by the LSSU (Durham University).  
 Skin cut from the back of each specimen was rolled or orientated flat and put 
into Tissue-Tek® O.C.T.™ compound (Sakura, Agar Scientific, Netherlands), then snap 
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frozen in liquid nitrogen and kept at −80°C. Skin sections (7 µm), were cut on a cryostat 
(LEICA CM 3050S) and attached to ColorFrost®Plus slides (Thermo Shandon Ltd, 
Cheshire, UK). The slides were dried for 2 hours at room temperature, and then used 
immediately for immunofluorescence staining or haematoxylin and eosin (H&E) 
staining.  
 Skin from 5dN mice was also cut from wax blocks. This involved the skin being 
fixed in 4% PFA and dehydrated in alcohol before being embedded in paraffin. Wax 
sections were cut using a microtome and then floated on distilled water to keep flat 
before being adhered to slides, with care taken to remove all bubbles. This process was 
conducted on a hot plate where the slides were left overnight to dry out.  
  
3.2.3.3. PPARγ  Immunofluorescence Analysis in Vivo 
Once the effects of the different antibodies had been established in vitro on cells 
from the 3T3 F442A cell line, these antibodies were tested in vivo on rodent back skin 
apart from the PPARγ (B-5) Santa Cruz antibody which was not used in vivo, because it 
didn’t look to have potential specificity in vitro. 
Immunofluorescence analysis (IF) was conducted on a number of different ages 
with different combinations of fixation and specimen types as shown in Table 3.3.  
 
Table 3.3: Summary of ages and specimen types the listed primary antibodies were tested 
on using immunofluorescence staining. 
PPARγ 
 Age (days) Type  Section ABR Santa Cruz Abcam 
Abd 
Serotec 
14.5 Mouse Frozen     
16.5 Mouse Frozen     
Mouse     
Embryonic 
18.5 
Rat 
Frozen 
    
1 Mouse Frozen     
3 Mouse Frozen     
4 Mouse Frozen     
Newborn 
5 Mouse Paraffin     
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3.2.3.3.1. Frozen sections (IF) 
 All four antibodies were tested on frozen sections. The staining protocol was 
conducted in the same way as is described in section 3.2.1.3 except that sections were 
attached to slides as opposed to coverslips and so incubations were not conducted in 
wells of 6 well plates, but instead carried out in a humidity chamber to prevent the 
sections drying out. Each step was carried out for the same length of time and the 
conditions, as well as respective secondary antibodies used are listed in table 3.4. 
Samples incubated with the Abd Serotec PPARγ antibody were subjected to no fixation 
as well as both acetone and PFA fixation steps, because there was no pre-indication as 
to which would be more successful, if any. 
 
Table 3.4: Table showing the primary antibody manufacturers, respective secondary 
antibodies and the conditions used in immunofluorescence staining of frozen sections in 
vivo 
Manufacturer Blocking serum Dilution Fixation 
Secondary 
Antibody 
Affinity 
Bioreagents Donkey 1:500 Acetone 
Donkey anti-
rabbit (FITC) 
Santa Cruz Goat 1:100 Acetone Goat anti-mouse (FITC) 
Abcam Donkey 1:100 PFA Donkey anti-rabbit (FITC) 
No 
fixation 
Acetone Abd Serotec Donkey 1:50 
PFA 
Donkey anti-
rabbit (FITC) 
  
3.2.3.3.1.1. Mouse on Mouse Protocol 
 When staining in skin sections, using an antibody raised in mouse, some steps 
are needed to prevent the antibody staining everything. A mouse on mouse (MOM) kit 
(Vecta FMK-2207) was used for the Santa Cruz E-8 antibody in skin sections. The 
immunofluorescence staining was also conducted without using the MOM kit to act as a 
control. See Appendix II for all working solutions. 
 Sections were fixed in ice-cold acetone for 10 minutes and then air-dried, before 
being washed twice for 2 minutes in PBS. The slides were incubated in the ‘mouse 
blocking reagent working solution’ for 1 hour and then washed twice in PBS for 2 
minutes. Next was an incubation in the ‘’diluent working solution’ for 5 minutes and 
the excess was tipped off. The primary antibody from Santa Cruz was diluted in the 
‘diluent working solution’ and the slides were incubated in it for 30 minutes and then 
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washed a further 2 times in PBS for two minutes. The ‘biotinylated anti-mouse reagent’ 
was then put on the slides and left for 10 minutes and washed off 2 times for 2 minutes 
in PBS. The slides were lastly incubated in the ‘fluorescin avidin DCS working 
solution’ for 5 minutes and washed twice in PBS for 5 minutes before being mounted in 
Vectashield. 
3.2.3.3.2. Paraffin Sections (IF) 
 Slides with 5dN mouse skin paraffin sections attached were allowed to cool and 
then de-paraffinised thoroughly in histoclear twice for 5 minutes each. The sections 
were then hydrated through a graded series of washes in ethanol. This started with 2 x 3 
minutes in 100% ethanol then 2 x 2 minutes in 95% ethanol and finally 2 x 2 minutes in 
70% ethanol. The slides were then washed twice in water for 5 minutes.   
 An antigen retrieval step using a 10mM sodium citrate buffer, pH6 (appendix 1) 
was conducted by suspending the slides in a beaker containing this buffer and placing in 
a microwave for 20 minutes. This was then left to cool for 15 minutes before the slides 
were rinse in PBS. 
 Immunfluorescence staining was then continued in the same way as frozen 
sections blocking with 20% donkey serum and using the Abd Serotec PPARγ antibody 
at a concentration of 2.5µg/ml in 1% donkey serum/PBS (see section 3.2.1.3). 
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3.3. Results 
 
3.3.1. 3T3 F442A Cells in Culture 
 In order to first investigate the different PPARγ antibodies in vitro, 3T3 F442A 
cells were brought up from frozen and put into culture in 6-well plates. Pictures were 
taken of these cells to show they were healthy and confluent before the media was 
changed to induce adipocyte differentiation (Figure 3.1). These images showed that 
some of the cells were already spontaneously differentiating because some clearly had 
lipid droplets in (Figure 3.1F).  
 One 6-well plate was then supplied with an adipogenic induction media to 
induce differentiation and another 6-well plate was supplied with the normal DMEM 
cell culture media. After 2 days of incubation and before the cells were 
immunofluorescently stained for PPARγ, observations of lipid droplet accumulation in 
the cells were made. They showed a certain degree of differentiation in the untreated 
cultures (Figures 3.2A-C), but a much higher proportion of cells differentiating in those 
with adipogenic medium (Figures 3.2D-F). 
 
 
Figure 3.1: Images of 3T3 F442A cells in culture before the addition of adipogenic media. 
Cells have proliferated and adhered to the coverslips. (A-C) lower resolution. (D,E) higher 
resolution. (F) zoomed in image to show representation adipocyte containing lipid droplets. 
Images were taken using a Zeiss Axiovert 10. (A-C) scale bar = 65µm. (D,E) scale bar = 
40µm.  
 
 
. 
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The cells were fixed for staining from 2 days after addition of adipogenic 
medium. Some wells were left for 10 days to show that the cells fully differentiated into 
terminal adipocytes. Cells that were stained with oil red O to show the presence of 
lipids in the cells revealed a substantial amount of red coloration implicating successful 
differentiation of the cells (Figure 3.3). Visualisation of the individual cells was not 
easy because of the degree of confluence.  
 
Figure 3.2: Images of 3T3 F442A cells in culture after the change of culture media. (A-C) 
not induced to differentiate. (D-F) induced to differentiate. Arrows label adipocytes. Images 
were taken using a Zeiss Axiovert 10. (A,D) scale bar = 65µm. (B,C,E,F) scale bar = 40µm.  
 
 
. 
Figure 3.3: Oil red O analysis of 3T3 F442A cells after 10 days in culture. (A-C) lower 
resolution. (D,E) higher resolution. (F,G) magnified image to show lipid droplets that have 
been stained red. Images were taken using a Zeiss Axiovert 10. (A-C,G) scale bar = 65µm. 
(D-F) scale bar = 40µm.  
 
 
. 
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3.3.2. In vitro versus in vivo Immunofluorescent Staining of PPARγ   
 
The role and timing of PPARγ involvement in adipogenesis in vitro is well 
documented. Thus PPARγ immunofluorescent staining of the 3T3-F442A in vitro cell 
line was conducted with the aim of evaluating the working capabilities of five different 
primary antibodies of PPARγ, prior to investigating its activities in vivo. Cells were 
induced to differentiate into adipocytes using adipogenic medium and after 2 days were 
stained for PPARγ expression. Other cells were left in culture without being induced to 
differentiate to control the effects of the adipogenic medium. Negative controls using no 
antibody binding to PPARγ, but only the fluorescent secondary antibody were 
conducted to show the level of background staining present and thus help determine a 
positive result.  
The antibody, PPARγ B-5 from Santa Cruz was observed to stain the cultured 
3T3 cells which had been induced to differentiate, but labelling revealed general 
background staining and was not specific to cell nuclei (Figure 3.4). Similarly in the 
non-induced cultures, the staining was clearly not nuclear (Figure 3.5) in that the blue 
nuclear stain, DAPI, did not correspond with the green fluorescence of the PPARγ 
antibody. Therefore it was decided that this antibody would be of no use for studying 
adipogenesis in developing mouse back skin in vivo. 
The next antibody investigated was a polyclonal antibody against PPARγ2 from 
Bioaffinity Reagents. As represented in Figure 3.6 this revealed a high degree of 
positive nuclear expression though interestingly more so in the cultured cells that had 
not been incubated with adipogenic medium (Figure 3.7). There was however a lot of 
background cytoplasmic staining with this antibody. This was not the case for the 
PPARγ E-8 antibody from Santa Cruz (Figure 3.8) which revealed clear nuclear staining 
of cells in differentiation medium, though not in every nucleus which is to be expected 
as not all the cells turn into adipocytes simultaneously. When the cells in normal 
medium were stained with this antibody (Figure 3.9), far fewer had positively stained 
nuclei. Lipid-droplets were observed in both the induced and non-induced 3T3 cells left 
in culture for longer than 2 days, which suggests that some of the cells spontaneously 
differentiate. 
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Figure 3.4: Analysis of PPARγ  B-5 (Santa Cruz) expression in 3T3 F442A cells induced 
to differentiate. Adherent cells stained with an antibody against PPARγ and counterstained 
with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently labelled PPARγ 
expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent images were taken 
using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 15µm.  
 
 
. 
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Figure 3.5: Analysis of PPARγ  B-5 (Santa Cruz) expression in 3T3 F442A cells not 
induced to differentiate. Adherent cells stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently 
labelled PPARγ expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 
15µm.  
 
 
. 
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Figure 3.6: Analysis of PPARγ2 (Affinity Bioreagents) expression in 3T3 F442A cells 
induced to differentiate. Adherent cells stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently 
labelled PPARγ expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 
15µm.  
 
 
. 
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Figure 3.7: Analysis of PPARγ2 (Affinity Bioreagents) expression in 3T3 F442A cells not 
induced to differentiate. Adherent cells stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently 
labelled PPARγ expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 
15µm.  
 
 
. 
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Figure 3.8: Analysis of PPARγ  E-8 (Santa Cruz) expression in 3T3 F442A cells induced 
to differentiate. Adherent cells stained with an antibody against PPARγ and counterstained 
with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently labelled PPARγ 
expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent images were taken 
using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 15µm.  
 
 
. 
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The results found using the two PPARγ primary antibodies from Affinity 
Bioreagents and Santa Cruz (Number E-8) were deemed positive and these two 
antibodies were subsequently used to further investigate PPARγ expression in vivo.  
With the knowledge that PPARγ has been found expressed postnatally (Rotman 
et al. 2006), back skin from 4 day-old newborn mice was first immunofluorescently 
stained with both antibodies. While in vitro there was positive nuclear staining for 
PPARγ, there was little to suggest positive expression in vivo. Some staining was 
Figure 3.9: Analysis of PPARγ  E-8 (Santa Cruz) expression in 3T3 F442A cells not 
induced to differentiate. Adherent cells stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently 
labelled PPARγ expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 
15µm.  
 
 
. 
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observed in the upper dermis, though it was difficult to tell if this was nuclear (Figure 
3.10). Hair follicles appeared to be stained throughout, although more strongly in the 
upper dermis. At a higher magnification (Figure 3.11) there was little evidence of 
labelling in the lower dermal cells surrounding the follicles where adipocytes are 
present or developing. This staining was repeated with the same results.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Analysis of PPARγ2 (Affinity Bioreagents) expression in 4-day newborn 
mouse back skin. Sections cut at 7µm, stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C) Controls showing no fluorescently 
labelled PPARγ expression. (D-F) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 65µm.  
 
 
. 
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Figure 3.11: Analysis of PPARγ2 (Affinity Bioreagents) expression in 4-day newborn 
mouse back skin (different view). Sections cut at 7µm, stained with an antibody against 
PPARγ and counterstained with DAPI. From left to right; DAPI, FITC, and merge 
(DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A) Control showing no 
fluorescently labelled PPARγ expression. (B-G) labelled using PPARγ primary antibody, 
showing two different views of the follicles through the skin sections. Fluorescent images 
were taken using a Zeiss Axio Imager M1. Scale bar = 40µm.  
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The Santa Cruz (PPARγ E-8) antibody was a mouse monoclonal, so a mouse on 
mouse kit (MOM) was used to stain 4-day newborn skin sections to prevent staining of 
endogenous mouse immunoglobulins. Some controls without using the MOM kit were 
also conducted to observe its effectiveness. Without the MOM kit fluorescent analysis 
of both PPARγ in the skin and the negative controls using only the fluorescent 
secondary antibody (Figure 3.12) showed non-specific staining throughout the skin and 
no obvious nuclear staining of adipocytes. Comparatively, with the MOM kit (Figure 
3.13), the PPARγ staining showed what appeared to be some more specific staining, 
though the negative controls without primary antibody incubation also exhibited a 
similar pattern. Therefore, it was not deemed reliable positive staining for PPARγ.  
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Figure 3.12: Analysis of PPARγ  E-8 (Santa Cruz) expression in 4-day newborn mouse 
back skin without using the MOM kit. Sections cut at 7µm, stained with an antibody against 
PPARγ and counterstained with DAPI. From left to right; DAPI, FITC, and merge 
(DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A,B) Control showing no 
fluorescently labelled PPARγ expression, 2 images to represent upper and lower levels of the 
skin. (C-E) labelled using PPARγ primary antibody, 3 images top to bottom show the different 
levels through the skin. Fluorescent images were taken using a Zeiss Axio Imager M1. Scale 
bar = 40µm.  
 
 
. 
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Figure 3.13: Analysis of PPARγ  E-8 (Santa Cruz) expression in 4-day newborn mouse 
back skin using a MOM kit. Sections cut at 7µm, stained with an antibody against PPARγ 
and counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). 
FITC represents the fluorescent labelling of PPARγ. (A,B) Control showing no fluorescently 
labelled PPARγ expression, 2 images to represent upper and lower levels of the skin. (C-G) 
labelled using PPARγ primary antibody, showing two different views and the different skin 
levels. Fluorescent images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm.  
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Due to the non-specific staining in mouse skin, the PPARγ E-8 (Santa Cruz) 
antibody was tested in rat skin as well. Late embryonic rat skin from 18.5 days was 
available and at this point early adipocytes are present and developing in the skin. The 
results illustrated in Figure 3.14, show a speckled distribution of staining (Figures 
3.14D, E and F). However, cells that appeared to be positively labelled in the FITC 
fluorescent images, when combined with the DAPI staining did not appear to show 
nuclear marking, though the labelling did differ from the negative control (Figures 
3.14A-C). 
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Figure 3.14: Analysis of PPARγ  E-8 (Santa Cruz) expression in 18.5-day embryonic rat 
back skin. Sections cut at 7µm, stained with an antibody against PPARγ and counterstained 
with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of PPARγ. (A-C) Control showing no fluorescently labelled PPARγ 
expression, 2 images to represent upper and lower levels of the skin. (D-F) labelled using 
PPARγ primary antibody, 3 images top to bottom show the different levels through the skin. 
Fluorescent images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm.  
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Both in vitro and in vivo analysis of the three anti-PPARγ primary antibodies – 
Santa Cruz B-5, Santa Cruz E-8 and Affinity Bioreagents – were not found to be 
sufficiently reliable, because of the contrasts between them. Two further different 
antibodies for PPARγ  were then investigated in order to find an antibody that could be 
deemed reliable in vivo.  
Firstly, an antibody from Abcam was tested in 3T3 F442A cells induced to 
differentiate into adipocytes. This showed some staining in a proportion of the cells as 
would be expected as not all the cells will be undergoing differentiation, however it is 
not limited to the nuclei of the cells (Figure 3.15). Cells that were not in adipogenic 
medium showed background staining of the cell cytoplasm, but not the nuclei (Figure 
3.16), more so than the cells induced to differentiate.  
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Figure 3.15: Analysis of PPARγ  (Abcam) expression in 3T3 F442A cells induced to 
differentiate. Cells grown on coverslips were stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently 
labelled PPARγ expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 
15µm. 
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 This antibody (Abcam) was then used to investigate PPARγ expression in vivo 
using mouse back skin of a variety of ages, both embryonic and postnatal (e14.5, e16.5, 
e18.5, 1dN and 3dN). These results are illustrated in figures 3.14-3.18. At both 
postnatal day 1 (Figure 3.17 and day 3 (Figure 3.18), the basal layer of the epidermis 
and cells at the periphery of hair follicles were positive for PPARγ, more so after 1 day 
than 3 days. There was no evidence of any positive PPARγ labelling in cells of the 
lower dermis. In comparison the controls displayed little background staining, 
Figure 3.16: Analysis of PPARγ  (Abcam) expression in 3T3 F442A cells not induced to 
differentiate. Cells grown on coverslips were stained with an antibody against PPARγ and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C,G-I) Controls showing no fluorescently 
labelled PPARγ expression. (D-F,J-L) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (A-F) scale bar = 40µm. (G-L) scale bar = 
15µm. 
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suggesting that the basal epidermal layer was genuinely positive for PPARγ, though this 
was not nuclear staining (Figures 3.17E and K and Figure 3.18H).  
 
 
 
 
 
 
Figure 3.17: Analysis of PPARγ  (Abcam) expression in 1-day postnatal mouse back skin. 
Sections were cut at 7µm and stained with an antibody against PPARγ (Abcam) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C) Control showing no fluorescently 
labelled PPARγ expression. (D-L) labelled using PPARγ primary antibody, showing two 
different views of the hair follicles. Fluorescent images were taken using a Zeiss Axio Imager 
M1. (A-I) scale bar = 65m. (J-L) scale bar = 40µm. 
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 In younger skin, little staining was seen at 14.5 days though at e16.5 and clearly 
at 18.5 days, the basal epidermal layer was clearly stained with bright fluorescence 
(Figures 3.20 and 3.21) in the same pattern seen postnatally (Figures 3.17 and 3.18). By 
e18.5 there was also some staining present in the developing follicles, reflecting the 
newborn picture. However there was no evidence of nuclear staining in cells of the 
lower dermis, where adipocytes develop. 
 
 
 
Figure 3.18: Analysis of PPARγ  (Abcam) expression in 3--day postnatal mouse back 
skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abcam) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-F) Controls showing no fluorescently 
labelled PPARγ expression, 2 images to represent upper and lower levels of the skin. (G-L) 
labelled using PPARγ primary antibody, 2 images to represent upper and lower levels of the 
skin. Fluorescent images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.20: Analysis of PPARγ  (Abcam) expression in 16.5-day embryonic mouse back 
skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abcam) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C) Controls showing no fluorescently 
labelled PPARγ expression. (D-F) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
 
 
. 
 
Figure 3.19: Analysis of PPARγ  (Abcam) expression in 14.5-day embryonic mouse back 
skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abcam) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C) Controls showing no fluorescently 
labelled PPARγ expression. (D-F) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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 The fifth anti-PPARγ antibody was supplied by ABD Serotec. As this antibody 
had not previously been used for immunofluorescence on frozen sections before, it was 
first tried on the cultured 3T3 cells using two different fixation procedures, acetone and 
PFA. When the cells were fixed in acetone, both the induced and the non-induced 3T3 
cells showed evidence of nuclear PPARγ staining (Figures 3.22 and 3.24). However, 
when fixed with PFA, the cells only demonstrated cytoplasmic staining for both 
induced (Figure 3.23) and not induced (Figure 3.25) cultures. Some of the cells also 
appeared to have shrunk and become distorted during the fixation process (Figure 3.23).  
Figure 3.21: Analysis of PPARγ  (Abcam) expression in 18.5-day embryonic mouse back 
skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abcam) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (A-C) Controls showing no fluorescently 
labelled PPARγ expression. (D-L) labelled using PPARγ primary antibody, showing a lower 
(D-F) and a higher (G-L) magnification. Fluorescent images were taken using a Zeiss Axio 
Imager M1. (A-F) scale bar = 65m. (G-L) scale bar = 40µm. 
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Figure 3.22: Analysis of PPARγ  (Abd Serotec) expression in 3T3 F442A cells induced to 
differentiate and fixed in acetone. Adherent cells fixed with acetone and stained with an 
antibody against PPARγ (Abd Serotec) and counterstained with DAPI. From left to right; 
DAPI, FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. 
(A-C) Controls showing no fluorescently labelled PPARγ expression. (D-I) labelled using 
PPARγ primary antibody. Fluorescent images were taken using a Zeiss Axio Imager M1. 
Scale bar = 40µm. 
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Figure 3.23: Analysis of PPARγ  (Abd Serotec) expression in 3T3 F442A cells induced to 
differentiate and fixed in PFA. Adherent cells fixed with 4% PFA and stained with an 
antibody against PPARγ (Abd Serotec) and counterstained with DAPI. From left to right; 
DAPI, FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. 
(A-C) Controls showing no fluorescently labelled PPARγ expression. (D-I) labelled using 
PPARγ primary antibody. Fluorescent images were taken using a Zeiss Axio Imager M1. (A-
F) scale bar = 40µm. (G-L) scale bar = 15µm 
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Figure 3.24: Analysis of PPARγ  (Abd Serotec) expression in 3T3 F442A cells not induced 
to differentiate and fixed in acetone. Adhered cells fixed with acetone and stained with an 
antibody against PPARγ (Abd Serotec) and counterstained with DAPI. From left to right; 
DAPI, FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. 
(A-C) Controls showing no fluorescently labelled PPARγ expression. (D-I) labelled using 
PPARγ primary antibody. Fluorescent images were taken using a Zeiss Axio Imager M1. (A-
F) scale bar = 40µm. (G-L) scale bar = 15µm. 
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This anti- PPARγ antibody from Abd Serotec was then used to study PPARγ 
expression in embryonic and postnatal mouse back skin. Both acetone and PFA fixation 
techniques were used, as wells as a no fixation step. In the early embryonic ages, only 
even background staining of the skin was observed after protocols using either no 
fixation or acetone fixation (Figures 3.26 2 and 3 and Figure 3.27 1). When fixed in 4% 
PFA, some positive staining was found in the upper dermis (Figures 3.26 4 and 3.27 2). 
However, this did not coincide with the DAPI labelling and so did not represent nuclear 
expression. The same distribution in the upper dermis was seen with e18.5 (Figure 3.28) 
and 1 day newborn mouse back skin, after PFA fixation (Figure 3.29). By postnatal day 
3, the positive staining was less obvious (Figure 3.30). Therefore, overall little 
specificity was identified in relation to the staining of PPARγ in vivo. 
 
Figure 3.25: Analysis of PPARγ  (Abd Serotec) expression in 3T3 F442A cells not induced 
to differentiate and fixed in PFA. Adherent cells fixed with 4% PFA and stained with an 
antibody against PPARγ (Abd Serotec) and counterstained with DAPI. From left to right; 
DAPI, FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. 
(A-C) Controls showing no fluorescently labelled PPARγexpression. (D-I) labelled using 
PPARγ primary antibody. Fluorescent images were taken using a Zeiss Axio Imager M1. 
Scale bar = 40µm. 
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Figure 3.26: Analysis of PPARγ  (Abd Serotec) expression in 14.5-day embryonic mouse 
back skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abd 
Serotec) and counterstained with DAPI. From left to right; DAPI, FITC, and merge 
(DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (1A-C) Controls showing 
3 merged images with no fluorescently labelled PPARγ expression. (1A,2) No fixation step. 
(1B,3) Fixed in acetone. (1C,4) Fixed in 4% PFA. (4A, B) Upper and lower views of the skin. 
(2-4) labelled using PPARγ primary antibody. Fluorescent images were taken using a Zeiss 
Axio Imager M1. Scale bar = 40µm. 
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Figure 3.27: Analysis of PPARγ  (Abd Serotec) expression in 16.5-day embryonic mouse 
back skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abd 
Serotec) and counterstained with DAPI. From left to right; DAPI, FITC, and merge 
(DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (1A-C,2A-C) Controls 
showing no fluorescently labelled PPARγ expression. (1) Fixed in acetone. (2) Fixed in 4% 
PFA. (1D-F,2D-F) labelled using PPARγ primary antibody. Fluorescent images were taken 
using a Zeiss Axio Imager M1. Scale bar = 40µm. 
 
 
. 
	   98	  
 
 
 
 
 
 
 
Figure 3.28: Analysis of PPARγ  (Abd Serotec) expression in 18.5-day embryonic mouse 
back skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abd 
Serotec) and counterstained with DAPI. From left to right; DAPI, FITC, and merge 
(DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (1A-C) Controls showing 
3 merged images with no fluorescently labelled PPARγ expression. (1A,2) No fixation step. 
(1B,3) Fixed in acetone. (1C,4) Fixed in 4% PFA. (2-4) labelled using PPARγ primary 
antibody. Fluorescent images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.29: Analysis of PPARγ  (Abd Serotec) expression in 1-day postnatal mouse back 
skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abd Serotec) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. (1A-C) Controls showing 3 merged images 
with no fluorescently labelled PPARγ expression. (1A,2) No fixation step. (1B,3) Fixed in 
acetone. (1C,4) Fixed in 4% PFA. (2-4) labelled using PPARγ primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.30: Analysis of PPARγ  (Abd Serotec) expression in 3-day postnatal mouse back 
skin. Sections were cut at 7µm and stained with an antibody against PPARγ (Abd Serotec) and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of PPARγ. Images of upper and lower views of the skin 
shown, to give a view of the whole skin. (1A-E) Controls showing merged images with no 
fluorescently labelled PPARγ expression. (1A,2) No fixation step. (1B-C,3) Fixed in acetone. 
(1D-E,4) Fixed in 4% PFA. (2-4) labelled using PPARγ primary antibody. Fluorescent images 
were taken using a Zeiss Axio Imager M1. (1A,2) scale bar = 65µm. (1B-E,3,4) scale bar = 
40µm. 
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Although the use of the Abd Serotec PPARγ antibody in frozen sections was not 
so successful, the protocol stated that this antibody had previously been used on paraffin 
wax sections. To further investigate if this antibody was capable of producing some 
positive nuclear labelling of where adipogenesis was taking place in the skin, specimens 
taken from 5-day old newborn mice were fixed, processed in paraffin wax, sectioned 
and stained for PPARγ using the suggested protocol. The wax sections had what looked 
like positive staining of slightly cuboidal shaped cells throughout the sections and in 
particular surrounding the follicles (Figure 3.31). However, when negative controls 
were examined a similar pattern of labelling was observed (Figure 3.31 1). It was 
therefore deduced that the staining protocol had led to non-specific labelling of cell 
types in the skin, possibly sebocytes or melanocytes. 
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Figure 3.31: Analysis of PPARγ  (Abd Serotec) expression in 5-day postnatal mouse back 
skin. Skin was fixed in paraffin blocks and sections were cut at 7µm, stained with an antibody 
against PPARγ (Abd Serotec) and counterstained with DAPI. From left to right; DAPI, FITC, 
and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (1A-E) 
Controls showing merged images with no fluorescently labelled PPARγ expression. (2,3) 
labelled using PPARγ primary antibody. (3) View through the whole skin shown in 2 images. 
Fluorescent images were taken using a Zeiss Axio Imager M1. (1A,2) scale bar = 65µm. (1B-
E,3) scale bar = 40µm. 
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3.3.3. PPARγ  Staining of Dermal Cell Spheres  
 To try to understand the discrepancy between PPARγ labelling in culture and in 
developing skin, 3-dimensional cell spheres were made using dermal cells taken from 
14.5-day embryonic mouse back skin. These cells were left to cluster and then after 2, 3, 
4, 5, and 6 days the spheres were frozen to stain with PPARγ. 3 different PPARγ 
antibodies were used: E-8 Santa Cruz, Abcam and Abd Serotec.  
 The spheres were stained with oil red O to detect the presence of lipids in 
developing adipocytes (Figure 3.32). There was red coloration present in all the sphere 
ages, particularly those spheres that were more densely clustered. After 5 days, the lipid 
droplets appeared bigger (Figure 3.32, 4a and b) and the image taken after 3 days shows 
the red coloration clustering in the centre of the cell sphere (Figure 3.32 2). This shows 
that adipose tissue is forming in the cell spheres taken from as early as e14.5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.32: Oil red O analysis of dermal cell spheres taken from embryonic day 14.5 
mouse back skin. (1) stained after 2 days . (2) stained after 3 days. (3) stained after 4 days. (4) 
stained after 5 days. (5) stained after 6 days. Fat droplets present in adipocytes visible as red 
coloration. Images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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 After 2 days in culture, when spheres had formed they were stained with 
PPARγ. For all three antibodies used and also the negative controls, a similar staining 
pattern was observed, though the background staining was slightly stronger using the 
Abcam and Abd Serotec primary antibodies (Figure 3.33). Brighter specks were seen in 
parts of the spheres, however when merged with the DAPI nuclear staining, the 
fluoresced specks did not coincide with the nuclei. In fact, the nuclei in the FITC 
images were not fluorescent at all, but instead registered black gaps in the staining. This 
suggested no PPARγ expression present after 2 days. 
 After 3 days in culture, the same result as 2 days was seen using the Santa Cruz 
antibody (Figure 3.34B). However, there was some nuclear staining of PPARγ 
expression found using the Abcam antibody (Figure 3.34D) and this differed from the 
controls where no nuclei were stained positive (Figure 3.34C). Abd Serotec was 
difficult to analyse due to a large amount of background staining but some of the 
fluoresced sections did coincide with the DAPI stained nuclei (Figure 3.34E).  
 After 4 days in culture, the spheres stained with Santa Cruz E-8 showed a 
uniform, but unexpected distribution of staining round the perimeter of each nucleus 
(Figure 3.35B). This differed significantly from that found using the PPARγ primary 
antibodies from Abcam and Abd Serotec, which showed clear nuclear expression. This 
was clear in the magnified sections (Figures3.35D and E). There still existed a degree of 
background staining, however this was also present in the negative control (Figure 
3.35C). 
 After 5 days in culture, the spheres stained with Santa Cruz PPARγ showed 
more fluoresced nuclei perimeters (Figure 3.36B). This was also seen after 4 days 
(Figure 3.35B). However, the images obtained with the Abcam antibody differed 
significantly. Whereas 4-day spheres there appeared to be nuclear expression, no 
nuclear expression was found in 5 day spheres (Figure 3.36D). There was still a degree 
of nuclear staining present in the Abd Serotec stained sections, though this was less 
obvious due to a high level of background staining (Figure 3.36E). 
 After 6 days in culture, there was brighter fluorescence surrounding the nuclei 
peripheries present in the Santa Cruz stained spheres, suggesting the expression was 
cytoplasmic (Figure 3.37B). In the Abcam stained spheres, there was some cytoplasmic 
fluorescence and some nuclear fluorescence, suggesting that cells were differentiating at 
different rates (Figure 3.37D). In the Abd Serotec stained spheres after 6 days, it was 
difficult to deduce whether specific nuclear staining was present (Figure 3.37E). Some 
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labelling did still appear to be nuclear, but the brighter fluorescence appears to have 
spread out.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.33: Analysis of PPARγ  expression in dermal spheres taken from e14.5 mouse 
back skin dermis and stained after 2 days. Sections were cut at 7µm, stained with one of 
three antibodies against PPARγ and counterstained with DAPI. From left to right; DAPI, 
FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A,C) 
controls showing merged images with no fluorescently labelled PPARγ expression and (C) is 
the negative control for both Abcam and Abd Serotec antibodies. (B,D,E) labelled using 
PPARγ primary antibodies. (B) Santa Cruz E-8. (D) Abcam. (E) Abd Serotec. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.34: Analysis of PPARγ  expression in dermal spheres taken from e14.5 mouse 
back skin dermis and stained after 3 day. Sections were cut at 7µm, stained with one of 
three antibodies against PPARγ and counterstained with DAPI. From left to right; DAPI, 
FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A,C) 
controls showing merged images with no fluorescently labelled PPARγ expression and (C) is 
the negative control for both Abcam and Abd Serotec antibodies. (B,D,E) labelled using 
PPARγ primary antibodies. (B) Santa Cruz E-8. (D) Abcam. (E) Abd Serotec. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.35: Analysis of PPARγ  expression in dermal spheres taken from e14.5 mouse 
back skin dermis and stained after 4 days. Sections were cut at 7µm, stained with one of 
three antibodies against PPARγ and counterstained with DAPI. From left to right; DAPI, 
FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A,C) 
controls showing merged images with no fluorescently labelled PPARγ expression and (C) is 
the negative control for both Abcam and Abd Serotec antibodies. (B,D,E) labelled using 
PPARγ primary antibodies. (B) Santa Cruz E-8. (D) Abcam. (E) Abd Serotec. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.36: Analysis of PPARγ  expression in dermal spheres taken from e14.5 mouse 
back skin dermis and stained after 5 days. Sections were cut at 7µm, stained with one of 
three antibodies against PPARγ and counterstained with DAPI. From left to right; DAPI, 
FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A,C) 
controls showing merged images with no fluorescently labelled PPARγ expression and (C) is 
the negative control for both Abcam and Abd Serotec antibodies. (B,D,E) labelled using 
PPARγ primary antibodies. (B) Santa Cruz E-8. (D) Abcam. (E) Abd Serotec. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 3.37: Analysis of PPARγ  expression in dermal spheres taken from e14.5 mouse 
back skin dermis and stained after 6 days. Sections were cut at 7µm, stained with one of 
three antibodies against PPARγ and counterstained with DAPI. From left to right; DAPI, 
FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of PPARγ. (A,C) 
controls showing merged images with no fluorescently labelled PPARγ expression and (C) is 
the negative control for both Abcam and Abd Serotec antibodies. (B,D,E) labelled using 
PPARγ primary antibodies. (B) Santa Cruz E-8. (D) Abcam. (E) Abd Serotec. Fluorescent 
images were taken using a Zeiss Axio Imager M1. Scale bar = 40µm. 
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3.4. Discussion 
 
When studying the process of adipogenesis in vivo, preadipocyte markers are 
essential for locating the developing cells, in order to make accurate assessment when 
researching key events. PPARγ has long been recognised as the main regulator of 
adipogenesis from early preadipocytes right through to terminal adipocytes. However, 
when used as an adipogenesis marker by immunohistochemistry on mouse skin, aged 
e17, e18, e19 and 1 day newborn (1dN), it was not found present in the lower dermis, 
but instead present in the epidermis (Wojciechowicz 2012). Wojciechowicz (2012) 
suggested investigating the capability of the PPARγ antibody to produce positive 
PPARγ expression, prior to using it as a marker, since the most obvious reasons for the 
absence of staining where adipocytes are maturing are problems with the antibody or 
the staining protocols. The aim of this chapter was therefore to determine the reliability 
of PPARγ antibody staining using the in vitro 3T3 F442A cell line. 3T3 cells have been 
studied in depth and it is known that PPARγ expression is present 42-60 hours after 
being induced to differentiate (Morrison and Farmer 1999; Wojciechowicz 2012). Here, 
in this chapter the same antibody used (Abcam) was tested, as well as four other anti-
PPARγ primary antibodies. These consisted of two Santa Cruz antibodies (B-5 and E-8) 
and one from Bioaffinity Reagents and another from Abd Serotec, all listed in section 
3.2. 
 
3.4.1. PPARγ  in vitro using the 3T3 F442A Cell Line 
When 3T3 F442A cells were grown in adherent culture, it was observed that 
some of the cells spontaneously differentiated into adipocytes, without the need for 
adipogenic-inducing medium. Proliferating 3T3 cells exhibit a fibroblast-like 
morphology, then after they reach confluency and growth arrest, induction media allows 
the cells to undergo mitotic clonal expansion needed for adipocyte differentiation 
(Moreno-Naverrete and Fernández-Real 2012). Growth arrest was suggested to be 
important for allowing cell differentiation (Pairault and Green 1979). Green and 
Kehinde (1976) observed that when growth arrest occurred, some 3T3 cells 
differentiated in culture. Therefore it is not unusual for 3T3 cells to differentiate 
spontaneously due to a high degree of commitment to the adipocyte lineage, more so 
with F442A than L1 ((Moreno-Naverrete and Fernández-Real 2012).  
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After inducing some of the 3T3 cells to differentiate, it was clear that the 
adipogenic cocktail induced a large proportion of the cells to differentiate and visibly 
show adipocyte features after 48 hours (Figures 3.2D-F). For example, the yellow 
coloration present in the images, when magnified revealed a vast quantity of lipid 
droplets within the cells, indicative of adipocytes (Figure 3.2). Oil red O staining of the 
3T3 cells left in culture for 10 days, clearly showed that adipocytes had differentiated 
and expanded (Figure 3.3), because some of the red-stained lipid droplets were 
substantially larger from those seen in Figure 3.2. 
3T3 F442A cells that were induced to differentiate were stained after 48 hours 
with 5 different PPARγ antibodies. Santa Cruz B-5 showed no positive staining (Figure 
3.4) while Santa Cruz E-8 (Figure 3.8) and Affinity Bioreagents (Figure 3.6) showed 
clear nuclear expression of PPARγ. The Santa Cruz E-8 antibody appeared to be more 
specific and the most reliable as there was clearly less cells stained in the non induced 
cultures (Figure 3.9), whereas the Affinity bioreagents antibody showed a degree of 
background staining which was also present in the controls. The Abcam PPARγ 
antibody staining showed some nuclear staining in the induced cells and a degree of 
cytoplasmic staining, suggesting the protein had been produced and was present in the 
cells (Figure 3.15). When stained with the antibody from ABD Serotec and fixed in 
acetone, there was a degree of nuclear staining, while when fixed in 4% PFA the 
staining was cytoplasmic like that of Abcam (Figures 3.22 – 3.25). The Abcam antibody 
was that used by Wojciechowicz (2012). It was hypothesised that one of the other 
antibodies may be more reliable in mouse back skin, considering in the 3T3 cells 
Abcam was not the strongest staining antibody, though there was positive staining 
found. 
 
3.4.2. PPARγ  in vivo in Rodent Back Skin 
Four of the PPARγ primary antibodies were investigated in vivo in back skin to 
determine if the results were similar using each antibody. The Santa Cruz B-5 antibody 
was not used as did not produce a positive result in vitro.  
The affinity bioreagent antibody strongly stained the follicles in 4-day newborn 
mouse skin, though there was no visible staining in the lower dermis where adipocytes 
are known to be present (Figure 3.10). Comparatively, the Santa Cruz E-8 antibody that 
worked really well in vitro, showed what appeared to be positive staining though when 
compared with the negative control it was the same (Figure 3.13). The mouse-on –
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mouse kit used was deemed unreliable, because when used in the same laboratory for 
other experiments the same results in the controls were found (unpublished). Without 
the MOM kit, background fluorescence of the mouse back skin was high (Figure 3.12).  
The Abcam antibody was used in mouse back skin to control if the result found 
was the same previously conducted (Wojciechowicz 2012). The same epidermal 
staining at the base of the epidermis was found, with some follicular staining from e16.5 
(Figure 3.20) and also present in e18.5 (3.21), 1 day and 3 day newborn (Figures 3.17 
and 3.18). Interestingly this was not found at e14.5 (Figure 3.19). This could relate to 
the development of hair follicles. Hair follicle initiation begins around e14/14.5 and it is 
known that adipocytes develop around the base of the hair follicles in the lower dermis 
of rodent skin and also pig skin (Hausman et al. 1981; Hausman and Martin 1982), It 
could be suggested that the commitment of dermal cells to the adipogenic lineage may 
require the formation of the hair follicles in order to receive signals from the hair 
follicle end bulbs present in the lower dermis. In the skin stained from e14.5, there were 
no follicles visible in the lower dermis. The expression of PPARγ may in fact come 
from the hair follicles which signal to the preadipocytes. Hair follicle initiation may 
trigger the expression of PPARγ and so indirectly hair follicle formation is the cause of 
preadipocyte commitment. 
When fixed in PFA, skin sections stained with the Abd Serotec antibody showed 
some staining in the upper dermis, close to the upper dermis from e18.5 (Figure 3.28) 
and also in the 1-day newborn skin (Figure 3.29). There is some staining of the lower 
dermis in the 3 day newborn samples, however when compared with the antibody 
control, there is the same staining which infers it to be background staining. 
 
3.4.3. E14.5 Dermal Cell Spheres in 3-dimensional Cell Culture 
 The e14.5 dermal cells were put into culture in media droplets and clustered to 
form spheres. After 2 days, there was already a degree of lipid content present in the 
spheres (Figure 3.32 1a) and this developed over a further 4 days. This showed that 
there was successful formation of adipocytes in the spheres taken as early as e14.5. This 
could infer that that the dermal cells are already capable of becoming adipocytes, earlier 
in development than previously though, but that there is a signal from the epidermis that 
prevents the formation of adipocytes until a later stage (Wojciechowicz 2012). 
However, not all the cells in the spheres differentiate into adipocytes. This could 
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suggest that there is already a developmental division between the upper and lower 
dermis, only the lower dermis requires an inhibiting signal.  
The images taken from e14.5 + 3 days shows the adipocytes stained red 
concentrated in the centre of the sphere (Figure 3.32 2). This may be different from 
some of the sections depending where in the sphere the section was taken. When the 
cells form spheres, the dermal cells could potentially organise into upper and lower 
dermis with the lower dermis in the centre. E14.5 skin is very fragile and difficult to 
separate; therefore, there could be some epidermal contamination, from which the 
epidermal cells may orientate on the perimeter of the sphere.  
After 3 days using the Abcam antibody (Figure 3.34D), and more clearly using 
the Abd Serotec antibody after 4 days (Figure 3.35E), there was nuclear expression of 
PPARγ present. This is respectively e18.5, which is the same time at which C/EBPα is 
expressed. Siersbæk and colleagues (2012) said that C/EBPα and PPARγ work together 
at a similar time point to initiate the cascade of adipogenic genes, sharing 35-60% co-
localisation (Lefterova et al. 2008; Schmidt et al. 2011). The cells are already 
committed but require induction from C/EBPα and PPARγ to start differentiating.  
There does not appear to be a role of PPARγ in early adipogenesis and commitment, 
although perhaps this comes from the hair follicles. 
After 6 days in culture, there was a thicker ring of fluorescence present in the 
Santa Cruz stained spheres, suggesting the expression was cytoplasmic and the protein 
was there (Figure 3.36B). This could be related to the idea that PPARγ presence is 
required to maintain the population of terminal adipocytes. 
The spheres contain only the dermal cells and so cannot be directly contrasted 
with what occurs in vivo. The hair follicles do not develop in the spheres. However, the 
3D sphere method is more beneficial than growing the dermal cells in 2D culture, 
because the in vivo environment is 3D. Culturing the dermal cells does show what these 
cells are capable of alone without other signals from other tissues and developing 
organs, which proves useful in concluding that these cells are capable of becoming 
adipocytes as early as e14.5.  
 
While some of the antibody staining looks positive, each antibody produces a 
significantly different distribution. This does not produce reliable data for the presence 
of PPARγ. As well as this, no positive staining was found to coincide with the dermal 
fat layer. Either PPARγ is not important to the dermal adipose layer or the antibodies do 
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not work so well using the immunofluorescence technique on frozen sections. This does 
not necessarily mean that PPARγ is not important for adipose development, but perhaps 
the dermal adipose layer is regulated in a different way, or that the signal comes from 
the hair follicles, or is only needed later in adipogenesis. However, other avenues need 
to be explored to find a marker of early adipogenesis. A dominant negative mutant of 
PPARγ shows what appears to be normal adipocyte development, though when looked 
at closer, the organ has more white adipose tissue (Gray et al. 2006). PPARγ may be 
required to produce normal adipogenesis, but precursor cells are committed prior to 
PPARγ expression. 
Affinity bioreagents shows staining of the base of the epidermis. PPARγ may be 
required by hair follicles and then signals to other transcription factors down the follicle 
to the adipocytes around the base of the hair follicles. 
 
3.4.4. Further Work 
This is by no means conclusive evidence. While some of the antibodies appear 
to work very well in vitro, there is such a degree of difference in the staining in vitro 
and vivo, between the antibodies, even though all of them are staining for PPARγ. The 
immunofluorescence method is maybe not reliably accurate enough. In line with what 
the literature states, that expression in 3T3 cells is 42 to 60 hours after induction 
(Morrison and Farmer 1999), it would be beneficial to confirm using Western blot 
analysis that the PPARγ protein is present around this time in the cells and then also use 
in the skin to confirm the presence of PPARγ in the skin. Western blot analysis may be 
more effective use of the antibodies. A good control would be to make spheres with the 
3T3 cells. This would show whether the difference in the staining were due to the 2D 
vs. 3D environment or were tissue specific differences.  
The cells don’t cluster uniformly across all the spheres. A reason for the 
differential staining in vitro could be that when there is less cell-to-cell interaction the 
signalling is different. The density of the spheres could be calculated and the density 
compared with the degree of PPARγ expression and adipocyte formation.  
The e14.5 spheres have not been influenced by the waves of hair follicle 
formation and it is thought that there is interaction between adipogenesis and hair 
follicle formation. Spheres from different ages could be put into culture in the same way 
and the level of expression and oil red O staining should be analysed. However, most 
importantly, the first step is to confirm an effective PPARγ antibody or method of 
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detecting PPARγ for use in this investigation. 3T3 cells are developed from 3T3 mouse 
embryos and may be already committed so they are not as reliable as in vivo. However, 
they are useful for studying the effectiveness of the antibodies. 
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CHAPTER 4: 
Establishing the Models; 
Experimenting with Organ and Cell 
Culture using both 2-Dimensional and 
3-Dimensional Methods 
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4.1. Introduction 
 
As introduced in chapter 1, a dermal adipose layer has recently been found to 
exist in the skin. The overall aim of this thesis is to investigate the role of key signalling 
pathways in dermal adipogenesis. To do so, a suitable experimental model is required. 
Many different types of model system have been used to study the process of 
development. Three main types of model are discussed in this chapter; mouse models, 
organ culture models and cell culture models.  
 
4.1.1. Mouse Models  
Model systems have been deemed appropriate ways of studying many biological 
processes, both by in vitro and in vivo means. In response to the fact that it is difficult to 
fully understand what is going on during development in a normally functioning 
organism, knockout and other transgenic mouse models, including those with silenced 
or mutated genes are found throughout research. For example, a C/EBPβ-C/EBPδ 
double knockout mouse was created by Tanaka and colleagues (1997) using gene 
targeting and led to the conclusion that these genes are needed for terminal 
differentiation. Another is example is that when Caveolin-1 (Cav-1) was knocked out 
and caused abnormal adipocytes with irregular lipid metabolism and prevented diet-
induced obesity (Razani et al. 2002). Mice have been deemed appropriate for studies 
throughout research as they are small and manageable and their gestation cycle is 
relatively short at 19-21 days long (Green, 2013). By observing what happens when 
normal development is disrupted, the role of certain genes at different timings and 
localisations can be used to infer what is occurring during normal development. For 
example in the study of adipogenesis, by knocking out C/EBPα, brown and white 
adipocytes cannot accumulate and the mice die shortly after birth (Wang et al. 1995) 
This also occurred with PPARγ null mice, which were embryonic lethal (Barak et al. 
1999).  
Mouse models are useful to infer the effects of certain genes during 
development, e.g. the C/EBPβ-C/EBPδ double knockout mouse (Tanaka et al. 1997) or 
Cav-1 knockout mice (Razani et al. 2002). However, they also have their limitations 
e.g. short-term survival, and there is not enough known about the molecular basis of 
development of the dermis to produce a mouse model for this project. What would be 
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used as the driver in the dermis to create a transgenic mouse? Mouse models are also 
too expensive and there is not enough time available on this project.  
 
4.1.2. Organ Culture Models  
 An alternative to mouse models is to use organ culture and perform experiments 
of these cultures. Many different research groups have used similar methods of 
culturing skin. Whatever the research question, the basic requirements of these organ 
culture models are the same, including the ability of the skin to survive and be 
metabolically active. Additionally the isolated skin contains all the cell types present 
that could be influencing the development and/or growth of the structure. 
Kao et al. (1983) focused on developing a short-term organ culture model of skin 
from 7 to 8 week old mice to investigate cutaneous toxicity. Yasuoka et al. (2008) used 
a similar technique with human skin. Organ cultures have also proved beneficial as a 
way of replicating in vivo activities, ex vivo for developing skin. Kashiwagi et al. (1997) 
used whole back skin of embryos grown on filters coated with type 1 collagen in a 
medium containing 1% foetal bovine serum. A similar substrate organ culture model 
was employed by Richardson et al. (2009) to investigate the influence of KGF and FGF 
pathways on follicle development. This method involved the microdissection of small 
pieces of dorsolateral skin around e14 and the skin was normally maintained for 72 
hours. A similar technique was initiated by Wojciechowicz (2012) with older (e16.5) 
skin to investigate adipogenesis. 
 
4.1.3. Cell Culture Models 
Cell cultures can also be used to study adipogenesis In fact, most of what is 
known about the cellular and molecular basis of adipogenesis originally comes from 
3T3 cell lines. These include, the 3T3-F442A and 3T3-L1 cell lines. These lines were 
generated from embryos of Swiss mice (Todaro and Green 1963). Lipid accumulation 
was found to occur in these cells after they had reached 100% confluency (Green and 
Kehinde 1974). Factors can be added to these cells to induce or inhibit adipogenesis, 
which makes them useful for studying what effects different growth factors might be 
having on the ability of the cells to differentiate.  
These cell lines are cost effective as they can provide an unlimited number of 
cells of a pure population and differentiate efficiently without the ethical restrictions 
that come with using animal or human tissue (Kaur and Dufour 2012; Siersbæk et al. 
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2012). While there are many advantages to using cell lines as opposed to primary cells, 
with their usage also comes a number of disadvantages. Since they have been 
genetically altered, they may not be as similar to primary cells as desired and passaging 
the cells may cause further genotypic and phenotypic alterations (Kaur and Dufour 
2012). Confirmation should always be done with primary cell and the findings 
associated with cultured cell lines are not definitive. As well as this, in comparison with 
cells in vivo, the two-dimensional environment that the cells are cultured in does not 
reflect that of the three-dimensional environment of tissues in the body. 
Other cell lines have been produced from adult adipose tissue. For example, the 
preadipocyte cell line AP-18, which was created from an adult C3H/HeM mouse, 
subepidermal layer of ear skin (Doi et al. 2005). Primary cultures are better and have 
also been produced from adult tissues of many species including rodents. 
Primary cells, in this case cells taken from the dermis of the skin, can be used to 
study development through cell culture. Both two-dimensional and three-dimensional 
culture techniques can be used. In the Jahoda group, the 3D spheroid cell culture 
technique has been used extensively (Higgins et al. 2009; Wojciechowicz 2012). This 
technique is used in this project to create a model system to study adipogenesis. 
Adipogenesis has been much more extensively studied in vitro using cell lines 
compared with in vivo. This is partly because in vitro methods are more accessible. 
They are also less likely to be influenced by other cell types and developmental 
processes occurring alongside adipogenesis (adipocyte formation). Due to full genome 
microarray analysis studies, however, Wojciechowicz (2012) as well as others have 
shown that there are many fundamental differences between in vitro and in vivo, 
including those associated with gene expression. For example, Cebpβ, Cebpδ and Stat5 
were not found in vivo, but were found in vitro (Wojciechowicz 2012). This has 
encouraged the need for more in vivo and in-vivo like methods of investigation and cell 
culture methods are largely artificial. 
 
 The aim of this chapter was to establish a model with which to study and be able 
to manipulate adipogenesis in vitro. The initial approach was the development of a 
whole skin organ culture model. I replicated Wojciechowicz’s (2012) organ culture of 
foetal mouse skin in order to develop a method of investigating the effects of altering 
specific signalling pathways on the development of adipocytes and lipid accumulation 
in the dermis. The aim was, to generate an in vivo-like environment ex vivo, so that, 
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different factors involved in signalling pathways could be applied directly to the culture 
to examine their influences on adipogenesis at key time points. This reduces the 
influences of other developmental events that occurring at around the right time, while 
still leaving the skin in its correct in vivo-like organisation. Within the general protocol, 
a number of different variables were experimented with, including medium type, serum 
concentration and length of culture. When considerable inconsistency was encountered, 
a different strategy was employed. This involved the establishment of primary dermal 
cultures from embryonic skin and the development of a novel 3D spheroid model using 
hanging drop techniques. Adipogenesis in these structures were compared with that of 
the same cells in regular 2D monolayer culture. The results suggest that the 3D model is 
a relatively robust representation of adipogenic activities in the dermis. 
 
4.2. Material and Methods  
 
4.2.1. Origin, Maintenance and Breeding of Mice  
 Mouse back skin aged from e14.5 to e18.5 was taken from the FVB strain from 
the Durham University Life Sciences Support Unit (LSSU). Mice were kept at 21°C, 
55% humidity on a 12 hour light/dark cycle. They were fed on the Harlan Teklad 2013 
Rodent Maintenance diet and watered ad libitum.   
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Images of whole embryos taken from FVB mice at specific time points. 
Embryos photographed before manipulation. (A) 14.5 day embryo. (B) 16.5 day embryo. (C) 
17.5 day embryo. (D) 18.5 day embryo. Images were taken in dark field using a Zeiss Stemi 
SV 11. Scale bar = 3mm. 
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Vaginal plug analysis was used to obtain skin from embryos at specific ages. 
The presence of a vaginal plug the morning after breeding pairs had been kept together 
was used as an indication of a successful mating and the embryos were noted at 0.5 days 
gestation at this point. Animals were killed using CO2/cervical dislocation. 
 
4.2.2. Isolation of Skin Samples  
 Skin samples were taken from FVB embryos between 14.5 and 18.5 days, 
mainly 16.5-day-old embryos (e16.5). The skin along the back of the embryos was held 
taut by two pins before two longitudinal incisions were made as shown below in Figure 
3.2. The skin was then carefully separated from the underlying muscle layer using a 
circular motion to detach it. Three or four transverse cuts were made to divide the piece 
into two or three depending on the size of the embryo in relation to its age. This process 
was repeated on the other side.  
 
 
 
 
 
 
 
 
4.2.3.1. Establishment of Organ Cultures  
 Collagen coated filters were first prepared. Nucleopore filters (Whatman) were 
coated with rat tail collagen (Sigma) (Appendix III). These were then placed on the lid 
of a petri dish before being left under UV overnight and then kept in the fridge.  
 A drop of media was placed in a 35mm dish on which a collagen-coated filter 
was placed with the shiny surface facing upwards. This was then lifted to the surface by 
carefully pipetting 2ml of media underneath it. Different serum concentrations and 
types of media were trialled to determine whether any of them were more successful 
than the others in allowing healthy and consistent culture results. Both Modified Eagle’s 
Medium (MEM: Gibco, Paisley UK) and William’s E Medium (Gibco, Paisley UK) 
Figure 4.2: Diagram depicting where the mouse skin was taken from. 16.5 day old 
embryo. Arrows show where pins were placed. Dotted line shows where the skin was cut. 
Scale bar = 3mm 
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were used and supplemented with 0%, 1% and 2% foetal bovine serum (Sigma, MO 
USA).  
 The skin pieces were carefully transferred to these filters with the epidermis 
facing upwards and the dermis in contact with the filter. Approximately 5 pieces were 
placed on each filter in each dish. Images were taken (Zeiss Stemi SVII microscope 
with AxioCam ERc5s and Axiovision software) before the dishes were transferred to an 
incubator at 37°C, 5% CO2. Alongside this, some skin pieces were suspended in 
hanging drops of media to experiment with different methods of culturing the skin 
pieces. 
 After three days the skin pieces were put into Tissue-Tek® O.C.T.™ compound 
(Sakura, Agar Scientific, Netherlands) and orientated flat using fine tweezers so 
sections can be cut right through the skin (see figure 4.3).  These were snap frozen in 
liquid nitrogen and kept at −80°C. Skin sections (7µm and 10µm), were cut on a 
cryostat (LEICA CM 3050S) and attached to ColorFrost®Plus slides (Thermo Shandon 
Ltd, Cheshire, UK). The slides were dried for 2 hours at room temperature, and then 
either used immediately or frozen before immunofluorescence staining, oil Red O lipid 
detection or haematoxylin and eosin (H&E) staining. Frozen slides, were defrosted 
before staining.  
 
 
 
 
 
 
 
4.2.3.2. Establishment of the Cell Culture System 
Throughout the cell culture, the cells were cultured in a culture medium, referred 
to as the “basic medium”. This consisted of modified essential medium (MEM) (Gibco) 
Figure 4.3: Schematic showing the orientation of the skin pieces in the freezing boats in 
preparation for sectioning. 3 different views are shown. Left is an aerial view from above 
and Right shows both side views.   
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with 10% foetal bovine serum (Sigma) and antibiotics; 10U/ml penicillin, 100µg/ml 
streptomycin  (Gibco) and 2µg/ml fungizone (Sigma). 
4.2.3.2.1. Production of Single Cell Suspensions from Mouse Dermis 
 Skin pieces obtained from foetal mouse back skin were put in a 6% 
Pancreatin/5% Trypsin cocktail in Earle’s solution (1:1:2) (Appendix III)) at 4ºC for 
between 30-90 minutes according to age. Fine tweezers were then used to carefully 
prise apart the dermis from the epidermis. Dermal pieces were transferred to sterile 
Earle’s solution before being incubated in a warm working solution of DNase I 
(Sigma)/Collagenase II (Appendix III) at 37ºC for 15-20 minutes. Mechanical 
dissociation was carried out with a 1ml pipette to form a single cell suspension of the 
dermis. The suspension was diluted with 2ml of 10% FBS-MEM and filtered through a 
cell strainer (70µm nylon mesh; Fisherbrand), before being centrifuged at 1000rpm for 
5 minutes. The supernatant was carefully poured off leaving a cell pellet which was 
resuspended in 1ml of the basic medium. 
 A haemocytometer was used to count the number of cells collected (appendix 
IV). This was to ensure consistency in cell number across each experiment and between 
2D and 3D culture methods. 
 
4.2.3.2.1.1. Density Separation using Ficoll PM400 (Dermis purification) 
 To try to reduce the chance of contamination of the dermal cells with epidermal 
cells, Ficoll PM400 (GE Healthcare, Life Sciences) was used to separate the densities of 
the cells (keratinocytes and fibroblasts). Two ficoll fraction mixtures were created. For 
the density of fibroblasts, 1.05 grams of Ficoll was added to 1ml sterile PBS. For the 
density of keratinocytes, 1.06 grams of Ficoll was added to 1ml sterile PBS. These were 
left to mix overnight at 4C. The 1.05g solution was then pipetted on top of the 1.06g 
solution and left for 1 hour at room temperature before use (Figure 4.4). All processes 
were conducted in a microbiological safety cabinet to reduce the risk of contamination.  
 In order to separate the cell densities, the single cell suspensions described in 
section 4.2.3.2.1 were pipetted in the 1ml basic medium into the prepared Ficoll. This 
was then centrifuged at 8000g/rcf for 1 hour. The cell pellet present in the top fraction 
was then taken off and resuspended in 1ml basic medium, before being put into cell 
culture.  
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4.2.3.2.2.Two-dimensional and 3-dimensional Culture Techniques 
 2D and 3D culture techniques were used and at specific time-points. 3D was 
also transferred to 2D. Different incubation times were experimented with to reach what 
was considered the optimum for the survival of the cells and successful formation of the 
spheres. Originally the 3D spheres were put into 2D to adhere for just 24 hours, but this 
was extended to two days. Table 4.1 illustrates the finalized timings used for these 
procedures.  
 
Table 4.1: The final incubation times for cells in the cell culture model 
Incubation Time (Days) Embryonic Age 
(Days) 2D 3D 3D to 2D 
15.5 7 5 2 
16.5 6 4 2 
17.5 5 3 2 
18.5 4 2 2 
 
 As well as the length of time, other variables were experimented with, including 
the size of the well, number of cells and whether to use coverslips or not.  
 To show clearly the methodology of the cell culture model experimented with, 
in this chapter and chapter 5, a schematic diagram was made. 2D, 3D and 3D to 2D 
culture was combined to establish the model system (Figure 4.5). 
 
 
 
Figure 4.4: Schematic showing FICOLL set-up. 2 different fractions were used: 1.05 grams 
of Ficoll in 1ml PBS and 1.06 grams Ficoll in 1ml PBS. 
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4.2.3.2.2.1 Two-Dimensional Cell Culture  
 Many different cell numbers (from 6000 to 600,000 cells) were tried to 
determine an optimum experimental method. Finally 24,000 cells were settled on so that 
numbers could be kept relatively consistent with the 3D culture methods. 
 To each well of a 6-well plate (Bio-weiner, Sigma) or 35mm dish (Nunc), 24000 
cells were added in 2ml of basic medium. These were then incubated at 37°C, 5% CO2. 
When first establishing the models, media was changed every two days though this was 
found to have more of a negative effect than leaving the media for the duration of the 
incubation and reducing infection/contamination risk. While 6-well plates were used for 
the final experiments, 24-well plates were also experimented with. As well as this, in an 
attempt to use the cells for immunofluorescence analysis, coverslips were placed in the 
bottom of the wells before pipetting the cells on top.  
 After the respective durations in culture, representative pictures were taken of 
the cells (Zeiss Axiovert 10 with AxioCam ERc5s) before being washed in PBS 
(3x5mins) in preparation for analysis (e.g. Oil Red O or immunofluorescence analysis). 
  
4.2.3.2.2.2. Three-Dimensional Cell Culture 
 Spheres were created by pipetting 10µl drops containing 3000 or 6000 cells onto 
the petri dish lids, evenly spaced and not too close to the edge. Control dishes using the 
original (much higher) cell density suspensions were also set up, termed “concentrated 
spheres”. 25ml of sterile distilled H20 was put into each petri dish and the drops were 
Figure 4.5: Schematic showing the cell culture model system used in this chapter. Skin 
pieces taken from the mouse embryos were separate to produce dermal pieces. Dermis pieces 
were mechanically separated to produce a single cell suspension. This was put into 2D and 3D 
culture and then analysed. Some 3D spheres were transferred to 2D and then analysed.  
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suspended over this to prevent them from drying out (Figure 4.5). Petri dishes 
containing 25ml of sterile distilled H20 but no spheres were placed above and below 
before being transferred to the incubator (37C, 5% CO2).  
 After the respective durations in culture as described in table 4.1, representative 
images were taken of the spheres (Zeiss Stemi SVII). 10-15 spheres were embedded in 
Tissue-Tek® O.C.T.™ compound (Sakura, Agar Scientific, Netherlands), snap frozen in 
liquid nitrogen and kept at −80°C.  
 
4.2.3.2.2.3. Three-Dimensional to Two-Dimensional Cell Culture Transfer 
 Images were taken of the spheres (Zeiss Stemi SVII) before being transferred to 
2D culture. Different experiments transferred different number of spheres from 1 sphere 
per well of a 24 well plate to pipetting all the spheres into one 35mm dish. However, for 
comparison with dishes containing 24,000 cells in 2D culture, the method used 
consistently was that four spheres (4x 6000 cells) were plated in 200ul of the basic 
medium in the centre of each well of a plate. These were allowed to adhere and grow 
out for 1-2 days. Spheres were also transferred onto coverslips for one of the 
experimental repetitions and left to adhere for a couple of hours in an incubator before 
more media was added. 
After the durations in culture listed in table 4.1, representative pictures were 
taken of the spheres having grown out and adhered, before being washed in PBS (3x 5 
minutes) in preparation for analysis (e.g. Oil Red O or immunofluorescence analysis). 
 
4.2.3.2.2.4. Whole Skin Cultures 
 To observe the effects of contamination, the cell culture model system was set 
up with whole skin. To do so, both the epidermis and dermis pieces were made into a 
single cell suspension and cultured together. The dermis and epidermis was still 
separated to make it easier to break up the cells. The cells were then put into 2D and 3D 
culture in the same way as the dermal cells as described above (section 4.2.3.2.2). 
 
4.2.4. Oil Red O Analysis 
Slightly different staining protocols were used depending on the type of sample 
being analysed. The organ culture frozen skin sections were stained in the same way as 
the frozen sphere sections cut from the frozen blocks (see sections 4.2.3.1 and 
4.2.3.2.2.2). 
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4.2.4.1. Frozen Skin and Sphere Sections 
 Following incubation for the required period, spheres were either put into 2D 
cell culture in 6 well plates or frozen in OCT for subsequent analysis. Sections (10µm) 
were cut on a cryostat (LEICA CM 3050S) and attached to ColorFrost®Plus slides 
(Thermo Shandon Ltd, Cheshire, UK). Slides were left to dry at room temperature for 
1hour 30 minutes and then washed in PBS (3x 5 minutes) followed by fixation in 
calcium formal (Appendix I) for 1 hour. They were then incubated with 60% 
isopropanol (Sigma) for 15 minutes and stained with a working solution of oil red O 
(Appendix 1) for 15 minutes. Slides were briefly washed in 60% isopropanol to remove 
excess oil red O and then rinsed in water. They were counterstained by dipping each 
slide in Shandon instant haematoxylin (Thermo Scientific, Cheshire, UK) and then 
rinsing in water. Slides were mounted in pre-warmed glycergel (DakoCytomation Inc. 
California, USA) and coverslipped. Images were taken on a Zeiss Axio Imager (M1) 
microscope using Volocity software. 
 
4.2.4.2. 2D Cell Oil Red O Staining Method 
 A shortened staining protocol was used for the cells. After cell culture and 
pictures had been taken on a Zeiss Axiovert 10 microscope using Axiovision software 
and a Zeiss AxioCam ERc5s camera (put earlier), the cells adhered to 6 well plates 
grown in 2D and those transferred from 3D-2D were washed in PBS and then fixed in 
calcium formal for 10 minutes. The wells were then immediately stained or stored in 
PBS at 4°C prior to staining.  
 An incubation with 60% isopropanol was followed by 10 minutes with a 
working solution of oil red O. A short wash in 60% isopropanol was then used to 
remove any excess oil red O followed by two careful washes in PBS to make sure the 
spheres remained adhered to the plastic. The cells were then stored in PBS at 4°C before 
pictures were taken. 
 
4.2.4.3. Oil Red O Quantification 
 While in most cases, the images in these experiments clearly showed a 
difference in the amount of lipid detected in the cells subjected to different experimental 
conditions (2D vs. 3D), another aim was to establish a means of quantifying the level of 
oil red O to support these visual assessments. A number of experimental variables were 
adapted as the best potential method of quantification was experimented with. 
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 Wells had been stained with oil red O (Sigma) and stored in PBS at 4°C. Before 
quantification, the PBS was pipetted off and the wells were allowed to dry out for 
several minutes. 100% isopropanol was added to each well or 35mm dish. Varying 
amounts were experimented with - from 100µl to 1ml. A cell scraper (Greiner bio-one) 
was also used at one point to detach and dissociate the cells and spheres from the base 
of the wells. This was to ensure all oil red O was picked up. The wells were then fairly 
vigorously shaken for 10 minutes to take off any oil red O present in the cells. Serial 
sampling was conducted across 3 wells. The 100ml of isopropanol in each well was 
collected and added together with that from 2 other wells to create one sample. 
 
Using a nanodrop and UV-Vis software, the absorbance values of oil red O from 
each well were read at 510nm. A spectrophotometer was also tried, whereby the volume 
of isopropanol collected was made up to 1ml and measured. Each reading was repeated 
three times to make sure the results were consistent and generate an average. 100% 
isopropanol was used as a blank and each solution was vortexed, before reading to 
evenly distribute the oil red O. 
 
 
 
 
 
 
Figure 4.6: Diagram depicting serial sampling of oil red O for quantification. 100% 
isopropanol with the oil red O from the cultured cells was collected to together from 3 wells of 
the 6-well experiment plate and read at 510nm on a nanodrop using UV-Vis software.  
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4.2.5. Immunofluorescence Analysis 
 
Table 4.2: Summary of primary antibodies, fluorescent secondary antibodies and 
conditions used for immunofluorescent staining 
Antibody/ Factor 
Name Manufacturer 
Raised 
in 
Clonality 
(P/M*) Dilution 
Secondary 
antibody used 
Goat anti 
rabbit (FITC) 
C/EBPα Santa Cruz Rabbit P 1:100 
Goat anti 
rabbit (594) 
FABP4 R&D Systems Goat P 1:50 Goat anti mouse (FITC) 
Pan-keratin Zymed Mouse  1:100 Goat anti mouse (FITC) 
PECAM1 DSHB Mouse  1:100 Goat anti mouse (FITC) 
* P - polyclonal; M – monoclonal 
 
Table 4.3: Details of the corresponding secondary antibodies used for immunofluorescence 
Secondary Antibody Manufacturer Dilution 
Donkey anti rabbit 
(FITC) 
AlexaFluorR 488 
AlexaFluor 594 Invitrogen 1:500 
Goat anti rabbit 
(FITC) AlexaFluor
R 488 Invitrogen 1:500 
Goat anti mouse 
(FITC) AlexaFluor
R 488 Invitrogen 1:500 
 
4.2.5.1. Indirect Immunofluorescence  
 Approximately six sections cut at 7µm were attached to the slides and then 
allowed to dry (see section 4.2.4.1). Slides were then fixed, blocked and stained for the 
specific factors described below. During staining, slides were kept in a humidity 
chamber in the dark to prevent the sections from drying out and the fluorescence fading. 
After staining, the slides were mounted in anti-fade Mowiol (or Vectashield to 
counterstain with DAPI if they had not been incubated with DAPI. Slides were stored at 
4°C in the dark. 
Immunofluorescence analysis was performed on a Zeiss Axio Imager M1 
microscope with Volocity software. For each age, negative controls were produced 
whereby there was no incubation with the primary incubation but 1% goat (or donkey 
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serum/PBS overnight. The same secondary antibodies were used to observe non-
specific staining. 
 
4.2.5.1.1. Preadipocyte Marker – C/EBPα  
In order to determine whether cells were committed to the adipocyte lineage 
before morphological changes occurred the preadipocyte marker, C/EBPα was stained 
for using indirect immunofluorescence. 
While originally slides with skin sections were not fixed but first washed in PBS 
(3 x 5 minutes), 2D cells on coverslips and 3D sphere sections were fixed prior to 
C/EBPα staining using 4% PFA for 15 minutes followed by permeabilisation for 5 
minutes in 0.5% Triton-X (Appendix I). Sections were then blocked in 20% goat serum 
(Sigma, MO, USA) for 30 minutes and washed in PBS for a couple of minutes. The 
slides were incubated with C/EBPα (1:100, Santa Cruz) in 1% goat serum/PBS 
overnight at 4°C or left at room temperature for 2 hours. The slides were washed three 
times in PBS for 5 minutes and incubated with a goat anti-rabbit fluorescent secondary 
antibody (Invitrogen, 1:500) for 1 hour at room temperature. After 55 minutes of 
incubation with the secondary antibody, 4′,6-diamidine-2′-phenylindole, 
dihydrochloride (DAPI) (KPL, Maryland, USA) was added to the slides for 5 minutes. 
Three more 5-minute washes in PBS were conducted before being coverslipped and 
mounted.  
 
4.2.5.1.2. Pan keratin 
 To determine the degree of epidermal contamination, if any, in the dermal cell 
spheres a pan-keratin antibody also known as cytokeratin was used to stain for 
epidermal cells. Sections were washed in PBS (3x 5min) and fixed in ice-cold methanol 
for 15 minutes followed by ice-cold acetone for 5 minutes. They were then blocked in 
10% goat serum for 1 hour or 20% goat serum for 30 minutes at room temperature. 
Slides were incubated with the pan-keratin primary antibody (Zymed, 1:100) overnight 
at 4C. 3 x 5 minute PBS washes were then conducted prior to incubation with a goat 
anti-mouse secondary antibody for 1 hour at room temperature. To this, DAPI (1:5000) 
was added for 5 minutes. 3 x 5 minute PBS washes were undertaken before slides were 
mounted in Mowiol and coverslipped. 
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4.2.5.1.3. PECAM1 
 A PECAM antibody was used to detect if blood vessels were developing. The 
slides were fixed in ice-cold methanol for 15 minutes and then ice-cold acetone for 5 
minutes, followed by 2, 2 minute washes in PBS. The sections were then blocked in 
20% goat serum for 30 minutes and washes 3 x 5 minutes in PBS before being 
incubated with the PECAM antibody overnight. 3 x 5 minutes PBS washes were 
conducted and then the slides were incubated with the goat anti-mouse secondary 
antibody for 1 hour at RT. Slides were mounted and coverslipped. 
 
4.2.6. Haematoxylin and Eosin (H&E) Staining 
This was used to recognize the structure of the skin/spheres in particular to 
determine whether the sections were healthy and thus determine the reliability of the 
culture systems.  
The slides were washed in distilled water for 5 minutes and then incubated for 5 
minutes in haematoxylin (Haematoxylin prepared according to Gills; Sigma). They 
were rinsed in distilled water and then washed for 5 minutes in tap water. The slides 
were then dipped in acid ethanol 6-8 times before being washed in tap water twice for 
one minute and once for 2 minutes in distilled water. The sections were then 
counterstained with eosin (Sigma, Egham, UK) for less than 30 seconds. A series of 
washes were then conducted; 3 x 1 minutes washes in 75% ethanol, 2 x 2 minute 
washes in 100% ethanol and 2 x 2 minute washes in histoclear (National Diagnostics, 
Hull, UK). Coverslips were mounted in DPX (Agar Scientific Ltd., Stansted, UK) and 
left to dry for 2 hours in a fume cupboard. 
 
4.2.7.  Toluidine Blue Staining 
Slides were dried and then stained with a solution of 1g toluidine blue in 100ml 
70% ethanol for 3 minutes. Excess stain was washed off using water and slides were 
mounted in DPX and coverslipped. 
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4.3. Results 
 
4.3.1. Organ Culture Model 
 Many stages and varying techniques were undergone to develop this model. 
While in general the results from this model were not consistent and therefore the organ 
culture method was not deemed reliable enough to put to further use in this project, it 
did show some interesting results. The skin was observed during the course of the 
experiment and repeats of it to become familiar with the system. Eventually skin taken 
from embryonic day 16.5 aged embryos (e16.5) was focused on for the establishment of 
these models, though often other ages were readily available and were useful for 
investigating certain variables of the models. As well as this it was originally thought 
more appropriate to look later, though more recently it has been considered that 
commitment to the adipocyte and lineage and process of development actually starts 
much earlier. Part of this hypothesis comes from the fact that fat can still form from 
dermal cells separated from the epidermis as early as e14.5 as shown in the spheres in 
chapter 3. 
 In this section, the many stages of establishing this organ culture model are 
described. The model was persisted with, with several avenues being explored and 
many repeats conducted as not only was it deemed a promising way of looking at 
development in terms of it being closer to in vivo than in vitro cell line studies but it 
was also a manageable way of creating in vivo-like conditions ex vivo. It had also been 
used before in Jahoda’s lab.  
 
4.3.1.1. Morphology of Mouse Back Skin in Organ Culture 
One of the defining characteristics, after three days incubation, was the ridge 
that formed around the edge of the skin sections, thought to be a wound healing 
response. This was used as a positive indication that the skin was alive and developing 
and therefore potentially healthy. As well as this, the formation of follicles, visible as 
raised bumps on the surface of the skin, was suggested to show that the skin is 
developing in culture (Figures 4.7C and D). An example of both the ridge and the 
follicles are shown in figures 4.7C and D. A visible difference exists between the skin 
before and after culture. Conversely, the darker coloration of some skin pieces was 
considered a negative indication of its physical condition (Figure 4.8C).  
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Figure 4.7: Organ culture of 16.5 embryonic day mouse back skin. (A,B) Skin on collagen 
filters prior to incubation. (C,D) Skin on collagen filters are 72h incubation period. Images 
were taken using a Zeiss Axiovert 10 microscope. (A,C) bright field. (B,D) dark field. Scale 
bar = 1mm. 
 
 
. 
Figure 4.8: Organ culture of 16.5 embryonic day mouse back skin. (A,B) Skin on collagen 
filters prior to incubation. (C,D) Skin on collagen filters are 72h incubation period. Images 
were taken using a Zeiss Axiovert 10 microscope. (A,C) bright field. (B,D) dark field. Scale 
bar = 1mm. 
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While originally oil red O analysis was going to be conducted on the skin 
sections after 3-day incubations to determine what level of fat development was 
occurring (Wojciechowicz 2012), H&E staining was focused on while the model was in 
the process of development. This was to look at the quality of skin pieces rather than 
purely examining their fat content. This was because the skin pieces were found to vary 
and some were pathological or had formed a gap in the dermis of the sections. This gap 
was thought to be in response to the staining protocol (Figures 4.9D and E). Upon 
repetition of the staining, however, and use of a quick, less harsh toluidine blue staining, 
the gap in the dermis was still visible in some sections.  
Some of the sections exhibited follicles with darkened nuclei that had become 
concentrated circles rather than growing down from the epidermis and forming 
extended hair follicles, hence they had become pathological (Figures 4.9A-C). 
Therefore, developing the culture model to produce consistently healthy, developing 
skin pieces was the focus of the experiments, rather than the degree of red staining of 
the adipocytes at this stage.  
  
Figure 4.9: Oil red O analysis of organ cultured 16.5 embryonic day mouse back skin. Fat 
droplets present in adipocytes visible as red coloration. Images were taken using a Zeiss Axio 
Imager M1. (A,B,D) scale bar = 65µm. (C,E) scale bar = 40µm. 
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One day older skin aged 17.5 day embryonic was put into organ culture (Figure 
4.10) to elicit if perhaps the age of the skin was an impeding factor on why some of the 
skin pieces were not developing properly. It was found that younger skin was more 
responsive in culture than the older skin and the older pieces were darker in coloration 
(Figure 4.10 1E). As well as e17.5, skin left in culture for 4 days appeared darker as 
well.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10: Organ culture of 17.5 embryonic day mouse back skin. (1A,B, 2A,B) Skin on 
collagen filters prior to incubation. (1C,D, 2C,D) Skin on collagen filters are 72h incubation 
period. (1E, F) Skin on collage filters after 4 days/96 hours incubation. Images were taken 
using a Zeiss Axiovert 10 microscope. (A,C) bright field. (B,D) dark field. Scale bar = 1mm. 
 
 
. 
	   136	  
Skin pieces, with the muscle layer and some of the subcutaneous layer, termed 
‘thick skin’, were put into culture to determine if perhaps the skin wasn’t surviving, 
because it needed the tissue layers beneath the skin for maintenance. This was of no 
increased benefit as follicular growth was not clearly visible and the piece looked 
particularly dark after 72 hours in culture (Figure 4.11C). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.1.2. Use of Different Serum Concentrations 
This preliminary organ culture experiment was repeated with little positive 
advancement in the physical appearance of the skin, therefore different serum 
concentrations were experimented with. Figures 4.12-14 show representative pieces 
from these experiments and their repeats that produced similar results. It was considered 
that the factors in the serum may be helping or hindering the skin’s development thus, 
as well as the 1% serum, organ culture dishes were set up with 0% serum and 2% 
serum. This revealed not much difference between the pieces. In general, follicle growth 
was present in many of the skin pieces and the pieces cut were of a more uniform shape. 
While not much overall difference was exhibited, the pieces were not consistent under 
Figure 4.11: Organ culture of 17.5 embryonic day mouse thick skin pieces. (A,B) skin on 
collagen filters prior to incubation. (C,D) skin on collagen filters are 72h incubation period. 
Images were taken using a Zeiss Axiovert 10 microscope. (A,C) bright field. (B,D) dark field. 
Scale bar = 1mm. 
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each condition. For example, two separate pieces supplied with 0% FBS/MEM were 
different in that while piece 1 (Figures 4.12a-h) showed developing follicles, piece 2 
(Figures 4.12i-p) developed less well with a split in the skin’s dermis. In 1% 
FBS/MEM, the wound healing response at the edge of the skin pieces occurred though 
the dermis did have a split in both pieces (Figure 4.8o). Those subjected to 2% 
FBS/MEM showed clear expansion of the epidermis but different follicular 
development (Figure 4.14). 
 
 
 
 
 
 
 
 
Figure 4.12: 16.5 embryonic day organ cultured skin in 0% FBS/MEM. (a-h) piece 1. (i-
p) piece 2. (a,e,i,m) bright field images and (b,f,j,n) dark field images, taken on Zeiss 
Axiovert 10. (c-h and k-p) after 72 hours in culture. (c,d,k,l) H&E staining and (g,h,o,p) 
toluidine blue staining, images were taken using a Zeiss Axio Imager M1. (a,b,e,f,I,j,m,n) 
scale bar = 1mm. (c,g,k,o) scale bar = 65µm. (d,h,l,p) scale bar = 40µm. 
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Figure 4.13: 16.5 embryonic day organ cultured skin in 1% FBS/MEM. (a-h) piece 1. (i-
p) piece 2. (a,e,i,m) bright field images and (b,f,j,n) dark field images, taken on Zeiss 
Axiovert 10. (c-h and k-p) after 72 hours in culture. (c,d,k,l) H&E staining and (g,h,o,p) 
toluidine blue staining, images were taken using a Zeiss Axio Imager M1. (a,b,e,f,I,j,m,n) 
scale bar = 1mm. (c,g,k,o) scale bar = 65µm. (d,h,l,p) scale bar = 40µm. 
 
 
 
. 
Figure 4.14: 16.5 embryonic day organ cultured skin in 2%FBS/MEM. (a-h) piece 1. (i-p) 
piece 2. (a,e,i,m) bright field images and (b,f,j,n) dark field images, taken on Zeiss Axiovert 
10. (c-h and k-p) after 72 hours in culture. (c,d,k,l) H&E staining and (g,h,o,p) toluidine blue 
staining, images were taken using a Zeiss Axio Imager M1. (a,b,e,f,I,j,m,n) scale bar = 1mm. 
(c,g,k,o) scale bar = 65µm. (d,h,l,p) scale bar = 40µm. 
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4.3.1.3. Changing from MEM to William’s Medium 
The organ culture method was then tried with a different type of media, known 
as William’s media; the higher glucose concentration could potentially aid the survival 
and better growth of the skin in culture. Alongside this, organ culture dishes with 
modified essential medium (MEM) were also set up as a direct comparison, the results 
of which are discussed previously in section 4.3.1.2. For both types of media, 0%, 1% 
and 2% serum concentrations were investigated. H&E staining was then conducted to 
determine whether any one combination of conditions was behaving optimally. When 
provided with no serum, clear follicle down growth occurred, especially in one of the 
pieces (Figure 4.15f). The skin pieces were more regularly shaped. It can be suggested 
that perhaps the more regular, even shaped skin pieces are more capable of healthy and 
realistic development. This was also the case with those supplemented with 1% 
FBS/William’s E media, whereby the even shaped piece (Figure 4.16a-h) had grown a 
lot healthier than piece 2 (Figure 4.16i-p). With 2% foetal bovine, while one piece 
appeared to have lost all evidence of follicular down growth, a second piece had visible 
follicle down growth, expansion of the epidermis and presence of a wound healing 
response clearly illustrated by epidermal growth round the edge of the skin piece 
(Figure 4.17k). 
Figure 4.15: 16.5 embryonic day organ cultured skin in 0%FBS/William’s E. (a-g) piece 
1. (h-o) piece 2. (a,d,h,l) bright field images and (b,e,i,m) dark field images, taken on Zeiss 
Axiovert 10. (c-g and j-o) after 72 hours in culture. (c,f,g,j,k,n,o) H&E staining, images were 
taken using a Zeiss Axio Imager M1. (a,b,d,e,h,i,I,m) scale bar = 1mm. (c,j,n) scale bar = 
65µm. (f,g,k,o) scale bar = 40µm. 
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Figure 4.16: 16.5 embryonic day organ cultured skin in 1% FBS/William’s E. (a-h) piece 
1. (i-p) piece 2. (a,e,i,m) bright field images and (b,f,j,n) dark field images, taken on Zeiss 
Axiovert 10. (c-h and k-p) after 72 hours in culture. (c,d,g,h,k,l,o,p) H&E staining, images 
were taken using a Zeiss Axio Imager M1. (a,b,e,f,I,j,m,n) scale bar = 1mm. (c,g,k,o) scale 
bar = 65µm. (d,h,l,p) scale bar = 40µm. 
 
 
 
. 
Figure 4.17: 16.5 embryonic day organ cultured skin in 2% FBS/William’s E. (a-h) piece 
1. (i-p) piece 2. (a,e,i,m) bright field images and (b,f,j,n) dark field images, taken on Zeiss 
Axiovert 10. (c-h and k-p) after 72 hours in culture. (c,d,g,h,k,l,o,p) H&E staining, images 
were taken using a Zeiss Axio Imager M1. (a,b,e,f,I,j,m,n) scale bar = 1mm. (c,g,k,o) scale 
bar = 65µm. (d,h,l,p) scale bar = 40µm. 
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4.3.1.4. Oil Red O Analysis of Organ-cultured Skin 
While H&E staining (and often the quick toluidine blue staining) became the 
primary focus in comparing the different pieces, it was of interest to see if the difference 
in the quality of the skin was having an effect on adipocyte formation in the lower 
dermis. Organ-cultured skin pieces that had been frozen down were later stained with 
oil red O. Culture supplied with MEM and supplemented with either 0%, 1% or 2% 
FBS (Figure 4.18) exhibited skin pieces that were not as well developed and appeared to 
show more red staining (Figures 4.18 2a and 2c) than those which evidence would 
suggest were healthier (Figure 4.18 1b). Comparatively with William’s E media, the 
degree of healthy development did not relate to the level of oil red O staining visible 
(Figure 4.19). There was evidence of variety across the pieces, which is reason in itself 
that the culture system is currently not successful enough to use as a suitable model for 
further investigation. Ideally, with respect to the fact that all the skin pieces here were of 
the same age, the level of adipocyte development interpreted by the degree of red 
coloration from the oil red O should have been relatively similar. 
The follicles have already started to form by e16.5, once initiated around 
e14/14.5 (Figures 4.20 1a-c), therefore, one would expect to see apparent follicles 3 
days after organ culture. Comparatively, however, the oil red O stained skin (Figure 
4.20.2) illustrated that the follicles became pathological. This was an indication that the 
model was not appropriate to further study adipogenesis at this stage. 
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Figure 4.18: Oil red O analysis of organ cultured 16.5 embryonic day skin in MEM. (1) 
no serum. (2) 1% FBS. (3) 2% FBS. Fat droplets present in adipocytes visible as red 
coloration. Images were taken using a Zeiss Axio Imager M1. (1a,2a/b,3a/b) scale bar = 
65µm. (1b/c,2c-e,3c) scale bar = 40µm. 
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Figure 4.19: Oil red O analysis of organ cultured 16.5 embryonic day skin in William’s 
E. (1) no serum. (2) 1% FBS. (3) 2% FBS. Fat droplets present in adipocytes visible as red 
coloration. Images were taken using a Zeiss Axio Imager M1. (1a/b,2a/b,3a/b) scale bar = 
65µm. (1c/d,2c-e,3c) scale bar = 40µm. 
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Figure 4.20: Oil red O analysis of 16.5 embryonic day skin before and after 72h organ 
culture in 1% FBS/MEM. (1) e16.5 normal skin (2) e16.5 skin post 72h organ culture. Fat 
droplets present in adipocytes visible as red coloration. Images were taken using a Zeiss Axio 
Imager M1. (1a/b,2a/b) scale bar = 65µm. (1c/d,2c-e) scale bar = 40µm. 
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4.3.2. The Cell Culture Model 
 Next, the potential of creating a cell culture model, closer to reality than using 
cell lines was investigated. Firstly, cells taken from the dermis of e16.5 mouse embryos 
were plated into a 35mm dish to determine if this was a viable way of developing a 
potential model (Figure 4.21). After 7 days, the cells were confluent and split. One dish 
was left unsplit as a control (Figure 4.21E and F). There were some dark granular 
shapes within the cells, which suggested lipid droplets had formed, thus adipocytes 
developed in culture. These cells were later stained with oil red O (Figure 4.21D and F). 
 
 Dermal cells were then again put in culture for 10 days and one dish for 14 days. 
This proved to be too long: the fibroblasts took over the culture and any early 
adipocytes or preadipocytes that may have been present were unable to thrive and were 
instead outcompeted. It was therefore deduced from this, that in order to develop the 
model in terms of optimizing the variables, potentially both the cell number and number 
of days in culture should be reduced. This was repeated and the cells were fixed and 
stained with oil red O after 5-7 days, which was determined better than 10 days. 
 Upon showing that the dermal cells can successfully thrive in 2D culture, the 
cells were also put into 3D culture as spheres in hanging media drops. These were first 
taken from e17.5 skin alongside the organ culture model and seeded at 3000 cells per 
sphere. Control spheres using the concentrated cell suspension were also set up at 
Figure 4.21: Cell culture of 16.5 embryonic day mouse back skin. (A-C,E) unstained in 
culture images. (A) after 3 days. (B) after 6 days. (C,D) Cells split. (E,F) Cells not split (D,F) 
Oil red O staining. Fat droplets present in adipocytes visible as red coloration. Images were 
taken using a Zeiss Axiovert 10. Scale bar = 65µm.  
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150,000 cells per sphere (Figure 4.22A-D). It was found that a high proportion of the 
3000 cell spheres did not aggregate particularly well, however, the concentrated spheres 
aggregated well, so it may be that the cell count in the 3000 cell spheres was not high 
enough. The hanging drops containing the 3000-cell spheres were collected and put into 
two-dimensional culture in 35mm dishes. The cells coped well when transferred from 
3D to 2D culture and adipocytes formed (Figure 4.22). This had positive implications 
for improving the cell culture model. 
Spheres transferred from 3D to 2D culture were originally spun down at 
1000rpm for 5 minutes and resuspended. Some of the cells clumped and others grew in 
a 2D manner. This may be why there were clusters of adipocytes (Figure 4.22). It was 
found more advantageous to pipette the spheres straight into 2D (Figure 4.24) and allow 
the spheres to adhere to the substrate as this way they were still to some extent in 3D 
culture and allowed less manipulation of the cells, preventing/reducing any changes or 
stress-related responses upon disturbance.  
 
Figure 4.22: 3-dimensional spheres put into 2-dimensional culture. (A-D) concentrated 3D 
spheres. Images taken on Zeiss Stemi SV11. (E-J) 3D to 2D culture. Images taken on Zeiss 
Axiovert 10. (G-J) Oil red O staining of fat droplets. Arrows label adipocytes. (A,B) scale bar 
= 2mm. (C,D) scale bar = 1mm. (E,G,I) scale bar = 65µm. (F,H,J) scale bar = 40µm. 
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The next experiment and available e18.5 mice were used to determine what 
numbers of cells were most appropriate in both 2D and 3D culture for this model to be 
improved and reliably usable. Both 3000 and 6000 cells were seeded in each well of 
both 24 well plates and 6 well plates (Figure 4.23). Spheres were also formed with both 
3000 and 6000 cell drops in 10ul of 10% FBS/MEM (Figure 4.25).  
 
After 3 days, the spheres were transferred into 2D culture. Both the 3000 and 
6000 cell spheres were put into 35mm dishes (Figure 4.24e-h) and individual 3000-cell 
spheres were put in wells of a 24 well plate (Figure 4.24i-j). The spheres did not adhere 
well and the cultures were not clean. It was considered that the cells should be filtered 
through a cell strainer to prevent contaminants being present after the skin separation 
process. There was variation in the levels of successful adherence and outgrowth of the 
spheres, meaning results in terms of quantifying the level of oil red O and thus lipid 
content in the spheres would not be consistently reliable. It was decided that 6000 cell 
spheres would be used in future as 3000 dermal cells were not sufficient to form defined 
aggregations. Putting 3000 or 6000 cells into 2D culture was not sufficient as the cell 
were unable to communicate and did not proliferate and develop particularly well 
(Figure 4.23). As well as this the spheres grew better in 6 well plates (Figures 4.24a-h) 
and when there were other spheres nearby, compared with isolating each sphere 
(Figures 4.24i and j). To keep it consistent 6 well plates were then used. 
Figure 4.23: 2-dimensional cell culture of 18.5-day embryonic mouse dermis. (a-d) images 
taken of both 3000 and 6000 cells in culture after 4 days. (e-h) oil red O staining of fat 
droplets. Images taken on a Zeiss Axiovert 10. (a,e,c,g) scale bar = 65µm. (b,f,d,h) scale bar = 
40µm. 
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While 3000 seemed to form better spheres with e18.5 (Figure 4.25) than e16.5, it was 
still clear 6000 cells were less of a risk as more consistently aggregated better. There 
was a high level of red staining in the spheres from e18.5, showing they have 
differentiated into adipocytes (Figure 4.25). 
 
 
 
Figure 4.24: 3-dimensional to 2-dimensional cell culture of 18.5-day embryonic mouse 
dermis. (a-d) images taken of both 3000 and 6000 cell spheres in 2D culture after 1 day. (e-l) 
oil red O staining of fat droplets. (e-h) 6-well plates. (i-l) 24-well plates. Images taken on a 
Zeiss Axiovert 10. (a,e,c,g,I,k) scale bar = 65µm. (b,f,d,h,j,l) scale bar = 40µm. 
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 In order to increase reliability and uniformity across the experimental variables, 
the next step was to balance out the cell numbers between 2D and 3D culture. With 
6000 cells being put into drops for spheres, it was decided that four spheres should be 
transferred into each well for 2D culture. This would increase the chances of at least one 
sphere adhering and growing out successfully in each well. Therefore, 24000 cells were 
seeded into each well for the 2D comparison to even the original cell numbers.  
 In further development of the model, both e15.5 and e16.5 were next looked at. 
In order to conduct immunofluorescence analysis and potentially remove chances of 
excess oil red O inflicting on any potential quantification results, placing circular 
coverslips at the bottom of each well before transferring the spheres to 2D was trialled. 
However, the spheres did not adhere as well to the glass coverslip substrate, particularly 
those from cells of the younger age, e15.5 (Figures 4.26g-i). Many of the spheres were 
lost during the staining procedure with oil red o (Figures 4.26d-f), leaving only the 
outgrowth cells. While some of the e16.5 spheres did adhere, this was very few and 
Figure 4.25: 3-dimensional cell culture of 18.5-day embryonic mouse dermis. (a-h) images 
taken after 3 days in culture on a Zeiss Stemi SVII. (a,c,e,f) 3000 cell spheres. (b,d,g,h) 6000 
cell spheres. (I,j,k,l) oil red O staining of fat droplets in spheres. Images taken on a Zeiss 
Imager, M1. (i,j) without counterstain. (k,l) with haematoxylin counterstain. (a-d) scale bar = 
2mm.  (e-h) scale bar = 1mm. (i,k) scale bar = 65µm. (,j,l) scale bar = 40µm. BF = bright 
field, DF = dark field. 
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some of them had slipped to the edge of the coverslip before attaching (Figure 4.26B). 
This environment was less advantageous for growth than closer to the centre of the 
coverslip or indeed the well, because the cells grew better in the centre than at the 
edges. 
 There was little evidence of fat development in 2D culture (Figures 4.27c-e) 
compared with the 3D spheres (Figure 4.29). Cells taken from e16.5 dermis 
successfully produced cell spheres while e15.5 did less so (Figure 4.28). When stained 
with oil red O these spheres showed clear development of adipocytes in culture (Figure 
4.29). More red coloration in the e15.5 spheres after 7 days (Figures 4.29A and B) 
appears to be observed compared with the e16.5 spheres after 6 days (Figures 4.29C and 
D). It was deemed appropriate to leave the cells in culture for a certain number of days 
in relation with their age. This was to keep the age of the cells consistent; 6 days for 
e16.5 and 7 days for e15.5. Some of the spheres were transferred to 2D for the last day 
of culture, i.e. 5+1 or 6+1 (Figure 4.26).  
Figure 4.26: 3-dimensional to 2-dimensional cell culture of 15.5- and 16.5-day embryonic 
mouse dermis. (A-C,G-I) Images taken 1 day after transfer to 2D. (A-F) e16.5. (G-I) e15.5. 
(D-F) Oil red O staining, The main part of the sphere has undetached. (A) Adhered sphere. (B) 
Sphere adhered to edge of coverslip. (C, G-I) Unstuck spheres. Images taken on a Zeiss 
Axiovert 10. (A,B,D,E,G) scale bar = 65µm. (C,F,H,I) scale bar = 40µm. 
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Figure 4.27: 2-dimensional cell culture of 16.5-day embryonic mouse dermis. (1,2,3) 
Images taken of culture after 3, 4 and 6 days respectively. (3c-e) Oil red O staining. Images 
taken on a Zeiss Axiovert 10. The arrows point to the edge of the coverslips. (1a/b,2a/c,3a/c) 
scale bar = 65µm. (2b,3b/d/e) scale bar = 40µm. 
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Figure 4.28: 3-dimensional cell culture of 15.5- and 16.5-day embryonic mouse dermis. 
Images taken of e15.5 (Left) and e16.5 (Right) spheres. (1,2) 6000 cell spheres. (3,4) 
Concentrated cell spheres. Pictures taken of the 6000 cell spheres before transferring to 2D. 
Pictures taken of concentrated spheres after 6 days. Pictures taken on a Zeiss Stemi SVII. 
(1a/b,2a/b,3a/b,4a/b) scale bar = 2mm.  (1c/d,2c/d,3c/d,4c/d) scale bar = 1mm. BF = bright 
field, DF = dark field. 
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The experiment was conducted twice with e15.5 and e16.5 cell cultures, to make 
sure contamination wasn’t influencing the experiment. Coverslips were not used and 
when transferring the spheres to 2D 6 well plates, they were still allowed to adhered for 
several hours before adding more media. Many of the spheres, however, still became 
unstuck when the rest of the media was added or during oil red O staining and the cells 
shrunk after fixation (Figure 4.30). 
 
Figure 4.29: Oil red O analysis of 15.5- and 16.5-day embryonic mouse dermal spheres. 
Spheres stained with oil red O and images taken on a Zeiss Imager M1. (A,C) scale bar = 
65µm. (B,D) scale bar = 40µm.  
 
 
. 
	   154	  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.30: 2-dimensional cell culture of 15.5-day embryonic mouse dermis. Images 
showing shrunken cells after fixation. Images taken on a Zeiss Axiovert 10. Scale bar = 65µm. 
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When repeated, the spheres adhered and grew out better without the coverslips, 
though the main part of the spheres still became unstuck after oil red O staining 
(Figures 4.32D and E).  
Figure 4.31: 2-dimensional cell culture of 16.5-day embryonic mouse dermis. Images from 
5 and 6 days in culture. (C,F) Oil red O staining after 6 days. Images taken on a Zeiss 
Axiovert 10. (A-C) scale bar = 65µm. (D-F) scale bar = 40µm. 
 
 
. 
Figure 4.32: 3-dimensional to 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis. Images taken 1 day after transfer to 2D. (D,E) Oil red O staining, The spheres have 
adhered and grown out in 6-well plates in culture. Images taken on a Zeiss Axiovert 10. 
(A,B,D) scale bar = 65µm. (C,E) scale bar = 40µm. 
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Two factors were adapted to improve the adherence of the spheres and thus the 
quality of the analysis. The spheres were put into 2D culture for 2 days instead of one, 
by removing a day off the 3D culture time, e.g. instead of 5+1, 4+2 was used (Figure 
4.35). As well as this, allowing the spheres to adhere in just 200µl of media in the 
middle of the well was trialled and it was found that the cells still grew well as well as 
adhering much better. Due to incubation only being needed for 1 or 2 days, using 200µl 
of media was not a problem as the cells still thrived. Length of calcium formal fixation 
was also decreased for 7 minutes, though this proved an insignificant change.  
The 2 dimensional cell culture was carried out in the same way. In comparison 
with the 3D into 2D cell culture, there was less fat development in 2D as shown not 
only in the representative culture images but the analysis with the lipid stain oil red O 
(Figure 4.34 and 4.35). 
 
Figure 4.33: 3-dimensional cell culture 16.5-day embryonic mouse dermal cells. Images 
taken after 5 days in culture. (A-F) 6000 cell spheres. (G-L) Concentrated cell spheres. 
Pictures taken on a Zeiss Stemi SVII. (A,B,G,H) scale bar = 2mm.  (C-F,I-L) scale bar = 
0.5mm. BF = bright field, DF = dark field. 
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The spheres had aggregated well (Figure 4.36) and when stained with oil red O 
for lipid detection, there was some red staining visible, though this was less than that 
found with e18.5 (Figure 4.25). Putting the spheres into 2D for two days rather than 
solely one meant the main body of the sphere as well as the outgrown cells remained 
stuck and successfully stained with oil red O (Figures 4.35G-L). Clear shapes of 
adipocytes were seen in the dense aggregations and some of the cells spread out from 
the spheres. Not all the cells differentiated into adipocytes. This was a positive 
correlation with the fact that only part of the dermis forms adipose tissue. 
 
 
Figure 4.34: 2-dimensional cell culture of 16.5-day embryonic mouse dermis. 
Representative images from 6 days in culture, (C,F,I,L) taken closer to the edge of the 
substrate. (G-L) Oil red O staining after 6 days. Images taken on a Zeiss Axiovert 10. (A-C,G-
I) scale bar = 65µm. (D-F,J-L) scale bar = 40µm. 
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Figure 4.35: 3-dimensional to 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis. Images taken 2 days after transfer to 2D. (G-L) Oil red O staining, The spheres have 
adhered and grown out in 6-well plates in culture. Images taken on a Zeiss Axiovert 10. (A-
C,G-I) scale bar = 65µm. (D-E,J-L) scale bar = 40µm. 
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Figure 4.36: 3-dimensional cell culture of 16.5-day embryonic mouse dermal cells. Images 
taken after 6 days in culture. (A-D,G) 6000 cell spheres. (E,F) Concentrated cell spheres. (A-
D) Images taken on a Zeiss Stemi SVII. (E-G) Images taken on a Zeiss Imager, M1. (A,B) 
scale bar = 2mm. (C,D) scale bar = 0.5mm. (E) scale bar = 65µm. (F,G) scale bar = 40µm. BF 
= bright field, DF = dark field. 
 
 
. 
 
 
 
 
4.3.2.1. Epidermal Contamination 
 Alongside the 2D versus 3D comparison and 3D to 2D sphere transfer, some of 
the spheres were frozen down directly after the full incubation period decided upon, e.g. 
6 days for dermal cells taken from e16.5 skin. These were then stained with oil red O to 
investigate the degree of fat development occurring in the spheres in 3D to ensure that 
which develops when transferred to 2D isn’t due to the change in environment. This 
was conducted across all the ages experimented with and some interesting and 
somewhat unexpected results were found. 
 It was noticed that some of the spheres appeared to have dense clusters of cells 
in them, visible from the haematoxylin nuclear staining (Figure 4.37). This was queried 
as epithelial contamination from the epidermal-dermal separation step, i.e. the 
epidermal cells (keratinocytes) were clustering together separate from the dermal 
content of the spheres. While there was contamination, there was also evidence of 
increased adipocyte formation in the spheres from e16.5 to e18.5 (Figure 4.37). 
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A pan-keratin epithelial marker was used with immunofluorescence analysis. 
This showed that some but not all of the clusters corresponded to epithelial cells. There 
was a degree of contamination present shown by specific green staining using pan-
keratin (Figure 4.38). The arrows label those clusters that correspond to fluorescent 
staining in the FITC and merge images, while all the clusters have been labelled in the 
DAPI images to show that it is not all of them. 
 
Figure 4.37: Oil red O stained spheres of 15.5-, 16.5- and 17.5-day embryonic mouse 
dermis showing dense clusters. Spheres stained with oil red O and images taken on a Zeiss 
Imager M1. (A-D) Haematoxylin counterstain. (E,F) No counterstain. (A,C,E,F) scale bar = 
65µm. (B,D) scale bar = 40µm.  
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Figure 4.38: Analysis of Cytokeratin expression in 16.5-day embryonic dermal spheres. 
Sections were cut at 7µm, stained with an antibody against cytokeratin and counterstained 
with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of cytokeratin. (A-C) Control showing no fluorescently labelled 
cytokeratin expression.  (D-O) labelled using Cytokeratin primary antibody. Fluorescent 
images were taken using a Zeiss Axio Imager M1. (D-F) scale bar = 65µm. (A-C,G-O) scale 
bar = 40µm. Arrows label dense clusters of cells. In DAPI images all clusters labelled. In 
FITC/Merge images, only those which correspond to positive fluorescence are labelled. 
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The potential of ficoll to separate the densities of the two cell types – 
keratinocytes and fibroblasts – was explored in order to improve the purity of the 
dermal cell suspension prior to culture. A direct comparison of cultures using ficoll with 
those not using ficoll was conducted and the spheres were stained with pan keratin. This 
was first tried using the age e17.5 as the contamination if any would be more obvious 
by this age. It was expected that two fractions would be produced after centrifugation, 
however, only one layer (fibroblast layer) was seen (Figure 4.39C). This may have been 
because there were only a few epidermal cells which were not clearly visible as a 
distinct layer or that in fact the cells were too similarly dense for the separation to occur. 
The cell density generated was not sufficient to conduct a full experiment. Ficoll was 
then used in an e16.5 experiment to determine whether the separation of densities was 
easier at a younger age. Similarly one distinct cell layer in the form of a pellet formed 
on the surface of the ficoll (Figures 4.39A and B). 
Images of the spheres in hanging drops were taken of both 6000 cell spheres and 
concentrated cell spheres, this time of 40,000 cells per sphere (Figure 4.40). There was 
not a significant difference, between cells separated by ficoll and those not separated, in 
the morphology of the spheres. 
 
Figure 4.39: Photographs of Density Centrifugation using Ficoll PM400. Two fractions 
were used, 1.05g/ml and 1.06g/ml. (A,B) Embryonic day 16.5; 50ml falcons, formation of cell 
pellets in one layer of the top fraction shown by the black bar. (C) Embryonic day 17.5; 15ml 
falcon; no cell layer/s visible. Scale bar = 1mm. 
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The spheres were stained immunofluorescently with the cytokeratin antibody 
previously used (Figures 4.41 and 4.42). There was still epidermal contamination in the 
spheres with ficoll, shown by the brighter fluorescence of densely clustered sections in 
the spheres (Figure 4.42), though there were fewer clusters.   
Figure 4.40: 3-dimensional cell culture of 16.5-day embryonic mouse dermal cells with 
and without FICOLL. Images taken after 6 days in culture. (1,3) Without Ficoll density 
separation. (2,4) With Ficoll density separation. (1,2) 6000 cell spheres. (3,4) Concentrated 
cell spheres.  Images taken on a Zeiss Stemi SVII. (a,b) scale bar = 2mm. (c,d) scale bar = 
0.1mm. BF = bright field, DF = dark field. 
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Figure 4.41: Analysis of 16.5-day embryonic dermal spheres, without Ficoll 
fractionation. (A,B) Sections cut at 10mm were stained with oil red O to detect presence of 
fat. (C-N) Sections were cut at 7mm, stained with an antibody against cytokeratin and 
counterstained with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC 
represents the fluorescent labelling of cytokeratin. (C-H) 6000 cell spheres. (I-N) 
Concentrated cell spheres. (C-E,I-K) Control showing no fluorescently labelled cytokeratin 
expression.  (F-H,L-N) labelled using Cytokeratin primary antibody. Images were taken using 
a Zeiss Axio Imager M1. (D-F) Scale bar = 40µm. 
 
 
. 
	   165	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.42: Analysis of 16.5-day embryonic dermal spheres, with Ficoll fractionation. 
(A,B) Sections cut at 10mm were stained with oil red O to detect presence of fat. (C-N) 
Sections were cut at 7mm, stained with an antibody against cytokeratin and counterstained 
with DAPI. From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the 
fluorescent labelling of cytokeratin. (C-H) 6000 cell spheres. (I-N) Concentrated cell spheres. 
(C-E,I-K) Control showing no fluorescently labelled cytokeratin expression.  (F-H,L-N) 
labelled using Cytokeratin primary antibody. Images were taken using a Zeiss Axio Imager 
M1. Scale bar = 40µm. 
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Some of the spheres from both sets of conditions were put into 2D culture after 
4 days (Figure 4.44) and some of the cells were also incubated for 6 days in 2D culture 
(Figure 4.43). In both cases, little difference was found between the two, though in 
general the level of contamination appeared to be significantly reduced. As previously 
found, more adipose development occurred in 3D than 2D. It was decided that Ficoll 
would not be used in the model as it was a time-consuming step that ran the risk of 
reducing the cell numbers available for cell culture. 
 
Figure 4.43: 2-dimensional cell culture of 16.5-day embryonic mouse dermis with and 
without FICOLL. (A-H) After 4 days in culture. (I-X) After 6 days in culture, (Q-X) Oil red 
O staining after 6 days. Representative images taken on a Zeiss Axiovert 10. (A-D,I-L,Q-T) 
scale bar = 65µm. (E-H,M-P,U-X) scale bar = 40µm. 
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‘Whole skin cell’ whereby a single cell suspension was generated from the 
whole skin (epidermal and dermal) was cultured alongside dermal cultures to determine 
if the epidermal content was having a dramatic influence on the results gained and the 
success of the model (Figures 4.45-4.48). Results of the e17.5 experiment are shown. 
There were epidermal cells present in the mixed cultures (Figures 4.45C and G), 
comparatively with normal dermal cell cultures. The epidermal content did not seem to 
affect the fat content of the cultures (Figures 4.45D,H,L and P). 
Figure 4.44: 3 dimensional to 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis with and without Ficoll separation. (A-F) Without ficoll (G-L) With ficoll (D-F,J-
L) Oil red O staining after 4 days in 3D and 2 days in 2D. Representative images taken on a 
Zeiss Axiovert 10. (A,D,G,J) scale bar = 65µm. (B,C,E,F,H,I,K,L) scale bar = 40µm. 
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 In relation to the 3D spheres put into 2D culture (Figure 4.46), it could be 
inferred that there was slightly more fat development in the cultures of solely dermal 
cells in comparison with the cultures of dermal and epidermal cells. This, however, was 
a minute difference and so was unlikely that, when in cell culture, the epidermal content 
was having a dramatic effect on any adipogenesis that occurred.  
 
 
 
 
 
Figure 4.45: 2-dimensional cell culture of 17.5-day embryonic mouse skin. Both (A-H) 
combined dermal and epidermal cells, and (I-P) dermal cells. (A-M) After 3 days in culture. 
(B_D,F-H,J-L,N-P) After 5 days in culture, (D,H,L,P) Oil red O staining. Representative 
images taken on a Zeiss Axiovert 10. (A-D,I-L) scale bar = 65µm. (E-H,M-P) scale bar = 
40µm. 
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Figure 4.46: 3 dimensional to 2-dimensional cell culture of 17.5-day embryonic mouse 
skin. (A-D) Combined dermal and epidermal cells (E-H) Dermal cells. (B,D,F,H) Oil red O 
staining after 3 days in 3D and 2 days in 2D. Representative images taken on a Zeiss Axiovert 
10. (A,B,E,F) scale bar = 65µm. (C,D,G,H) scale bar = 40µm. 
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 There were significantly more epithelial cells in the spheres generated from 
dermal and epidermal cells combined (Figures 4.47J-O) in relation to those spheres 
from the dermis (Figures 4.47J-L). This was demonstrated by fluorescent labelling of 
the epithelial cells with a cytokeratin antibody. As with the 2D and 3D-2D cultures, 
there was little difference in the level of oil red O staining and therefore lipid content of 
the spheres between dermal plus epidermal spheres (Figures 4.47E and F) and just 
dermal spheres (Figures 4.48E and F). 
 
Figure 4.47: Analysis of 17.5-day embryonic combined dermal and epidermal cell 
spheres. (A-D) Images taken of 6000 cell spheres on Zeiss Stemi SVII. (E,F) Sections cut at 
10µm were stained with oil red O to detect presence of fat. (G-O) Sections were cut at 7µm, 
stained with an antibody against cytokeratin and counterstained with DAPI. From left to right; 
DAPI, FITC, and merge (DAPI/FITC). FITC represents the fluorescent labelling of 
cytokeratin. (G-I) Control showing no fluorescently labelled cytokeratin expression.  (J-O) 
labelled using Cytokeratin primary antibody. Images were taken using a Zeiss Axio Imager 
M1. (A,B) scale bar = 2mm. (C,D) scale bar = 0.2mm. (M-O) scale bar = 40µm. (G-L) scale 
bar = 15µm. 
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4.3.2.2. The Culture Model with E14.5 Dermal Cells 
 It was thought that adipogenesis might start even earlier, around the timing of 
hair follicle development initiation. One experiment was conducted using dermal cells 
taken from e14.5 mouse back skin, when there is less risk of contamination. The e14.5 
spheres showed lots of defined lipid droplets demonstrating that the cells of the dermis 
were capable of differentiating into adipocytes earlier (Figure 4.49). When transferred 
to 2D culture, there was visible formation of adipocytes, though most of them remained 
in the spheres and did not spread out (Figure 4.50). 
 
Figure 4.48: Analysis of 17.5-day embryonic dermal cell spheres. (A-D) Images taken of 
cell spheres on Zeiss Stemi SVII. (E,F) Sections cut at 10µm were stained with oil red O to 
detect presence of fat. (G-L) Sections were cut at 7µm, stained with an antibody against 
cytokeratin and counterstained with DAPI. From left to right; DAPI, FITC, and merge 
(DAPI/FITC). FITC represents the fluorescent labelling of cytokeratin. (G-I) Control showing 
no fluorescently labelled cytokeratin expression.  (J-L) labelled using cytokeratin primary 
antibody. Images were taken using a Zeiss Axio Imager M1. (A,B) scale bar = 2mm. (C,D) 
scale bar = 0.2mm. (G-L) scale bar = 15µm. 
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Figure 4.49: 3-dimensional cell culture of 14.5-day embryonic mouse dermal cells. Images 
taken after 8 days in culture of concentrated cell spheres. (A-D) Images taken on a Zeiss Stemi 
SVII. (E-G) Images taken on a Zeiss Imager, M1. (A,B) scale bar = 2mm. (C,D) scale bar = 
0.2mm. (E) scale bar = 65µm. (F,G) scale bar = 40µm. BF = bright field, DF = dark field. 
 
 
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   173	  
Figure 4.50: 3-dimensional to 2 dimensional cell culture of 14.5-day embryonic mouse 
dermal cells. Images taken after 2 days in 3D culture of 6000 cell spheres. (A-D) and after 6 
days in 2D culture (E-G). Cells stained with oil red O (H-M). (A-D) Images taken on a Zeiss 
Stemi SVII. (E-M) Images taken on a Zeiss Axiovert 10. (A,B) scale bar = 2mm. (C,D) scale 
bar = 0.2mm. (E,H) scale bar = 65µm. (F,G, I-M) scale bar = 40µm. BF = bright field, DF = 
dark field. 
 
 
. 
 
4.3.2.3. Epidermal-Dermal Separation 
 The older skin was found to separate much more easily into epidermis and 
dermis than the younger embryonic skin. For example, e18.5 skin needed only 30 
minutes in the trypsin/pancreatin solution, while e14.5 skin required 1 hour 30 minutes. 
It was found that it was more advantageous to be patient to minimise the chance of 
damaging the epidermis and therefore, epidermal contamination. Smaller pieces were 
easier to manipulate, so 3 pieces were more often cut from each side instead of two, 
particularly for larger embryos. 
	   174	  
 
4.3.2.4. Oil Red O Quantification 
The images in the experiments showed a difference between adipocytes 
differentiated, however, a way of quantifying the cells could support the observations. 
In the 3 dimensional hanging drop culture method, cells are known not to divide, 
whereas in 2-dimension, they do. Quantification of oil red O was used to investigate if 
even though there were less 3D cells there was still a higher number of red staining and 
therefore adipocytes because it is suspected that a 3D environment allows better 
differentiation. It proved difficult to quantify the oil red O.  
A serial sampling method was trialled, to collect enough oil red O to detect a 
result to compare 2D with 3D. For the 3D result, the 3D to 2D samples were collected. 
Firstly the samples were taken from the embryonic day 18.5 experiment. 
 
Table 4.4:  Results of oil red O absorbance from 2D and 3D cultures of embryonic day 
18.5 mouse back skin dermal cells, read at 510nm on both a nanodrop and 
spectrophotometer 
 2D plate 3D plate 
 Nanodrop Spectrophotometer Nanodrop Spectrophotometer 
1 0.035 0.051 0.044 0.043 
2 0.033 0.039 0.044 0.050 
3 0.028 0.026 0.036 0.044 
4 0.040 0.041   
5 0.045 0.047   
6 0.023 0.047   
7 0.045 0.056   
8 0.078 0.078   
Mean 0.041 0.048 0.041 0.046 
 
Only the wells that contained spheres adhered were selected for quantification. 
However, with the e18.5 experiment, there were few spheres stuck and so there were 
only 3 samples (Table 4.4). There was variation in the values collected from both the 
nanodrop and the spectrophotometer, though the average means were similar for both 
2D and 3D to 2D. It was thought that the oil red O may have not completely dissolved, 
therefore some of the results would detect higher than others and so the samples were 
filtered using a syringe filter twice before reading off the values.  
Next, using the results from the e17.5 experiment, samples were made and 
absorbances measured on the nanodrop which measured smaller amounts so was more 
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reliable than the spectrophotometer. The samples were filtered twice and three readings 
were taken from each sample to account for the level of variance found across different 
samples (Table 4.5). A control was also conducted to test the reliability, whereby empty 
wells containing no cells were stained with oil red O and then serially sampled for 
reading. This showed the level of background red staining that adhered to the wells.  
 
Table 4.5: Results of oil red O absorbance from 2D and 3D cultures of embryonic day 17.5 
mouse back skin dermal cells, read at 510nm on a nanodrop using UV-Vis software.  
     Mean Mean - Control 
 Control 0.016 0.014 0.010 0.013 - 
 1 0.039 0.027 0.037 0.034 0.021 
2D 2 0.026 0.022 0.025 0.028 0.015 
 3 0.065* 0.035 0.029 0.032 0.019 
 1 0.042 0.041 0.041 0.041 0.028 
3D to 2D 2 0.045 0.044 0.044 0.044 0.031 
 3 0.042 0.053 0.046 0.047 0.034 
*discarded from the mean. 
 
 One value (0.065*) was significantly higher and so discarded from the mean 
(Table 4.5). While the samples for 2D were generally lower than 3D (more than 5 times 
lower) there was still a lot of variability across both the samples and the readings for 
each sample. When control wells were stained, they read a lower absorbance, which 
suggested that the nanodrop readings were accurate to some extent, but that residual oil 
red O stuck to the wells during staining.  
 With the next experiment with 16.5-day embryonic back skin dermal cells, the 
samples were vortexed to mix the oil red O evenly within the isopropanol and a 100% 
isopropanol blank was measured at 0.002. A cell scraper was used to detach the cells 
and break them up in order to collect the entire sample and prevent the spheres from 
clumping together. This was compared with not using a cell scraper on the same 
experiment. 
The values were higher using the cell scraper (Table 4.6) which suggested that it 
was helping to break up the cells so all the oil red O so more of the oil red O is released. 
There was an anomaly (Table 4.6, with cell scraper 4), which was lower than the other 
values. This was compared with 2D with an average mean of 0.062 across the 12 
samples (Table 4.7). The values were more similar to those found using a cell scraper 
on 3D spheres with an average mean of 0.065 (not including the 0.027 value). Overall, 
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using this technique there was no significant difference in the level of oil red O 
quantified between 2D and 3D cultures, though variation across the samples did exist. 
Table 4.6: Result of oil red O absorbance of 3D cultures transferred to 2D from embryonic 
day 16.5 mouse back skin dermal cells.  
     Mean Mean - Blank 
 1 0.051 0.042 0.042 0.045 0.043 
 2 0.048 0.046 0.045 0.046 0.044 
3 0.043 0.050 0.043 0.044 0.042 No cell 
scraper 4 0.067 0.060 0.057 0.061 0.059 
 5 0.064 0.061 0.064 0.063 0.061 
 6 0.030 0.032 0.035 0.032 0.030 
 1 0.067 0.069 0.066 0.067 0.065 
 2 0.065 0.064 0.066 0.065 0.063 
3 0.070 0.069 0.068 0.069 0.067 With cell 
scraper 4 0.028 0.031 0.028 0.029 0.027 
 5 0.066 0.063 0.060 0.063 0.061 
 6 0.067 0.072 0.077 0.072 0.070 
Samples were collected both using a cell scraper and not using a cell scraper and average means 
were calculated before subtracting the isopropanol blank. 
 
Table 4.7: Result of oil red O absorbance of 2D cultures from embryonic day 16.5 mouse 
back skin dermal cells.  
    Mean Mean - Blank 
1 0.063 0.065 0.066 0.065 0.063 
2 0.061 0.063 0.062 0.062 0.060 
3 0.061 0.061 0.059 0.060 0.058 
4 0.057 0.056 0.057 0.057 0.055 
5 0.057 0.060 0.062 0.060 0.058 
6 0.065 0.066 0.065 0.065 0.063 
7 0.064 0.063 0.061 0.063 0.061 
8 0.075 0.074 0.074 0.074 0.072 
9 0.065 0.066 0.065 0.065 0.063 
10 0.061 0.060 0.063 0.061 0.059 
11 0.053 0.051 0.051 0.052 0.050 
12 0.073 0.081 0.098 0.084 0.082 
Average means were calculated before subtracting the isopropanol blank. 
 
4.3.3. Immunofluorescence Labelling of Markers  
 
4.3.3.1. C/EBPα  
 C/EBPα was first looked at in normal embryonic day 18.5 mouse back skin to 
detect the antibody’s presence, which had previously been found to be nuclear around 
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e18 (Wojciechowicz 2012). The labelling was found nuclear in the lower dermis, but 
also throughout the whole skin sample from this age; it was not localised around hair 
follicle end bulbs (Figure 4.51). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.51: Analysis of C/EBPα  presence in embryonic day 18.5 mouse back skin. 
Sections were cut at 7µm, stained with an antibody against C/EBPα and counterstained with 
DAPI. From top to bottom, DAPI, Rhodamine, and merge (DAPI/Rhodamine). Rhodamine 
594 represents the fluorescent labelling of C/EBPα. (1) Control showing no fluorescently 
labelled C/EBPα expression.  (2) labelled using C/EBPα primary antibody.(1D & 2D) 
magnified images to show nuclear staining. Images were taken using a Zeiss Axio Imager M1. 
Scale bar = 40µm. 
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 C/EBPα was then used on spheres to test its effectiveness for the model. The 
fluorescence adhered to the outside of the spheres (Figure 4.52) and did not appear 
positive reliable staining.  
 
 It was thought that considering C/EBPα nuclear expression had previously been 
found around e18 that spheres around this age should be labelled with C/EBPα. 
Therefore, spheres from e15.5 plus 3 days (Figure 4.53) and e16.5 plus 2 days (Figure 
4.54) were stained for C/EBPα. Spheres at the end of the experiment, e.g. e15.5 plus 7 
days and e16.5 plus 6 days were also investigated for a comparison. A different 
secondary antibody was also used. In the e15.5 spheres after 3 and 7 days there was still 
fluorescence round the periphery of the spheres (Figure 4.53). In the spheres taken from 
e16.5 dermal cells, there was a high degree of nuclear expression found after 2 days and 
by 6 days there was a less even distribution with a higher amount of fluorescence 
around the sphere periphery (Figure 4.54).  
Figure 4.52: Analysis of C/EBPα  presence in dermal cell spheres taken from embryonic 
day 16.5. Sections were cut at 7µm, stained with an antibody against C/EBPα and 
counterstained with DAPI. Control shows no fluorescently labelled C/EBPα expression. 
Images were taken using a Zeiss Axio Imager M1. (upper left) scale bar = 65µm. (upper 
right, lower left & right) scale bar = 40µm. 
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Figure 4.53: Analysis of C/EBPα  presence in dermal cell spheres taken from embryonic 
day 15.5 after 3 and 7 days. Sections were cut at 7µm, stained with an antibody against 
C/EBPα and counterstained with DAPI. From left to right, DAPI, FITC, Merge (DAPI/FITC). 
Control shows no fluorescently labelled C/EBPα expression. Images were taken using a Zeiss 
Axio Imager M1. (A,B,E) scale bar = 65µm. (C,D,F) scale bar = 40µm. 
 
 
. 
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Figure 4.54: Analysis of C/EBPα  presence in dermal cell spheres taken from embryonic 
day 16.5 after 2 and 6 days. Sections were cut at 7µm, stained with an antibody against 
C/EBPα and counterstained with DAPI. From left to right, DAPI, FITC, Merge (DAPI/FITC). 
Control shows no fluorescently labelled C/EBPα expression. Images were taken using a Zeiss 
Axio Imager M1. (A,B,D) scale bar = 40µm. (C,E) scale bar = 15µm. 
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Spheres created from e14.5 dermal cells were stained for C/EBPα and most of 
the cells showed nuclear expression of C/EBPα (Figure 4.55). However, whether this 
was a reliable result or not is unclear, considering the labelling on mouse back skin was 
unsuccessful and not all the dermal cells differentiate into adipocytes.  
 
4.3.3.2. PECAM1 
 Spheres from e14.5 dermal cells were also stained for PECAM1/CD31 to detect 
the presence of developing blood vessels. There was some labelling found in the 
spheres to suggest blood vessels were capable of developing alongside adipocytes, 
though there was a little staining in the control spheres, which could mean the 
fluorescence was picking up background between the cells (Figure 4.56). 
Figure 4.55: Analysis of C/EBPα  presence in dermal cell spheres taken from embryonic 
day 14.5 after 4 days. Sections were cut at 7µm, stained with an antibody against C/EBPα 
and counterstained with DAPI. From left to right, DAPI, FITC, Merge (DAPI/FITC). Control 
shows no fluorescently labelled C/EBPα expression. Images were taken using a Zeiss Axio 
Imager M1. (A,B,D) scale bar = 40µm. (C,E) scale bar = 15µm. 
 
 
. 
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4.4. Discussion 
 
4.4.1. Organ Culture Model 
In the majority of the experiments, embryos aged 16.5 day could be used. This 
was considered the best age to look at, as by this point the development of the hair 
follicles had been initiated and it was therefore considered that their effects would not 
be as major. While it would be beneficial to eliminate the effects of the developing hair 
follicles on adipogenesis, this would be unrealistic in terms of normal adipocyte 
development. Since the development of hair follicles and adipocytes are thought to 
interact, it may in fact be of use to eliminate the hair follicles and observe how 
adipogenesis proceeds.  
Figure 4.56: Analysis of PECAM1 presence in dermal cell spheres taken from embryonic 
day 16.5. Sections were cut at 7µm, stained with an antibody against PECAM and 
counterstained with DAPI. Control shows no fluorescently labelled PECAM1 expression. 
Images were taken using a Zeiss Axio Imager M1. (Upper right) scale bar = 65µm. (Left & 
Lower right) scale bar = 40µm. 
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It was found that the results across the different experiments were not consistent. 
Certain morphological features of the skin were used to assess the quality of the 
cultured pieces. These include follicle downgrowth, expansion of the epidermis and/ or 
dermis, darkness of the skin and wound healing response around the perimeter of the 
skin pieces. All these were thought to be positive indications of the skin’s quality, 
except the darkness of the skin, which was considered an indication of the skin turning 
pathological. Due to many of the pieces appearing pathological, different variables of 
the culture system were altered to determine if a more successful organ culture method 
could be created. Since this method had been used successfully before, though it was 
time-consuming the model was persisted with. 
The media and substrate for the skin to be cultured in needed to be as close to 
realistic conditions as possible. Serum, the most commonly used being foetal bovine 
serum, was added to the media. This contains hormones and growth factors amongst 
other things which help to stimulate growth and cell proliferation. Serum also provides 
binding and transport proteins and is involved in detoxification and maintaining the pH, 
allowing the cells to survive and grow healthily (Gstraunthaler 2003). While universally 
used as a media supplement for successful cell culture, serum use comes with its 
disadvantages. In particular, the precise contents of serum is not defined therefore some 
of its functions in culture are unknown (Bjare 1992; Gstraunthaler 2003). Serum can 
also vary from batch to batch so its effects many not be consistent. It is largely an 
unknown variable therefore for some of the experiments in this chapter, as well as using 
different concentrations, serum was omitted. Two different types of media were also 
experimented with to look for the optimum conditions. Modified Eagle’s Media, the 
standard media used for culture of skin was compared with using William’s E media 
(Section 4.3.1.3). William’s E media has been supplemented with amino acids and 
increased levels of glucose, which allows skin and hair follicles to grow in organ culture 
without the need for serum and was found to reduce cell death (Lu et al. 2007). 
William’s Media has been used in the organ culture of human hair follicles (Philpott et 
al. 1994). However, changing the media from MEM to William’s which contained 
Vitamin E, as well as removing the serum or increasing the percentage did not appear to 
have a positive more consistent effect on the cultured skin. It was therefore decided that 
an alternative more manipulative model should be looked into as while further 
developing this organ culture-type model would be beneficial to our understanding of 
adipogenesis in the lower dermis, there was limited time available. 
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4.4.2. Cell Culture Model 
 The results show that in general there is a higher proportion of adipocytes 
produced in 3D culture compared with 2D culture. This may be because 3D represents a 
more life-like environment since the cells are not in contact with a plastic or glass 
substrate and do not grow in monolayers.  
 Often the adipocytes grouped in clusters. This would suggest that there is 
signalling between neighbouring cells. The red staining was often found in the centre of 
the spheres. Perhaps the cells organise into the upper and lower dermis. Oxygen 
pressure is not reliable in the spheres and varies throughout, which may be why fat 
forms in the middle of the spheres. Hypoxia has been found to exist in cell spheres (Liu 
et al. 2013). Hypoxia in 3D spheroid cell cultures exists 200 microns from the surface 
of the spheres (Allison, 2014). As well as this, proliferation occurs more easily at the 
surface of the spheres.  
 Adipocytes formed from cells as early as e14.5 and in fact in a greater density 
than e16.5. This implies that the mesenchymal stem cells are committed to the 
adipocyte lineage a lot earlier than previously thought. Perhaps there is a process of 
inhibition at a later stage that prevents all of the cells becoming adipocytes. There are 
many mechanisms by which this could occur. The fact that the epidermis has been 
removed and is therefore not able to influence the development of the dermal cells 
could be a reason, i.e. the epidermis may have an inhibitory influence on the degree of 
adipocyte differentiation. As an alternative theory, the upper and lower dermis might be 
signalling to each other to prevent the upper dermis from developing fat. The cells may 
be capable of doing so, but a signal is required to prevent differentiation from occurring. 
The cell culture model is a mixture of upper and lower dermal cells, which are not in 
distinct layers, thus no signalling between the layers is possible. A possible hypothesis 
is that without a negative signal, all the dermal cells are capable of turning into 
adipocytes.  
In some of the earlier cell cultures, there was evidence of epidermal 
contamination. A Pan keratin antibody was used to detect the degree of contamination 
in the spheres. While more careful experimentation reduced the degree of contamination 
there were still some epidermal cells found in some of the cultures. The presence of 
these cells may have an impact on the degree of adipogenesis occurring in the cells 
taken from the dermis. Keratinocytes can proliferate rapidly. Ficoll was then used to 
separate the cell types by density. The cell densities for keratinocytes and fibroblasts 
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was taken from Reiners and Slaga (1983). The aim was to remove any keratinocytes 
from the fibroblast populations that had got into the cell suspension before the cells 
were put into culture. It was expected that two distinct layers would be seen in the Ficoll 
fractions, but in fact both times, a cell pellet was found floating on the top layer of 
Ficoll. This could be because the cells were actually less dense than expected, or that 
there were two layers, but the numbers of keratinocytes were so small they were 
difficult to see. One density was used for keratinocytes, while in actual fact they vary in 
density throughout the epidermis and the basal keratinocytes overlap with fibroblasts in 
terms of density (Reiners and Slaga 1983). When comparing the results found using 
Ficoll from not using Ficoll, the difference in both adipocyte formation and the number 
of cells stained with the pan keratin antibody did not appear to be significantly different. 
Therefore due to time constraints and the need for a high number of cells for the use of 
Ficoll, it was not used in the final model protocol to look at the signalling pathways. 
Epidermal contamination while considered an issue, would not render the model useless 
for looking at signalling pathways as it would still be looking at the effect they can have 
on the skin adipogenesis. Pan keratin was still used to monitor the levels of 
contamination across the experiments. This way, any anomalous results could be 
considered in relation to contamination. To observe what effects the epidermis might be 
having on the dermis in culture, whole skin cultures were also performed, whereby the 
whole skin was put into cell culture. There was less fat production. This may be because 
the cells have been dissociated and are not in a normal organisation. 
Not only is the epidermis thought to influence adipogenesis in the lower dermis, 
but blood vessel development (angiogenesis) has been implicated (Neels et al. 2004; 
Cao 2007). It occurs prior and during adipogenesis (Fukumura 2003; Hausman and 
Richardson 2004; Hausman and Hausman 2006; Wang et al. 2006) and has been 
previously suggested to be the reason for many of the genes found in the adipose 
microarrays. The microarray values depend on the location in the dermis selected, thus a 
blood vessel could be located. The antibody, PECAM1, was used to look for blood 
vessel formation in the spheres. These spheres showed blood vessel like structures in 
the spheres after 2 days which was around embryonic day 18.5. Thus, angiogenesis 
could be influencing adipogenesis. 
It was originally thought that if the later dermal cells were put into culture 50% 
of them would differentiate into adipocytes. Often the spheres showed a high degree of 
red staining and it was inferred that there must be a degree of cell-to-cell signalling. 
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Interactions between cells are important for development and aid the organisation of 
tissues and structures (Cooper 2000). 
The sphere model, initially looked like it was showing how the dermis alone 
behaved autonomously, however epithelial “contamination” was then found, so from 
e15 onwards, dermal cells plus epidermal influences were investigated. Comparing with 
2D was difficult since one of the differences between the 2D and 3D cultures was that 
the 3D have retained an epithelial influence. This being said the fact that the e14.5 3D 
spheres which have no epithelial cells still showed the same 3D vs. 2D difference 
suggested that at least a positive epithelial influence is not required from this point on.  
 
4.3.3. Oil Red O Quantification 
Establishing a method of quantifying the oil red O proved difficult. While 
originally it was thought that it would be appropriate to use 100% isopropanol to collect 
the oil red O from the wells and read the absorbance on a nanodrop, this method was 
found to be unreliable. One of the problems encountered was images showed that the oil 
red O had stained the lipid droplets within the cells; it had also adhered to the sides of 
the well where there were no cells. This meant that the oil red O collected included 
inconsistent excess from the sides of the wells. Secondly, staining the 3D spheres, 
which had been transferred to 2D culture was challenging. Often the spheres detached 
from the wells and it wasn’t certain that all the staining from inside the spheres had 
been collected. In order to make sure that all the cells were collected, a cell scraper was 
used on some of the wells to detach all the cells and therefore collect all possible oil red 
O. The results were inconsistent between the wells containing the same treatment. As 
well as this, some of the spheres disintegrated in the 100% isopropanol, which led to the 
chance that the absorbance readings could be wrong if particles were registered instead 
of a solution. In order to prevent this from being the case, some of the mixtures were 
briefly centrifuged so the cells that had been picked up in the isopropanol settled at the 
bottom of the eppendorf. This did not prevent anomalous results from being produced. 
While the method was found largely unreliable, there were some improvements in the 
consistency of the results found when three readings were taken from each data set, 
compared with the earlier attempts. However often the results also varied for the same 
samples. 
 
 
	   187	  
4.4.4. Further Work 
Oil red O quantification could really aid defining the visual results. A potential 
method of quantifying could involve counting the red stained cells in proportion to how 
many cells in a frame. Several frames could then be added together to create an average.  
This technique relies upon the images showing an overall representation of the cells 
growing in the wells. Another method could be conducted by staining the cells with 
lipid red and using flow cytometry to measure the level of fluorescence present. It 
should show that even though there are less 3D cells as proliferation does not occur like 
2D, there is still more red staining, thus 3D allows for better differentiation. 
In order to conduct the organ culture model without the influence of hair follicle 
formation, a mouse model that does not develop follicles could be used. If it is an 
epidermal mutation, could potentially recombine with another mouse dermis to observe 
if adipocyte development is inhibited. Conversely adult follicles could be cultured with 
the embryonic skin in co-culture. As well as hair follicle presence, the use of Ficoll to 
separate the epidermis from the dermis cell densities was found difficult, most likely 
because the densities can be very similar as keratinocytes have varying densities 
(Reiners and Slaga 1983). In order to better purify the dermal cell suspension, an 
experiment could be conducted using fluorescence-activated cell sorting (FACs) to 
separate the upper and lower dermis by detection of CD36. 
In all the skin ages (e14.5, e15.5, e16.5, e17.5 and e18.5), after culture, there 
was evidence of adipose development. In order to show that adipogenesis can also be 
inhibited and there find at which age it is too late to inhibit, SPARC (Secreted protein 
acidic and rich in cysteine) could be used as a control. Without SPARC (-/-) mice 
produce more adipose tissue, but in vitro, SPARC can inhibit adipogenesis (Nie and 
Sage 2009). In order to show inhibition of adipogenesis, isolate the  SPARC protein and 
transfect the cells using siRNAto block transcription, causing gene knockdown. This 
can either be transient so that the effects of adipogenesis inhibition at certain time points 
can be observed, or permanent by inserting a vector.  
In order to track the development, a marker of early adipogenesis is needed. 
C/EBPα was immunfluorescently stained for, but seemed to show inconclusive results. 
The periphery of the spheres fluoresced and when the skin was stained, there was no 
specificity; all the cells were labelled. Perhaps the antibody, like that of PPARγ 
(Chapter 3) is not suitable for immunofluorescence analysis on frozen sections. A future 
experiment could involve the use of Western blot analysis. 
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Potentially, if both models were working, they could be used in conjunction with 
each other to investigate adipogenesis. Why the skin organ culture model was not able 
to be recreated was questionable. However, if it were working perfectly would allow 
how specific influences affected adipogenesis at key times to be asked, in the context of 
all other influences being present – including hair follicles. The sphere model if taken 
from e14 or even earlier could look at the specific influences dermal cells have on each 
other. Embryonic day 16.5 was focused on, though as it is becoming increasingly more 
likely that adipogenesis starts earlier than the ages the microarray data was collected 
from (Wojciechowicz 2012), getting the model reproducible at a variety of ages so that 
it can be pushed back earlier would be beneficial. There are different stages of 
regulation during adipogenesis; therefore, it is still valuable to look at e16.5, after the 
establishment of the hair follicles. As well as this, some pathway signals influence hair 
follicle initiation and so by investigating later, follicles are already forming. It can be 
concluded that many different methods of studying development should be combined 
and no one such model can be accepted as identical to that found in a normal 
environment. While both models could be beneficial to the study of adipogenesis, in 
this case in terms of the role of particular signalling pathways, due to time constraints 
the cell culture model established here was used. Further investigation into the organ 
culture model may enable it to be developed for future work. While the organ culture 
model would be considered a more realistic model system, when testing factors, the 
signal is unspecific signal as both the epidermis and dermis receive it so in this case, 
perhaps the cell culture model would actually be better. 
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CHAPTER 5: 
The Signalling Pathway Question; 
Investigation into the Effects of 
Pathway Activators and Inhibitors 
of Three Signalling Pathways on 
Adipocyte Development  
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5.1. Introduction 
 
As well as those considered as the master regulators of adipogenesis, e.g. 
PPARγ and C/EBP family members, other factors have been found having positive or 
negative regulatory effects on the development (Lefterova and Lazar 2009). 
Signalling, including extracellular and intercellular signalling, is fundamental to 
the organisation of embryonic (and post-natal) development, involving differentiation 
and the growth of different cell types in the skin (Figure 5.1). A number of conserved 
families of signalling molecules orchestrate embryogenesis and similarly tissue 
regeneration (Hogan 1996). Microarray analysis data has shown that there are many 
factors linked in a number of signalling pathways. These interact with each other 
through both activating and inhibiting effects, which regulate development, including 
the development of fat (adipogenesis). Signalling pathways generally involve ligands, 
e.g. growth factors binding to receptors and triggering a signalling cascade and a 
number of cellular responses. Adipogenesis involves the induction of factors with cause 
the cells to commit to adipogenesis and the activation of a number of transcription 
factors downstream of signalling pathways that allow or prevent differentiation from 
occurring (Rosen and MacDougald 2006). Not only this, but these factors can also have 
different influences at different locations, timings and doses. For example, it is known 
that bone morphogenetic protein 4 (BMP4) has a concentration-dependent effect on the 
development of the dorso-ventral patterning of the neural tube with an opposing 
gradient of Sonic hedgehog (Shh) signalling. Cell-to-cell interactions, vasculature and 
innervations are also influential as to the effects signals and signalling pathways have 
(Gesta et al. 2007). 
The type of signalling can help to explain what sort of role a pathway can have 
on development. Different modes of signalling occur over different distances. For 
example, juxtacrine and autocrine signalling requires close cell to cell contact, while 
paracrine signalling can occur over short distances and intracrine signalling occurs 
within a cell. Epidermal growth factor (EGF) acts in an autocrine manner, while 
keratinocyte growth factor is thought to act in a paracrine manner. This means they 
signal between members of the same cell type by binding to receptors on the surface of 
these cells (autocrine) (EMBL-EBI 2013) or the cell releases the signal to affect nearby 
cells (paracrine). How these different types of signalling work together and cross-talk is 
important for understanding cell signalling networks. These ligands, e.g. EGF, as 
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mentioned previously, bind to specific receptors and this triggers a signalling cascade to 
control many processes within a cell. This includes changes in size and shape or 
transcriptional activity (Millar 2005).  
Transgenic and knockout mouse models can be used to understand the roles of 
these growth factors and pathways in development, as described in sections 3.1.1.  
While useful to a certain degree, these can impact other tissues and organogenesis 
across the body so there is a need to look at different methods to isolate the study to 
their effects on the skin (dermal fat in particular). As the dermal adipose (fat) layer has 
only recently been recognised as distinct from the subcutaneous adipose layer beneath 
the skin and also of separate developmental origin, it could be thought that these 
signalling pathways may be acting differently from those already studied. 
 Most fundamental cellular signalling pathways have an effect on adipogenesis 
with several of them having both positive and negative controls. Many different 
signalling pathways have been shown to influence adipogenesis in vitro, e.g. 
EGF/EGFR and Wnt pathways, but their effects in vivo are not as well known. Highly 
conserved signalling pathways including BMP, EGF/EGFR and more recently 
KGF/KGFR have been implicated as some of the important signalling pathways in hair 
follicle morphogenesis (Richardson et al. 2009) and more recently for their association 
with adipocytes and potential role in adipogenesis in the dermis of the skin. Activation 
and inhibition of these pathways at certain times and in certain locations is key to the 
successful development adipocytes and the committed precursor cells. A network of 
transcription factors and events involved in the signalling cascade can be seen expressed 
in microarrays. These can all interact to create a balance of activating and inhibitory 
effects, of which is largely unknown. A link has been suggested between hair follicle 
and adipose tissue development, thus further implicating these pathways in 
adipogenesis (Festa et al. 2011). The exact roles and effects these pathways play in 
adipogenic development is largely unknown (Gesta et al. 2007). The aim is to improve 
our understanding of the roles these signalling pathways have on adipogenesis. It is 
important to note that while these three pathways are looked at in more detail there are 
other pathways and signals implicated in adipogenesis, e.g. Wnt, Notch, Hedgehog and 
other FGF pathways other than FGF-7/KGF (Zehentner et al. 2000; Rosen and 
MacDougald 2006). 
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5.1.1. The EGF/EGFR Signalling Pathway  
Epidermal growth factor (EGF) is a member of the epidermal growth factor 
superfamily. This is a growth factor involved in growth, proliferation and differentiation 
of many different cell types. It acts as a ligand to the epidermal growth factor receptor 
(EGFR), which signals to the nucleus through a signalling cascade. EGFRs 
(EGFR/ErbB1, HER2/ErbB2, Her3/ErbB3 and HER4/Erb4) are a family of 
transmembrane receptors and are important in regulating cell behaviour, e.g. 
proliferation and differentiation (Huang et al. 1999; Massutí 2003; Sugawara et al. 
2010). These receptors have an extracellular ligand-binding domain and a cytoplasmic 
domain with tyrosine-kinase activity. EGFR can be received by several activating 
ligands including EGF, TGFα, heparin-binding EGF (HBEGF), betacellulin and 
amphiregulin (Massagué and Pandiella 1993; Yamanishi 1998). It is expressed in basal 
keratinocytes, sebocytes, outer root sheath (ORS) cells and in the dermal ducts of 
eccrine sweat glands (Nanney et al. 1986; Yamanishi 1998).  
The signalling pathway involves these ligands inducing dimerization and 
autophosphorylation of the receptors. Homodimers (with EGFR) or heterodimers (with 
ERBB2,3 or 4) form (Massutí 2003; Sugawara et al. 2010). Phosphorylated tyrosine 
residues become the binding sites for Src-homology 2 (SH2) parts of Grb-2, Shc 
Figure 5.1: Extracellular activators and inhibitors regulate adipogenesis. Many factors 
influence adipogenesis and induce signalling pathways. KGF is a more recent extracellular 
signal. Adapted from Rosen and MacDougald (2006).  
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proteins and phospholipase C-g which lead to downstream signalling cascades and a 
number of cellular responses (Yamanishi 1998; Yarden et al. 2007; Sugawara et al. 
2010). The downstream modification of enzymes, adaptor proteins, second messengers 
and transcription factors involved in this signalling cascade can induce a number of 
different signal transduction cascades including Ras-Raf-MEK-MAPK and PI3-kinase. 
Many pathways cross-talk to each other, e.g. the EGF/EGFR pathway with the 
MAP kinase pathway. MAP kinase is activated by EGF and also insulin through Ras 
(Suga et al. 1997). In EGF signalling, the EGF receptor binds to growth factor receptor-
bound protein 2 (Grb-2)/son of sevenless (Sos) to activate Ras. Alternatively EGF and 
insulin phosphorylate Shc forming Shc/Grb-2/Sos complex, which activates Ras. As 
well as MAP kinase, Raf-1 kinases and MEKs are activated. Not only does the MAP 
kinase interact with the EGF signalling cascade, but also phosphatidylinositol 3 (PI3)-
kinase binds to Ras (Rodriguez-Viciana et al. 1994; Suga et al. 1997) and can 
consequently activate Raf-1 kinase. In EGF signalling, Cbl and ErbB3 proteins recruit 
PI3-kinase to the EGF receptor and are phosphorylated and thus become docking 
proteins between EGFR and PI3-kinase. (Soltoff et al. 1994; Fukazawa et al. 1996; 
Suga et al. 1997).  
This pathway is fundamental to the correct development of hair and skin 
(Sugawara et al. 2010). The ligands that bind to EGFR have been found to inhibit 
developing hair follicles but the mechanisms by which this occurs are largely unknown 
(Richardson et al. 2009). A number of mouse models have been created to understand 
the role of EGFR in the skin. EGF plays an important role in control of adipocyte 
differentiation (Serrero and Mills 1991). Waved-2, which has a mutated Egfr gene has 
wavy hairs and curled whiskers (Keeler 1935; Sugawara et al. 2010). However, these 
mice only show a mild abnormal phenotype, but targeted gene disruption results in 
mortality either embryonically or post-natally with the latest survival being 
approximately three weeks (Sugawara et al. 2010). Premature hair follicle 
differentiation, epidermal atrophy and decreased keratinocyte proliferation is exhibited 
by these mice (Threadgill et al. 1995; Sugawara et al. 2010). EGFR is also thought to 
be involved in the inflammatory response as demonstrated by replacing Egfr with the 
human EGFR cDNA as the hair follicles experience inflammation and degrade over 
time (Sibilia et al. 2003; Sugawara et al. 2010). Waved-5 mice (Lee et al. 2004), also 
named Velvet (Du et al. 2004) with the Egfrwa5 allele that codes for a dominant 
negative receptor, show a heterozygous phenotype unlike Waved-2 mice. These mice 
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have defective wavy hairs and curled whiskers as does the mutant Dsk5 mouse, which 
also has a thickened epidermis (Fitch et al. 2003; Sugawara et al. 2010).  
EGFR knockout mice have been created from a number of different mouse 
strains, while some of these are lethal, e.g. CF-1; others survive but with a thin stratified 
epithelium and reduced numbers of disorientated follicles (Yamanishi 1998). In these 
mice, the appearance of irregular epithelial tissues is not limited to the skin but can also 
be found in other organs and tissues including the lung. EGFR knockout mice died early 
on and so effective studies are limited. Disrupting the EGF receptor has resulted in 
malfunctions during late follicle development, which would suggest that EGF signalling 
has a positive influence on hair follicle formation (Murillas et al. 1995; Richardson et 
al. 2009). It also had no adipocytes between the hair follicles (Murillas et al. 1995). In 
contrast others suggest it has a negative effect; Hair follicle formation is inhibited in 
terms of both timing and dose when supplied with EGFR ligands (HBEGF and 
amphiregulin), but epidermal differentiation does occur as shown by analysis of 
downstream molecular markers and microarray profiling (Kashiwagi et al. 1997; 
Richardson et al. 2009). It can therefore be suggested that when investigating this 
pathway the timings at which it is studied are crucial to the role it plays.  
Microarray analysis has shown epidermal growth factor receptor (EGFR) to be 
upregulated in the lower dermis of embryonic mouse skin, which provoked interest in 
its role in adipogenesis (Wojciechowicz 2012). It was found that EGFR presented 
opposite effects during the process of adipocyte development, i.e. if the cells were 
differentiated EGF promoted this, whereas if the cells were not yet committed, 
adipocyte differentiation was inhibited (Wojciechowicz, 2012). This receptor interacts 
with EGF and has been found to play a role in adipogenesis in vitro (Adachi et al. 1994; 
Wojciechowicz 2012) though the point during development at which EGF is supplied is 
important.  
Wojciechowicz (2012) developed an organ culture model as described in 
Chapter 4 in which to study the effects of this pathway on adipocyte development. Skin 
in culture was supplied with an EGF activator or inhibitor. Embryonic day 15/15.5 skin 
did not show any adipocytes while by e16-17 those supplied with the activator showed 
adipocyte staining. By e18/19 adipocytes were clearly visible, particular in the lower 
dermis and surrounding the hair follicles. Their development was not impeded by the 
presence of an inhibitor. This shows that the timing of the activation of the pathway is 
crucial to localised development of fat and the commitment of the precursor cells. This 
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model was repeated in the current study prior to experimenting with the cell culture 
model, the development of which is described in chapter 4. From this previous work, it 
can be hypothesised that EGF induces adipocyte development, but does not have an 
effect on cell commitment. EGF is also not the only activating ligand of EGFR. It is 
therefore important when looking at the pathway to inhibit the receptor rather that 
purely the growth factor. An EGF inhibitor (AG1478) was used to contrast the effects 
of EGF. 
 
5.1.2. The TGFβ/BMP Signalling Pathway  
Within the transforming growth factor-β (TGFβ) superfamily, one of the largest 
families of signalling molecules, are grouped the bone morphogenetic proteins (BMPs), 
whose functions are more diverse than this name suggests (Massagué and Chen 2000; 
Gesta et al. 2007). They are known not only for their involvement in bone formation but 
also for being multifunctional through vertebrate development, involved in cell 
proliferation, differentiation and also apoptosis throughout the body, including the skin 
(Hogan 1996; Botchkarev 2003). BMP signalling receptors are transmembrane serine-
threonine kinases of which two types exhibit, I and II (Massagué and Weis-Garcia 1996; 
Hogan 1996; Botchkarev 2003). Individually these receptors have a low affinity for 
BMP but in a heterotetrameric complex of types I (BMPR-IA and BMPR-IB) and II 
(BMPR-II), BMP dimers can bind with high affinity (Botchkarev 2003). The type I 
receptor is transphosphorylated by the type II kinase at the GS box region of the 
cytoplasmic domain. In mammalian cells in vitro, one BMP can recognise several type 
II receptors and therefore phosphorylate different type I receptors, which then causes a 
downstream signalling cascades (Hogan 1996).   
 
 
 
 
 
 
 
 
 
Figure 5.2: The BMP receptor. Type I and type II serine threonine kinase receptors form a 
heteromeric complex. Based on Hogan 1996 (adapted from Massagué and Weis-Garcia 1996). 
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Characterization of downstream signalling of BMP is limited; though 
Drosophila are thought to have similar signalling cascades and has been used for much 
of the research into this pathway. BMPR-IA also known as activin-like kinase-3 (ALK-
3) and has been found to induce adipocyte differentiation whereas BMPR-IB induces 
osteogenesis. It is therefore important to clarify which aspects are experimented with, as 
the BMP pathway can have both positive and negative influences on adipocyte 
development. The BMP pathway is particularly complex because opposing effects have 
been found in almost every situation. 
The BMP signalling pathway can occur and be regulated at many different 
levels from the cell surface, to the cytoplasm and in the nucleus. The pathway 
mechanisms can be “canonical” which is SMAD-dependent or “noncanonical”, SMAD-
independent (Botchkarev 2003; Rosen and MacDougald 2006). In the “canonical” 
pathway, the binding of BMP to the receptor complex is regulated by SMADS. Smad1, 
Smad5 and Smad 8 are phosphorylated by BMPR-I kinases, which cause complexes to 
form with Smad4. These heteromeric complexes are then translocated to the nucleus to 
induce transcription of target genes (Botchkarev 2003; Rosen and MacDougald 2006). 
This pathway is somewhat more complex with some Smads inhibiting this process, e.g. 
Smad 6 and Smad 7 and the involvement of other regulatory proteins e.g. AMSH and 
Smurf1 (Zhu et al. 1999; Botchkarev 2003). The effects of BMP binding are further 
regulated in the nucleus where the binding of cofactors to the Smad complex can have 
positive or negative effects on the target genes (Botchkarev 2003). The “noncanonical” 
pathway involves binding to BMPR-IA and then joining with BMPR-II with subsequent 
activation of the mitogen-activated protein (MAP)-kinase pathway (Nohe et al. 2002; 
Botchkarev 2003). Once activated, the receptor complex interacts with intracellular 
adaptor protein XIAP. This triggers the binding of TAK1 binding protein (TAB1) 
leading to the activation of the MAPK family member, TGFβ activated kinase 1 (TAKI) 
(Yamaguchi et al. 1999). 
While it is well known that BMPs are involved in body patterning, including 
neural patterning, it has also been shown that they are involved in other aspects of 
development. Evidence has been found that BMPs can induce both proliferation and 
differentiation for different cell types. It may therefore be that BMPs can cause different 
effects in different cell types and depending on the concentrations the cells are exposed 
to (Hogan 1996). Not only can the function of BMPS differ in relation to their 
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concentration, but also in relation to the type of mesenchymal cell and what other 
regulatory factors are present (Rosen and MacDougald 2006). 
Members of the TGFβ family, including BMPs, have been found to have an 
influence on adipogenesis and be involved in differentiation of adipocytes (Zamani and 
Brown 2011; Siersbæk et al. 2012)). TGFβ and elements of its signalling pathway are 
expressed in cultured adipocytes, but it has previously been shown to inhibit 
differentiation in vitro pre-adipocytes and transgenic overexpression of TGFβ causes 
adipose development to fail (Rahimi et al. 1998; Rosen and MacDougald 2006). 
Conversely blocking TGFβ, by using dominant-negative TGFβ receptor expression or 
SMAD inhibition, causes increased adipocyte development (Choy et al. 2003; Rosen 
and MacDougald 2006). Commitment to the adipocytes lineage of mesenchymal cells 
has been found to involve BMP4 (Tang et al. 2004). BMP2 is also thought to influence 
adipogenesis but requires other signalling molecules e.g. TGFβ to interact and acts in a 
concentration-dependent manner. For example, at low concentrations it can stimulate 
cells in vitro to undergo adipogenesis (zur Nieden et al. 2005), while at higher 
concentrations osteogenesis and chondrogenesis is more likely to occur (Wang et al. 
1993; Rosen and MacDougald 2006). BMP2 was also found to inhibit adipogenesis 
when supplemented with retinoic acid in the 3T3-F442A cell line. The consensus could 
be that the presence of BMP2 is to direct cells away from the adipocytes lineage, but it 
cannot act alone. As well as BMP2, BMP7 has been found to direct cells away from the 
adipogenic lineage and down the osteogenic lineage from MSCs, though this is 
concentration-dependent (Gesta et al. 2007). The cells experimented with however, are 
in vitro cell lines, therefore it is of interest to see what occurs in vivo mesenchymal 
cells.  Some knockout mouse models in vivo die prior to adipocyte development 
limiting in vivo studies. For example, BMP4 knockout mice die early in embryogenesis 
because of defects in gastrulation and the mesoderm (Winnier et al. 1995). The 
Schnurri2-2 (SHN2) gene downstream of BMP2 has however been found to interact 
with PPARγ and C/EBPα expression and is necessary for adipogenesis in vivo as well 
as in vitro (Jin et al. 2006; Gesta et al. 2007). SHN2 is translocated to the nucleus upon 
induction by BMP2 and joins the SMAD proteins SMAD1, SMAD4 as wells as CEBPα 
on the PPARγ2 promoter (Jin et al. 2006; Rosen and MacDougald 2006). 
BMP antagonists e.g. noggin or follistatin regulate the pathway by binding to 
BMPs with a higher affinity that the receptors (Botchkarev 2003). Smad6 and Smad7 
are also antagonists because they prevent Smad1, Smad5 and Smad8 from being 
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phosphorylated (Botchkarev 2003). Therefore, looking at the effects of inhibiting BMP 
is important, because BMP may in reality in this situation be being blocked during 
certain stages of adipogenesis. Looking at both the effects of BMP and an inhibitor of 
BMP can therefore give a better understanding of what might be happening in the 
dermis in relation to the BMP pathway at this point in development. In this project an 
inhibitor of BMPR1A, also referred to as DMH1 is used to do so.  
BMPs, BMP antagonists, BMP receptors and Smad proteins work together to 
produce spatio-temporal patterns of expression to regulate development throughout the 
body, including in the skin epithelium and mesenchyme (Botchkarev and Sharov 2004). 
As well as this, similarly to the EGF/EGFR pathway, the BMP pathway interacts with a 
number of different pathways to create the overall regulatory and developmental effects. 
For example, EDA and its receptor EDAR as part of the Wnt pathway are crucial to hair 
follicle morphogenesis and interact with BMP to determine patterning of the follicles 
(Richardson et al. 2009). 
BMP signalling has been found crucial to many stages of development of the 
skin epidermis and hair follicle formation. At induction of the hair follicles, BMP-2 and 
BMPR-IA are expressed at the placode, and BMP-4 and noggin are expressed on the 
mesenchymal condensation cells. Noggin-knockout mice lack all secondary follicles, 
while overexpressing Noggin increased the density of follicles (Botchkarev et al. 1999; 
Botchkarev and Sharov 2004). In general BMP-2 has been found to be expressed more 
in the epithelium while BMP-4 is expressed more prominently in the mesenchyme, 
which works in conjunction with EGF to control hair follicle development. In this 
project, BMP-4 is the chosen BMP for its implication in adipogenesis (Rosen and 
MacDougald 2006). Mice that lack BMP2 or BMP4 die prior to adipocyte development, 
therefore in vivo studies have been limited.  
 
5.1.3. The KGF/KGFR Signalling Pathway  
Keratinocyte growth factor (KGF) is part of the fibroblast growth factor (FGF) 
family and is also known as fibroblast growth factor 7 (FGF7) (Finch et al. 1989; 
Aaronson et al. 1991; Guo et al. 1993; Guo et al. 1996). KGF is a 194 amino acid 
protein and is capable of secretion by encompassing a signal peptide (Finch et al. 1989; 
Rubin et al. 1995). FGFs control a number of cellular responses, critically by regulating 
cell proliferation, differentiation and migration in embryogenesis, though they are also 
involved in control in the adult organism (Eswarakumar et al. 2005). It is produced by 
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stromal fibroblasts, though its mitogenic activity is on keratinocytes in the skin (Guo et 
al. 1993; Rubin et al. 1995; Guo et al. 1996). It has, therefore, been suggested that it 
might mediate mesenchymal-epithelial communication (Rubin et al. 1995).  
Fibroblast growth factor receptors, FGFRs are tyrosine kinase receptors (RTKs), 
which have an extracellular ligand-binding domain with immunoglobulin-like (Ig) 
domains, a transmembrane domain and a cytoplasmic domain, which contains a 
catalytic protein tyrosine kinase core and regulatory sequences (Hunter 2000; 
Eswarakumar et al. 2005). Isoforms have been isolated from both mouse and human 
cells with three Ig loops though originally thought to only have two and bind KGF with 
the same affinity (Miki et al. 1992; Rubin et al. 1995). FGFR isoforms are formed by 
alternative splicing. KGF (FGF7) is received by an alternatively spliced variant of 
FGFR2 (Peters et al. 1992; Johnson and Williams 1993; Guo et al. 1996). This is 
created by alternative splicing in the third Ig-like domain of the extracellular domain 
called D3. This alters the ligand-binding, thus specifically FGFR2b binds FGF7 as well 
as FGF10 (Eswarakumar et al. 2005). By creating molecules with different 
combinations of the second and third Ig loops it was found that the third Ig loop is 
responsible for the majority of KGF’s affinity for KGFR (Cheon et al. 1994; Rubin et 
al. 1995) FGFR2b is also referred to as KGFR and is only expressed in epithelial cells 
(Guo et al. 1993).  
KGF/KGFR pathway is a paracrine pathway. KGFR binds both KGF and aFGF 
(Rubin et al. 1995). These signalling molecules bind to the receptor’s tyrosine auto-
phosphorylation sites and the associated docking proteins (FRS2α and FRS2β) become 
tyrosine phosphorylated and induce the formation of other complexes with additional 
signalling proteins, Gab1 and the effector proteins, Grb2/Sos complexes and Shp2. 
Shp2 is phosphorylated in response to FGF stimulation and also complexes with Grb2 
molecules. This leads to activation of MAP kinase, PI-3 kinase, chemotaxis and cell 
proliferation. This was found by isolating fibroblasts from FRS2α-/- embryos (Hadari et 
al. 2001; Eswarakumar et al. 2005). 
A number of procedures and mouse models have been used to determine the 
roles of KGF. Homologous recombination shows that alongside other FGFs, KGF is 
fundamental to the majority of mouse development stages and organogenesis 
(Eswarakumar et al. 2005). Targeted disruption of FGF7 results in hair follicle and 
kidney deficiency (Guo et al. 1996; Eswarakumar et al. 2005). When transgenic mice 
are created with KGF expression targeted to the basal epidermal layer, controlled by the 
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human K14 promoter, the function is altered from paracrine to autocrine and epidermal 
thickening and proliferation occurs (Guo et al. 1993). Not only this, but there is 
noticeable suppression of both hair follicles and adipogenesis (Guo et al. 1993). Even 
very low levels of KGF blocked fat formation, which suggested that adipose tissue is 
particularly sensitive to KGF. These mice are very frail and as adults exhibit 
hypersalivation with abnormal differentiation of the salivary glands (Guo et al. 1993; 
Yamanishi 1998).  
Guo et al. (1996) used embryonic stem cell technology to knockout KGF. This 
resulted in defects in the hair shaft, making the fur appear matted due to KGF 
influencing the matrix cells. Epidermal growth and morphology appear normal, as does 
the wound healing response. Contrastingly, when KGFR is truncated, wound healing 
cannot occur correctly (Werner et al. 1994), which would suggest KGF is important for 
wound healing or perhaps the receptors can be influenced by other factors/ligands other 
than KGF (e.g. aFGF) (Guo et al. 1993). 
Richardson et al. (2009) also show that KGF can inhibit hair follicle formation 
in a time and dose-dependent manner but epidermal differentiation does occur. Mouse 
model work has also shown that when the FGFR2(IIIb) receptor is inhibited, hair 
follicle density decreases and development is negatively impacted (Petiot et al. 2003; 
Richardson et al. 2009). Over expression of FGFR2 dominant negative also inhibits hair 
follicle formation (Werner et al. 1994), while over expression of KGF in the epidermis 
inhibits follicle development (Guo et al. 1993). 
While it is known to be important in epidermal growth and regeneration, its role 
in adipose tissue is not as well known. Adipogenesis can be described as preadipocyte 
proliferation and differentiation and is fundamental to adipose tissue growth, which can 
lead to obesity. KGF has been found upregulated in rat models subjected to maternal 
protein restriction (MPR), where foetal nutrition has been limited and so 
overcompensation occurs (Zhang et al. 2010). Individuals subjected to MPR exhibit 
increased adipose tissue growth and obesity risk, which may correlate with the 
upregulation of KGF. Zhang et al. (2010) used in vitro models e.g. 3T3-L1 and rat 
primary preadipocytes to look at the role of KGF in adipogenesis. KGF was found to 
stimulate preadipocyte proliferation in an autocrine fashion controlled by the PI3 kinase 
signalling pathway. This was demonstrated by the activation of the PI3 kinase 
downstream target, protein kinase Akt (Zhang et al. 2010). While proliferation is 
stimulated, differentiation of adipocytes is not: as shown by no change in lipid 
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accumulation or expression levels of adipocyte markers, aP2 and PPARγ. This differs 
from the paracrine role of KGF in the epidermis (Finch and Rubin 2004). Having shown 
the importance of KGF in adipogenesis in vitro, there is now a need to reliably test its 
role in vivo. (Zhang et al. 2010). KGF has therefore been shown to be able to affect 
differentiation and development and not just proliferation and is necessary for 
mesenchymal-epithelial interactions (Yamanashi 1998). It is involved in the 
development of a number of organs including the skin, lungs, kidneys and salivary 
glands (Rubin et al. 1995; Yamanishi 1998). KGF is known for stimulating keratinocyte 
proliferation but more recently has been found to be involved in preadipocyte 
proliferation (Zhang et al. 2010). This activity is stronger than EGF in vitro (Yamanishi 
1998). The effect on mesenchymal tissues including adipose tissue may be mediated 
through the effects KGF has on the epidermis and hair follicles as an indirect effect. 
Can KGF actually have a direct influence on dermal cells or is it mediated through 
signals from the epidermis? 
The role of the KGFR pathway in epidermal growth and wound healing as well 
as associated processes including hair follicle formation and adipogenesis is largely 
unknown. While more is known in relation to the epidermis, the fact that the FGFR2 
receptor is expressed at the point at which epidermal-mesenchymal interactions may be 
influencing development (Peters et al. 1992; Guo et al. 1993) suggests that KGF may 
have a wider impact on a number of cell types and tissues, including dermal tissues. 
There is, therefore, a need for ways of investigating the influences this pathway has and 
this is one reason KGF and its respective pathway may be a suitable candidate to study 
to further our understanding of adipogenesis, particularly in the skin.  
 While there is currently limited evidence on the importance KGF might be 
having on adipogenesis in the skin, there was however an experiment conducted in 
Jahoda’s lab, which prompted further analysis to be done with respect to it. Here 
immunofluorescence showed that there was positive labelling of KGF in the lower 
dermis in relation to the H&E stained skin. It was just above the muscle layer, as early 
as embryonic day 13. This would suggest that KGF may be more important than 
originally thought, thus not just involved in keratinocyte development but also in the 
dermis, in particular the lower dermis where adipocyte development is taking place.  
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5.1.4. Aims of the Chapter 
Prior to Wojciechowicz’s work there was no evidence of an in vivo experiment 
to look at the EGF-EGFR signalling pathways’ involvement in differentiation in the 
lower dermis during late mouse embryonic development. Her results act as a control in 
terms of how the models respond to this pathway. Both the organ culture model that 
was previously used, and a novel cell culture model were used to look at this pathway. 
The aim of these models is to act in a manner, which closely resembles that found in 
vivo. An inhibitor and an activator of EGFR were used and the accumulation of lipids in 
the cells was examined using Oil Red O staining. This cell culture technique was then 
used to test the roles of two other pathways in adipogenesis: the TGFβ/BMP and 
KGF/KGFR pathways. 
 
5.2. Materials and Methods  
 
First, the organ culture model, which was previously used by Wojciechowicz 
(2012) and experimented with as described in section 4.2 was applied to look at the 
EGF/EGFR pathway. Four to five pieces of skin were placed on collagen filters in each 
35mm dish. To investigate this pathway, the media was supplemented with an activator 
of EGFR or an inhibitor. EGF/amphiregulin or InSolutionTM AG1478 (Calbiochem) 
respectively (Appendix III). Table 5.1 shows the concentrations used. A control dish 
Figure 5.3: KGF expression in the lower dermis at e13. H&E staining of the skin at 
embryonic day 13 and immunofluorescence labelling of KGF. Images taken from an 
experiment conducted in Jahoda C.A.B.’s research group (Richardson and Jahoda, accessed 
August 2013). 
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was set up alongside with normal 1% FBS/MEM. This experiment was repeated 4 
times. 
Due to time constraints, since the organ culture model was deemed unreliable, 
due to the lack of consistency shown between repeats, it was not used to investigate the 
other pathways. However, the 2D/3D cell culture model described in section 4.2 was 
used to investigate all three pathways; EGF/EGFR, BMP and KGF/KGFR.  
 Sets of 2-dimensional cultures in 6-well plates were set up alongside plates of 3-
dimensional spheres. One was supplemented with an activator (EGF, BMP4 or KGF), 
one with the inhibitor (AG1478 or DMH1) and one acted as control with 10% FBS-
MEM (Appendix III). No KGF inhibitor was used. Controls containing 100ng/ml of 
DMSO were also established, as this was the maximum concentration, which the 
growth factors had been dissolved in. 6000 cell spheres were made in 10ul drops. For 
each experiment, an extra dish of spheres with much higher cell numbers was made 
from the original 1ml cell suspension. This was conducted on embryos from day 16.5 
and at least two repeats were made for each pathway.  
After pilot experimentation it was decided not to disturb the cells and therefore 
not change the media during the culture period. After 5 days, 4 spheres were put into 
each well of a 6 well plate, suspended in 200ul of 10%FBS/MEM, for each activator 
and inhibitor. After a further two days, images were taken and the cells were then fixed 
in calcium formal for 10 minutes and stored in PBS at 4ºC prior to oil red O analysis. 
This was conducted on both the 2D cultures, 3D spheres put into 2D and the 3D spheres 
frozen in OCT as described in section 4.2.4.  
 
Table 5.1. The concentrations of the activation and inhibition factors used to test each 
pathway. 
Factor Concentration 
EGF/EGFR Pathway 
EGF+ 100ng/ml 
Amphiregulin+ 
+ 
1ug/ml 
AG1478- 50uM 
BMP Pathway 
BMP4+ 1ng/ml 10ng/ml 100ng/ml 
DMH1- 19ng/ml 190ng/ml 1.9ug/ml 
KGF/KGFR Pathway 
KGF+ 1ng/ml 10ng/ml 100ng/ml 
*All factors were added to the 10% FBS-MEM with antibiotics before the required cell densities were 
added. 
+ Activation; -  Inhibition 
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5.2.1. Oil Red O Quantification 
 The oil red O quantifying method, described in chapter 4.2 was used to quantify 
the volume of lipids and therefore adipocytes by measuring the level of red coloration 
present. E16.5 mouse back skin dermal cells cultured in 2D and in 3D spheres that were 
then transferred to 2D culture were investigated. Both the EGF/EGFR pathway and 
TGFβ/BMP pathways were quantified. 
 
5.2.2. EDU Treatment of KGF Spheres 
 In addition to the model established with cells from e16.5 skin, spheres were set 
up from e14.5 dermal cells and treated with 10ng/ml or 100ng/ml of recombinant KGF. 
After three days, the spheres had aggregated and were pulsed with EDU (Click-IT® 
EDU Imaging Kit: Invitrogen, Oregon, USA) for four hours to look at rates of 
proliferation. To do this, new drops of 10% FBS/MEM with 2.5µg/ml of EDU were 
created and the each sphere was transferred to a new drop. Only the spheres treated with 
10ng/ml of KGF had aggregated so only these were given EDU. Alongside this, as a 
control, untreated spheres of the same age were also pulsed with EDU. After 4 hours, 
the spheres were snap frozen in liquid nitrogen and stored at -80ºC prior to staining. 
 Immunofluorescence analysis of the EDU was then carried out on the spheres. 
Sections were cut at 7µm and adhered to ColorFrost slides. These were left to dry for 1 
hour 30 minutes before being fixed in 4% PFA for 15 minutes. After rinsing in 1x PBS 
the slides were permeabilised in 0.1% Triton X for a further 15 minutes and then 
washed for 5 minutes in PBS. The slides were then incubated in an EDU reaction 
cocktail (Appendix III) for 30 minutes at room temperature in the dark. Three PBS 
washes for 5 minutes were then followed by mounting the slides in Mowiol with DAPI. 
Slides were kept in the dark at 4°C prior to images being taken on the Zeiss Imager, 
M1. 
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5.3. Results  
 
5.3.1 EGF/EGFR Pathway 
 
5.3.1.1. Organ Culture Model 
 Firstly, the organ culture model system was replicated. Chapter 4 demonstrates 
that it was tried with both MEM and William’s media and 1%, 2% or no serum and still 
no reliably consistent results were produced. Section 4.2.1 shows the different controls 
produced for this. While this was the case, in the early stages of developing the model, 
skin was also supplemented with the EGF activator, amphiregulin or inhibitor, 
AG1478) to show whether the results found were consistent with those published by 
Wojciechowicz (2012) in Jahoda’s lab. There was variability in the skin pieces cultured 
in 1% FBS/MEM as a control and how they developed in organ culture (Figure 5.4), 
which limited the reliability of that seen with the inhibitor (EGF-) and activator (EGF+). 
For example, EGF+ (Figure 5.5) and the controls (Figure 5.4) were darker in coloration 
compared with EGF- (Figure 5.6).  
 
 
Figure 5.4: Organ culture of 16.5 embryonic day mouse back skin in 1% FBS/MEM. 
Three separate skin pieces are shown (1,2,3) both before (a,b) and after incubation for 3 days 
(c,d). Images were taken using a Zeiss Axiovert 10 microscope. BF = bright field. DF = dark 
field. Scale bar = 1mm. 
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Figure 5.5: Organ culture of 16.5 embryonic day mouse back skin in 1% FBS/MEM 
supplemented with the EGF activator (EGF+). Three separate skin pieces are shown (1,2,3) 
both before (a,b) and after incubation for 3 days (c,d). Images were taken using a Zeiss 
Axiovert 10 microscope. BF = bright field. DF = dark field. Scale bar = 1mm. 
 
 
. 
Figure 5.6: Organ culture of 16.5 embryonic day mouse back skin in 1% FBS/MEM 
supplemented with the EGF inhibitor (EGF-). Three separate skin pieces are shown (1,2,3) 
both before (a,b) and after incubation for 3 days (c,d). Images were taken using a Zeiss 
Axiovert 10 microscope. BF = bright field. DF = dark field. Scale bar = 1mm. 
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The skin pieces treated with EGF- exhibited significant follicle bumps and no 
clear ridge round the edge of the skin after 3 days incubation (Figure 5.6c,d), compared 
with the skin treated with EGF+. EGF may play a role in the wound healing response as 
well. The control pieces (Figure 5.4) and those supplemented with the EGF activator 
(Figure 5.5) had defined ridges around the edge of the skin pieces. 
H&E and toluidine blue staining was conducted on the sections cut from the 
incubated skin pieces, represented in figures 5.7 and 5.8. Control results produced from 
the same experiment were analysed in chapter 4 (Figure 4.13). EGF+ and EGF- culture 
was set up alongside to attempt to replicate the method (Wojciechowicz 2012). While 
some follicular development occurred with EGF+ (Figure 5.7), they were not as well 
developed as those in the skin treated with the inhibitor (Figure 5.8). 
 
 
Figure 5.7: 16.5 embryonic day organ cultured skin in 1% FBS/MEM supplemented with 
the EGF activator (EGF+). (a-h) piece 1. (i-p) piece 2. (a,e,i,m) bright field and (b,f,j,n) 
dark field, taken on Zeiss Axiovert 10. (c-h and k-p) after 72 hours in culture. (c,d,k,l) H&E 
staining and (g,h,o,p) toluidine blue staining, images were taken using a Zeiss Axio Imager 
M1. (a,b,e,f,I,j,m,n) scale bar = 1mm. (c,g,k) scale bar = 65µm. (d,h,l,o,p) scale bar = 40µm. 
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Figure 5.8: 16.5 embryonic day organ cultured skin in 1% FBS/MEM supplemented with 
the EGF inhibitor (EGF-). (a-h) piece 1. (i-p) piece 2. (a,e,i,m) bright field and (b,f,j,n) dark 
field taken on Zeiss Axiovert 10. (c-h and k-p) after 72 hours in culture. (c,d,k,l) H&E 
staining and (g,h,o,p) toluidine blue staining, images were taken using a Zeiss Axio Imager 
M1. (a,b,e,f,I,j,m,n) scale bar = 1mm. (c,g,k,o,p) scale bar = 65µm. (d,h,l) scale bar = 40µm. 
 
 
 
. 
  
 
 
 
 
This experiment was repeated twice more with the EGF+ and EGF- variables. 
Sections cut from the cultured skin pieces under all 3 conditions (control, EGF+ and 
EGF-) were stained with oil red O staining to determine the adipocyte content. Those 
pieces cultured in 1%FBS/MEM (Figure 5.9) appeared healthy with a clear defined 
ridge round the perimeter of the skin pieces, raised follicular bumps and the skin was 
not dark in colour (Figures 5.9C and D). However, when stained with oil red O and 
counterstained with a haematoxylin nuclear stain, the follicles had formed dark 
concentrated circles which looked pathological and there was limited oil red O staining 
(Figures 5.9E-H). The pieces cultured with the EGF activator, amphiregulin, had 
developed fat in the skin dermis. The skin also expanded, though the red staining was 
visible in original location of the lower dermis in a line across the skin (Figure 5.10). 
There was little evidence of developing follicles in the EGF+ skin. Comparatively, the 
EGF inhibitor appeared to impede on fat development, as there was no clear red staining 
in the dermis of the skin (Figures 5.11E-H). Some follicular down growth, however, 
was seen stained with haematoxylin (Figure 5.11F). 
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Figure 5.9: Oil red O analysis of organ cultured 16.5 embryonic day mouse back skin in 
1% FBS/MEM. (A,B) Skin prior to incubation. (C,D) Skin after 72 hours in culture. (E-F) 
Fat droplets present in adipocytes visible as red coloration. Images were taken using a Zeiss 
Stemi SVII and oil red O images were taken using a Zeiss Axio Imager M1. (A-D) scale bar = 
1mm. (E,F) scale bar = 65µm. (G,H) scale bar = 40µm. 
 
 
. 
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Figure 5.10: Oil red O analysis of organ cultured 16.5 embryonic day mouse back skin in 
1% FBS/MEM with the EGF activator (EGF+). (A,B) Skin prior to incubation. (C,D) Skin 
after 72 hours in culture. (E-F) Fat droplets present in adipocytes visible as red coloration. 
Images were taken using a Zeiss Stemi SVII and oil red O images were taken using a Zeiss 
Axio Imager M1. (A-D) scale bar = 1mm. (E) scale bar = 65µm. (F-H) scale bar = 40µm. 
 
 
. 
Figure 5.11: Oil red O analysis of organ cultured 16.5 embryonic day mouse back skin in 
1% FBS/MEM with the EGF inhibitor (EGF-). (A,B) Skin prior to incubation. (C,D) Skin 
after 72 hours in culture. (E-F) Fat droplets present in adipocytes visible as red coloration. 
Images were taken using a Zeiss Stemi SVII and oil red O images were taken using a Zeiss 
Axio Imager M1. (A-D) scale bar = 1mm. (E,F) scale bar = 65µm. (G) scale bar = 40µm. 
 
 
. 
	   211	  
While some of the results were similar to those previously found they were not 
consistent and by no means conclusive. Simultaneously, a potential cell culture model 
was being developed, the process of which was explained in chapter 4. This proved 
much more successful and so was also used to look at the EGF/EGFR pathway as well 
as the two other pathways investigated. 
 
5.3.1.2. Cell Culture Model 
 The EGF/EGFR pathway was then investigated using this cell culture model. 
The cells taken from 16.5-day embryos were put into two-dimensional culture to show 
that the environment in which the cells are grown is important to their growth and 
development. The experiment was repeated several times as summarised in figure 5.12. 
It was observed that the cells grown as a control in 10% FBS-MEM proliferate and 
develop and to a similar extent to those supplemented with EGF (Figures 5.12 column 1 
and 2). Comparatively, the cells taken from the dermis and supplemented with the 
inhibitor AG1478 did not cope so well in 2-dimensional culture. A few cells survived 
after 4 days (Figures 5.12C,F and I) similarly to that found after 6 days with no further 
growth (Figures 5.12L,O and R).  
Cells were also grown in 3-dimensional spheres and then put into 2-dimensional 
culture, at the same density (Figure 5.13). These cells flourished under the influence of 
the EGF inhibitor. In fact, the majority of the cells developed into adipocytes after a 
further two days in culture, which was visible prior to staining with oil red O (Figures 
5.13M-R). On the other hand, the spheres supplied with the EGF activator and allowed 
to adhere and grow out for two days showed little development of fat and formation of 
adipocytes (Figure 5.13). There is a significant replicable difference between these two 
treatments as shown by repeating the experiment several times. The EGF inhibitor 
produced distinctly more adipocytes than the control treatments without supplements.  
After 4 days, the control spheres (Figures 5.14B,E,H,K) were had a smaller 
average diameter of 0.09mm compared with both the EGF+ (0.20mm) and EGF- 
(0.15mm) treated spheres-. This could be used to infer that the factors are having some 
effect on the cells. After 6 days, the spheres under all three conditions were smaller in 
diameter, by 0.05mm (Figure 5.14). The average diameters of these spheres were 
measured using Image J. 
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Figure 5.12: 2-dimensional cell culture of 16.5-day embryonic mouse dermis. (1,2,3) From 
left to right, EGF+, Control with DMSO and EGF-. Images taken of culture after 4 days (A-I) 
and 6 days (J-R). Images taken on a Zeiss Axiovert 10. (A-E,J-N) scale bar = 65µm. (F-I,O-
R) scale bar = 40µm. 
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Figure 5.13: 3 dimensional into 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis. (A-F) EGF+ with the EGF activator. (G-I) Control with DMSO. (J-L) Control without 
DMSO. (M-R) EGF-with EGF inhibitor. Images taken of culture after 4 days in 3D and 2 days 
in 2D. Images taken on a Zeiss Axiovert 10. (A,B,G,J,M-O) scale bar = 65µm. (C-
F,H,I,K,L,P-R) scale bar = 40µm. 
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While some of the cells were damaged to some extent under oil red O staining 
(Figures 5.15 and 5.16), there was a greater degree of red staining visible in the 3D to 
2D culture compared with 2D. Not only this, but also more cells contained red staining 
in the AG1478 treated cells than any of the other treatments. It could even be said that 
when supplied with the EGF activator, there was even less adipocyte development than 
the controls. 
 
Figure 5.14: 3 dimensional cell culture of 16.5-day embryonic mouse dermis.  From left to 
right, spheres grown under the conditions, EGF+, EGF-. Images taken of culture after 4 days 
(A-F) and 6 days (G-L). Images taken on a Zeiss Stemi SVII. Scale bar = 0.2mm. BF = bright 
field. DF = dark field. 
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Figure 5.15: Oil red O analysis of 2-dimensional cell culture of 16.5-day embryonic 
mouse dermis. From left to right, EGF+, Control and EGF-. Images taken of culture after 6 
days (J-R). Images taken on a Zeiss Axiovert 10. (A,B,D,G) scale bar = 65µm. (C,E,F,H,I) 
scale bar = 40µm. 
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To further the analysis of 3D culture through the formation of dermal cell 
spheres, which worked well, cells that were left to develop in spheres for the full 6 days 
prior to freezing, were stained with oil red O (Figure 5.17). The EGF+ spheres had more 
densely packed nuclei illustrated by the blue haematoxylin stain (Figures 5.17A-C) 
compared with the control and EGF-. This packing structure, correlated with the larger 
size of the EGF+ spheres (Figure 5.14). While it was difficult to determine cell numbers 
in the spheres due to not knowing at which point through the sphere the cross sections 
were taken, it could be suggested that there was more proliferation in the positive 
spheres.  
 
 
 
Figure 5.16: Oil red O analysis of 3-dimensional into 2-dimensional cell culture of 16.5-
day embryonic mouse dermis. From left to right, EGF+, Control and EGF-. Images taken of 
culture after 4 days in 3D and 2 days in 2D. Images taken on a Zeiss Axiovert 10. (A-D,G) 
scale bar = 65µm. (E,F,H,I) scale bar = 40µm. 
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 The experiment was also conducted with a slightly different protocol while the 
model was being established. This included investigating the effects of EGF at 
embryonic day 15.5 and leaving the spheres in culture for 5 days and 1 day in 2D 
culture. This was less effective because the spheres did not adhere and grow out as well 
and therefore oil red O staining was not good quality. While dermal cells taken from 
e15.5 were more fragile when it came to staining, it did show that EGF/AG1478 was 
having a similar influence to that found a day later at e16.5 (Figure 5.16).  
 
5.3.1.2.1. Oil Red O Quantification of the EGF/EGFR Pathway 
 During development of a method of oil red O quantification to support the visual 
assessments, EGF+ and EGF- cultures were investigated to see if the differences visible 
could also be quantified. There was little evidence to support the visibility of more 
adipogenesis with the EGF inhibitor, AG1478 and the values varied between samples. 
Figure 5.17: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis. Sections cut at 10µm and stained with Oil red O and counterstained with 
haematoxylin. From left to right, EGF+, Control and EGF-. Images taken of culture after 6 
days in 3D. Images taken on a Zeiss Axiovert 10. (A,D,G) scale bar = 65µm. (B,C,E,F,H,I) 
scale bar = 40µm. 
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Although with the inhibitor in 2D cultures there were very few cells, the oil red O 
values read high, which was not accurate. A bar chart illustrated the averages of each 
condition (Figure 5.18) and although there was one sample for EGF+ that showed a 
high value, the other sample was lower than both the control and EGF- values, which 
was not accurate in relation to what was seen in the culture images. 
 
Table 5.2: Oil Red O quantification of the EGF/EGFR pathway in 2D and 3D to 2D 
culture 
 EGF (+) AG1478 (-) DMSO Control 
 0.056 0.062 0.058 0.062 0.064 0.057 
3D 0.057 0.069 0.059 0.063 0.066 0.058 
 0.054 0.065 0.060 0.062 0.062 0.061 
Mean 0.056 0.065 0.059 0.062 0.064 0.059 
 0.038 0.058 0.042 
2D 0.037 0.059 0.045 
 0.038 0.055 0.046 
Mean 0.038 0.057 0.044 
Averages means were calculated for both 2D and 3D. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18: Oil red O quantification analysis of 3-dimensional cell spheres put into 2-
dimensional culture of 16.5-day embryonic mouse dermis. EGF+/EGF- Readings were 
taken on a nanodrop using UV-Vis software and read at 510nm absorbance. EGF+, EGF- and 
Control values are illustrated.  
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5.3.2. TGFβ/BMP Pathway 
 The BMP pathway was investigated using the cell culture model as described in 
Chapter 4. As both the inhibitor and activator had not been used before with respect to 
this model, three different concentrations were tried of both BMP4 and DMH1 and 
applied to 2D, 3D and 3D to 2D culture techniques. Firstly the dermal cells were 
cultured in 2D with the BMP activator (Figure 5.21) and the BMP inhibitor (Figure 
5.22). The cell densities were similar to the controls across both the activator and 
inhibitor two-dimensional cultures, with the cells more densely packed in the centre of 
the wells. Representative images in figure demonstrate that the cells that grew near the 
edge of the cells were of reduced quantity and confluence, e.g. figures 5.21C and 5.22E 
and F). Unlike that found with the EGF/EGFR pathway, there was little contrast 
between the effects both the inhibitor and activator of the BMP pathway were having on 
adipogenesis in 2D culture. This was the same after oil red O analysis of the 2D cultures 
of both the activator and the inhibitor (Figures 5.24 and 5.25). While inseparable in 
terms of adipocyte number, they were still present to some degree and it was noticed 
that the distribution was uneven. Often clusters of red stained adipocytes were seen, 
while other groups of cells had no adipocytes (Figures 5.23C and 5.24C). 
 
Figure 5.19: Oil red O quantification analysis of 2-dimensional cell culture of 16.5 –day 
embryonic mouse dermis. EGF+/EGF- Readings were taken on a nanodrop using UV-Vis 
software and read at 510nm absorbance. EGF+, EGF- and Control values are illustrated.  
 
 
. 
	   220	  
 
 
 
 
 
Figure 5.20: 2-dimensional cell culture of 16.5-day embryonic mouse dermis. Control 
images with DMSO taken of culture after 6 days. Images taken on a Zeiss Axiovert 10. (A,B) 
Images of two different frames from the centre (A) and edge (B) of the well, scale bar = 
65µm. (C) Image taken at a higher magnification, scale bar = 40µm. 
 
 
. 
Figure 5.21: 2-dimensional cell culture of 16.5-day embryonic mouse dermis 
supplemented with BMP4. Images taken of culture after 6 days. From left to right, Low 
(1ng/ml),  mid (10ng/ml) and high (100ng/ml) concentrations. Images taken on a Zeiss 
Axiovert 10. (A,B,D,E,G) scale bar = 65µm. (C,F,H,I) scale bar = 40µm. 
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Figure 5.22: 2-dimensional cell culture of 16.5-day embryonic mouse dermis 
supplemented with the BMP inhibitor, DMH1. Images taken of culture after 6 days. From 
left to right, Low (19ng/ml), mid (190ng/ml) and high (1.9µg/ml) concentrations. Images 
taken on a Zeiss Axiovert 10. (A,D,E,G,H) scale bar = 65µm. (B,C,F,I) scale bar = 40µm. 
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Figure 5.23: Oil red O analysis of 2-dimensional cell culture of 16.5-day embryonic 
mouse dermis. Control images with DMSO taken of culture after 6 days. Images taken on a 
Zeiss Axiovert 10. (A) scale bar = 65µm. (B,C) scale bar = 40µm. 
 
 
. 
	   222	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.24: Oil red O analysis of 2-dimensional cell culture of 16.5-day embryonic 
mouse dermis supplemented with BMP4. Images taken of culture after 6 days. From left to 
right, Low(1ng/ml),  mid (10ng/ml) and high (100ng/ml) concentrations. Images taken on a 
Zeiss Axiovert 10. (D,E,G) scale bar = 65µm. (A-C,F,H,I) scale bar = 40µm. 
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Like the 2-dimensional cultures, the conclusions drawn were the same from the 
3-dimensional into 2-dimensional culture set up (Figures 5.27 and 5.28). As well as 
recognising the adipocyte-type cells in culture through the appearance of circular lipid 
droplets within some of the cells, little difference was inferred after these cells were 
stained with oil red O. This experiment was repeated twice more with similar results as 
shown by the representative oil red O stained images from both the 2-dimensional 
culture and the 3D to 2D culture. However with the activator, BMP4 (Figures 5.27 and 
5.30) there were a few more adipocytes compared with the inhibitor, DMH1 (Figures 
5.28 and 5.31) though considering that in general less adipocytes can be seen after oil 
red O staining compared with prior to staining, it was difficult to confirm this as a 
reliable observation. 
 
Figure 5.25: Oil red O analysis of 2-dimensional cell culture of 16.5-day embryonic 
mouse dermis supplemented with the BMP inhibitor, DMH1. Images taken of culture after 
6 days. From left to right, Low (19ng/ml), mid (190ng/ml) and high (1.9µg/ml) 
concentrations. Images taken on a Zeiss Axiovert 10. (A,D,G) scale bar = 65µm. 
(B,C,E,F,H,I) scale bar = 40µm. 
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Figure 5.26: 3 dimensional into 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis. Control images with DMSO taken of culture after 4 days. In 3D and 2 days in 2D. 
Images taken on a Zeiss Axiovert 10. (A,B) scale bar = 65µm. (C) scale bar = 40µm. 
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Figure 5.27: 3 dimensional into 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis supplemented with BMP4. Images taken of culture after 6 days. From left to right, 
Low (1ng/ml), mid (10ng/ml) and high (100ng/ml)  concentrations. Images taken on a Zeiss 
Axiovert 10. (A,B,D,G,H) scale bar = 65µm. (C,E,F,I) scale bar = 40µm. 
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Figure 5.28: 3 dimensional into 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis supplemented with the BMP inhibitor, DMH1. Images taken of culture after 6 days. 
From left to right, Low (19ng/ml), mid (190ng/ml) and high (1.9µg/ml) concentrations. 
Images taken on a Zeiss Axiovert 10. (A,D,G) scale bar = 65µm. (B,C,E,F,H,I) scale bar = 
40µm. 
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Figure 5.29: Oil red O analysis of 3 dimensional into 2-dimensional cell culture of 16.5 –
day embryonic mouse dermis. Images taken after 6 days in culture. Images taken on a Zeiss 
Axiovert 10. (A) scale bar = 65µm. (B,C) scale bar = 40µm. 
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Figure 5.30: Oil red O analysis of 3 dimensional into 2-dimensional cell culture of 16.5-
day embryonic mouse dermis supplemented with BMP4. Images taken of culture after 6 
days. From left to right, Low(1ng/ml), mid (10ng/ml) and high (100ng/ml) concentrations. 
Images taken on a Zeiss Axiovert 10. (A,D,F) scale bar = 65µm. (B,C,E,G,H) scale bar = 
40µm. 
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Some of the spheres remained in culture for the full 6-day incubation period. 
However there was not a significant difference between the sizes of the spheres between 
the activator and inhibitor unlike that found with EGF compared with AG1478.  
 
 
 
 
 
 
 
 
Figure 5.31: Oil red O analysis of 3 dimensional into 2-dimensional cell culture of 16.5-
day embryonic mouse dermis supplemented with DMH1. Images taken of culture after 6 
days. From left to right, Low (19ng/ml), mid (190ng/ml) and high (1.9µg/ml) concentrations. 
Images taken on a Zeiss Axiovert 10. (A,D,G) scale bar = 65µm. (B,C,E,F,H,I) scale bar = 
40µm. 
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Figure 5.32: 3 dimensional cell culture of 16.5-day embryonic mouse dermis subjected to 
BMP+/- treatment.  (1) Control spheres. (2) Cultured with BMP4 of 3 different 
concentrations (BMP+) Low (1ng/ml),  mid (10ng/ml) and high (100ng/ml). (3) Cultured with 
DMH1 of three different concentrations (BMP-) Low (19ng/ml), mid (190ng/ml) and high 
(1.9µg/ml). Images taken of culture after 6 days. Images taken on a Zeiss Stemi SVII. Scale 
bar = 0.2mm. BF = bright field. DF = dark field. 
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 The spheres were frozen and sectioned before being stained with oil red O 
(Figures 5.33-5.35). Comparatively with what might have been observed in 3-
dimensional to 2-dimensional culture, it could be suggested that there was a higher 
degree of red staining of the spheres treated with the BMP inhibitor, DMH1 (Figure 
5.35). The fat droplets were a variety of sizes, some of which were clearly larger than 
others, more easily distinguished in figure 5.35. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.33: Oil red O analysis of 3-dimensional control cell spheres of 16.5-day 
embryonic mouse dermis supplied with DMSO. Sections cut at 10µm and stained with Oil 
red O and counterstained with haematoxylin after 6 days in culture. Images taken on a Zeiss 
Axio Imager M1. Scale bar = 40µm. 
 
 
. 
	   230	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.34: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis supplied with BMP4. Sections cut at 10µm and stained with Oil red O and 
counterstained with haematoxylin after 6 days in culture. (1) Low concentration of BMP4, 
1ng/ml. (2) Mid concentration of BMP4 10ng/ml. (3) High concentration of BMP4 100ng/ml. 
Images taken on a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 5.35: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis supplied with the BMP inhibitor, DMH1. Sections cut at 10µm and stained 
with Oil red O and counterstained with haematoxylin after 6 days in culture. (1) Low 
concentration of DMH1 19ng/ml. (2) Mid concentration of DMH1 190ng/ml. (3) High 
concentration of DMH1 1.9µg/ml. Images taken on a Zeiss Axio Imager M1. Scale bar = 
40µm. 
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5.3.2.1. Oil Red O Quantification of the TGFβ/BMP Pathway 
 As well as the EGF/EGFR pathway, the BMP pathway was quantified during 
establishment of the cell culture method. There was no significant difference between 
the different conditions in both 3D and 2D (Figures 5.36 and 5.37), which was the same 
found in culture images.  
 
Table 5.3: Oil red O quantification analysis of 3D and 2D cultures of e16.5 dermal cells 
under the TGFβ /BMP pathway 
 
 
 
BMP4 low BMP4 mid BMP4 high 
 0.055 0.062 0.064 0.062 0.057 0.064 
3D 0.052 0.062 0.064 0.066 0.057 0.063 
 0.055 0.062 0.066 0.066 0.060 0.060 
Mean 0.054 0.062 0.065 0.065 0.058 0.062 
 DMH1 low DMH1 mid DMH1 high 
 0.058 0.058 0.064 0.056 0.056 0.055 
3D 0.059 0.059 0.065 0.055 0.054 0.055 
 0.059 0.059 0.064 0.054 0.056 0.053 
Mean 0.059 0.059 0.064 0.055 0.055 0.054 
 BMP4 low BMP4 mid BMP4 high 
 0.044 0.053 0.051 
2D 0.045 0.058 0.051 
 0.043 0.057 0.050 
Mean 0.044 0.056 0.051 
 DMH1 low DMH1 mid DMH1 high 
 0.051 0.046 0.057 
2D 0.054 0.044 0.058 
 0.054 0.045 0.057 
Mean 0.053 0.045 0.057 
Average means were calculated for both 3D and 2D. 
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Figure 5.36: Oil red O quantification analysis of 3-dimensional cell spheres put into 2-
dimensional culture of 16.5 embryonic-day mouse dermis. BMP4/DMH1 Readings were 
taken on a nanodrop using UV-Vis software and read at 510nm absorbance. BMP4 and DMH1 
values are illustrated.  
 
 
. 
Figure 5.37: Oil red O quantification analysis of 2-dimensional cell culture of 16.5 –day 
embryonic mouse dermis. BMP4/DMH1 Readings were taken on a nanodrop using UV-Vis 
software and read at 510nm absorbance. BMP4 and DMH1 values are illustrated.  
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5.3.3. KGF/KGFR Pathway 
 Thirdly, the KGF/KGFR pathway was investigated using the cell culture model 
previously described. KGF was supplied to the cultures at three varying concentrations; 
1ng/ml, 10ng/ml and 100ng/ml. Primarily spheres were cultured and later put into 2-
dimensionl culture. The spheres supplied with a high concentration of KGF seemed to 
have an overall larger size than those with the smaller concentrations or no KGF at all 
(Figure 5.38). 
 
From the spheres that were put into 2-dimensional culture, an increase in 
adipocytes was observed from those spheres treated with KGF (Figure 5.40) compared 
with those untreated (Figure 5.39). The experiment was repeated twice to produce 3 sets 
of data and the figures showed representative images across these replicas.  
 
 
Figure 5.38: 3 dimensional cell culture of 16.5-day embryonic mouse dermis subjected to 
KGF treatment.  (A-D) Control spheres. Cultured with DMH1 of 3 different concentrations. 
Images taken of culture after 6 days. Images taken on a Zeiss Stemi SVII. Scale bar = 0.2mm. 
BF = bright field. DF = dark field. 
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Figure 5.39: 3 dimensional into 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis. Images taken of culture after 4 days in 3D and 2 days in 2D. Images taken on a Zeiss 
Axiovert 10. (A-C) scale bar = 65µm. (D-F) scale bar = 40µm. 
 
 
. 
Figure 5.40: 3 dimensional into 2-dimensional cell culture of 16.5-day embryonic mouse 
dermis supplied with KGF. (A-C) Low concentration of KGF. (D-F) Mid concentration of 
KGF. (G-I) High concentration of KGF. Pictures taken of culture after 4 days in 3D and 2 
days in 2D. Images taken on a Zeiss Axiovert 10. (A,D,G) scale bar = 65µm. (B,C,E,F,H,I) 
scale bar = 40µm. 
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The oil red O staining of these cultures showed that in general across all the 
spheres there seemed to be an increase in adipocytes present as the concentration of 
KGF was increased, in particular with the higher two concentrations (Figures 5.42D-I) 
compared with the controls (Figure 5.41). There were also cells not directly near the 
spheres, because the cells grew out with more adipocytes in the higher concentrations 
(Figures 5.42F and I). As well as this, some of the adipocytes within the spheres were 
more easily, which suggests that not all the adipocytes spread out of the spheres. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.41: Oil red O analysis of 3 dimensional into 2-dimensional cell culture of 16.5 –
day embryonic mouse dermis. Images taken of culture after 4 days in 3D and 2 days in 2D. 
Images taken on a Zeiss Axiovert 10. (A-C) scale bar = 65µm. (D-F) scale bar = 40µm. 
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Since the high adipocyte content of the spheres treated with the EGF inhibitor 
also was associated with low cell survival and overall cell count in the two dimensional 
culture, the KGF treatments were conducted in 2D culture to see if there was an 
association between high adipocyte content in 3D and low cell viability in 2D (Figure 
5.44). This however was not the case as the cells thrived when treated with all 
concentrations of KGF. In fact, compared with all other 2D experiments, KGF seems to 
encourage more fat development in 2D relative to the usual numbers found in 2D in 
relation to that found in the same treatments in 3D 
 
 
Figure 5.42: Oil red O analysis of 3 dimensional into 2-dimensional cell culture of 16.5-
day embryonic mouse dermis supplied with KGF. (A-C) Low concentration of KGF. (D-F) 
Mid concentration of KGF. (G-I) High concentration of KGF. Pictures taken of culture after 4 
days in 3D and 2 days in 2D. Images taken on a Zeiss Axiovert 10. (A,D,G) scale bar = 65µm. 
(B,C,E,F,H,I) scale bar = 40µm. 
 
 
. 
	   238	  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.43: 2-dimensional cell culture of 16.5-day embryonic mouse dermis. Images 
taken after 6 days in culture. Images taken on a Zeiss Axiovert 10. (A,B) scale bar = 65µm. 
(C,D) scale bar = 40µm. 
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Figure 5.44: 2-dimensional cell culture of 16.5-day embryonic mouse dermis treated with 
KGF. (A-C) Low concentration of KGF. (D-F) Mid concentration of KGF. (G-I) High 
concentration of KGF. Pictures taken after 6 days in culture. Images taken on a Zeiss Axiovert 
10. (A,D,G) scale bar = 65µm. (B,C,E,F,H,I) scale bar = 40µm. 
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Figure 5.45: Oil red O analysis of 2-dimensional cell culture of 16.5-day embryonic 
mouse dermis. Pictures taken after 6 days in culture. Images taken on a Zeiss Axiovert 10. 
(A,B) scale bar = 65µm. (C,D) scale bar = 40µm. 
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Figure 5.46: Oil red O analysis of 2-dimensional cell culture of 16.5-day embryonic 
mouse dermis treated with KGF. (A-C) Low concentration of KGF. (D-F) Mid 
concentration of KGF. (G-I) High concentration of KGF. Pictures taken after 6 days in 
culture. Images taken on a Zeiss Axiovert 10. (A,B,D,G) scale bar = 65µm. (C,E,F,H,I) scale 
bar = 40µm. 
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The 3-dimensional spheres stained with oil red O showed irregular distribution 
of adipocytes though they tended to group in clusters within the spheres (Figure 5.49). 
There was substantially more adipocyte staining found in the spheres treated with the 
mid concentration 10ng/ml of KGF and this tended to be concentrated in the centre of 
the sphere (Figure 5.49B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.47: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis Sections cut at 10µm and stained with Oil red O and counterstained with 
haematoxylin after 6 days in culture. Images taken on a Zeiss Axio Imager M1. Scale bar = 
40µm. 
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Figure 5.48: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis treated with the low concentration of KGF. Sections cut at 10µm and 
stained with Oil red O and counterstained with haematoxylin after 6 days in culture. Images 
taken on a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 5.49: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis treated with the mid concentration of KGF. Sections cut at 10µm and 
stained with Oil red O and counterstained with haematoxylin after 6 days in culture. Images 
taken on a Zeiss Axio Imager M1. Scale bar = 40µm. 
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5.3.3.1. EDU Labelling of Spheres 
All three KGF concentrations allowed more adipocyte formation than without 
KGF (Figure 5.47). However, KGF has been implicated in cell proliferation, so it may 
be that the cell numbers were higher and therefore proportionally there were not more 
adipocytes. EDU was used to detect proliferation. As described in the methods, a 4 hour 
pulse of EDU was conducted on spheres treated with KGF (Figure 5.51) and contrasted 
with spheres not treated with anything to determine if KGF induced more proliferation 
to occur (Figure 5.52).  
 
 
 
 
 
 
 
 
Figure 5.50: Oil red O analysis of 3-dimensional cell spheres of 16.5-day embryonic 
mouse dermis supplied with the high concentration of KGF. Sections cut at 10µm and 
stained with Oil red O and counterstained with haematoxylin after 6 days in culture. Images 
taken on a Zeiss Axio Imager M1. Scale bar = 40µm. 
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Figure 5.51: Analysis of Cell Proliferation using EDU on e14.5 + 3 day spheres with 
10ng/ml KGF. (1A-D) Images were taken after 3 days in 3-dimensional culture using Zeiss 
Stemi SVII with a 4 hour incubation with EDU. (1E-M) Sections were cut at 7mm, stained 
with for EDU labelling and counterstained with DAPI. From left to right; DAPI, FITC, and 
merge (DAPI/FITC). FITC represents the fluorescent labelling of EDU. Fluorescent images 
were taken using a Zeiss Axio Imager M1. (1A,B) scale bar = 2mm. (1C,D) scale bar = 0.2mm 
(1E-G) scale bar= 65µm. (1H-M) scale bar = 40µm. Arrows label example positive EDU 
labelling where cell proliferation has occurred.  
 
 
. 
	   244	  
 
 
 
 
  
In order to quantify if more proliferation occurred in the spheres treated with KGF, 
three sphere images were taken and the top left quarter of each corner was selected. All 
the cells and the proportion that was labelled with EDU (green) were counted (Table 
5.4). 
Table 5.4: Comparison of cell proliferation between spheres treated with KGF and 
spheres not treated with KGF. 
 Total number of cells 
EDU labelled 
cells 
Percentage of 
cells labelled 
with EDU (%) 
Average 
Percentage (%) 
 1 2 3 1 2 3 1 2 3  
With KGF 29 22 12 3 3 2 10.3 13.6 16.7 13.5 
Without KGF 43 29 31 2 1 1 4.65 3.45 3.23 3.78 
  
When the level of proliferation was observed, there was 3.57 fold more EDU present in 
the spheres treated with KGF, which suggested that KGF was influencing proliferation. 
Figure 5.52: Analysis of Cell Proliferation using EDU on control e14.5 + 3 day spheres 
without KGF. (1A-D) Oil red O staining on spheres shows adipocytes (2A,B). (2C-H) 
Sections were cut at 7mm, stained with for EDU labelling and counterstained with DAPI. 
From left to right; DAPI, FITC, and merge (DAPI/FITC). FITC represents the fluorescent 
labelling of EDU. Fluorescent images were taken using a Zeiss Axio Imager M1. (2C-E) scale 
bar= 65µm. (2A, F-H)) scale bar = 40µm. (2B) scale bar = 15µm.  
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5.4. Discussion 
 
5.4.1. EGF/EGFR Pathway 
It was found using the cell culture model that the inhibitor of EGF, AG1478 
induced adipocyte formation, while EGF could be thought to inhibit adipocyte 
formation. There could be many different ways by which this occurs. It is unclear as to 
whether this pathway is here influencing the commitment or differentiation steps of 
adipogenesis. That is, the inhibitor may be inducing more cells to become committed or 
EGF could be inhibiting the preadipocytes from differentiating though they may already 
be committed. Considering it is becoming increasingly more likely that adipogenesis 
starts earlier than previously expected prior to embryonic day 16.5 when this pathway 
was looked at, the more likely scenario is that the cells have already become committed 
to the adipocyte lineage at this stage and the EGF+ and EGF+ treatments are affecting 
the differentiation of these cells into terminal adipocytes. EGF disrupts normal hair 
follicle formation in vitro and in vivo (Philpott et al. 1994; Kashiwagi et al. 1997)) and 
so may change the results of adipogenesis in the culture model due to their linked 
development (Hausman et al. 1981). On the other hand, by e16.5 follicles are already 
developing so the EGF influence may be too late and therefore acting in a different way 
While this result was consistently found with the inhibitor, it seems to be 
opposite to that previously found using the organ culture model (Wojciechowicz 2012). 
This is by no means an indication that the results found can be deemed false, but more 
that it gives an interesting insight into the many roles this pathway may be playing in 
relation to adipogenesis. For example, it could be that the cell culture model not only 
has unorganised the dermal cells but also that there are no developing hair follicles or 
epidermal cells present during culture. Might the EGF/EGFR pathway regulate 
adipogenesis through the hair follicles or epidermis, thus a different effect is produced 
when these elements are eliminated? This result therefore could suggest that there is a 
definite link between adipogenesis and hair follicle formation and/or potential signalling 
between the epithelial and mesenchymal cell layer. In support of this when the organ 
culture model was repeated, it was found that when treated with the EGF inhibitor, 
increasingly defined placodes were observed, which inferred that this is having an effect 
on the hair follicles. Previous experiments, including the use of knockout mouse models 
have produced a number of effects on hair follicles which could be observed by the 
abnormal phenotypes of the hair structures, e.g. Waved-2 (Threadgill et al. 1995) or CF-
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1 (Yamanishi 1998). It is therefore known that the EGF/EGFR pathway is involved in 
hair follicle formation, but interestingly this project supports the idea that many of the 
pathways and their growth factors are having an indirect effect on development, i.e. 
there is a developmental link between these hair follicles and developing adipose tissue. 
As well as this, as Wojciechowicz had previously tried two concentrations and 
found the skin was unhealthy with one of them, only one concentration of both the 
activator and inhibitor was used. Considering many growth factors act in a 
concentration-dependent manner this may influence the results. EGF was found to 
influence adipocyte formation in a time and dose dependent manner (Hauner et al. 
1995; Harrington et al. 2007). To further the analysis of this pathway, it would therefore 
be important to experiment with a number of different concentrations to determine if it 
is indeed concentration-dependent. EGF may already have been expressed and be being 
produced in culture, thus the addition of more EGF or the inhibitor may be adding to 
this effect.  
The EGF/EGFR signalling pathway is required for normal adipocyte 
development only during a particular time period of postnatal murine skin development, 
though microarrays suggest it may be having an earlier influence as well. The inhibitor 
of EGF, producing a large increase in adipocytes may actually be an abnormal result, in 
that the normal number of adipocytes that should be produced from these 24,000 
cultured cells per well should be a lot less. It is difficult to tell which variable produces 
more realistic results, e.g. the controls may be equally less realistic, in that they are not 
in a normal dermis organization. However it was found that addition of EGF to human 
adipose tissue stromal cells did decrease adipose formation and lipid content (Hauner et 
al. 1995), so perhaps the results here are reliable. 
 Another characteristic observed from this experiment was that of the 3-
dimensional spheres after they had been stained with oil red O and counterstained with 
haematoxylin. In the dermal cell spheres that had been treated with EGF, the cells 
appeared to be more tightly packed and the spheres were also larger. This could suggest 
that EGF had induced cell proliferation to occur (Yaish et al. 1988; Anchan et al. 1991). 
As well as this, the cells might spread out or expand prior to differentiation into 
adipocytes. There might therefore be a link between proliferation or cell number with a 
decrease in adipocyte formation. Are the developing adipocytes more spread out or 
outcompeted by the proliferating fibroblasts? Cell-to-cell signalling may also be playing 
a role here in producing an adipose depot (Section 4.4). 
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5.4.2. TGFβ/BMP Pathway 
Out of all three pathways looked at, this pathway showed the least distinctive 
results, i.e. there was not a significant difference between the controls and either 
activator or the inhibitor. Unlike the EGF/EGFR pathway, three different concentrations 
of both BMP4 and the BMP receptor inhibitor, DMH1 were experimented with to 
prevent concentration-dependence being a determining factor of the results given. There 
was little difference as the concentration was changed, also shown when the oil red O 
was quantified. Rather than this suggesting that members of the BMP pathway do not 
act in a concentration-dependent manner it may be that the pathway is not playing a role 
at this point in development: it could be acting earlier or later. To further the 
investigation of this pathway, which has been implicated in adipogenesis, it would be 
valuable to look at its effects earlier in development, by using this model and 
conducting microarray analysis earlier than e17 (Wojciechowicz 2012). 
There was clearly a greater degree of red staining of the spheres than controls of 
those that were not put into 2-dimensional culture, but stained in 3-dimensional intact 
spheres. Perhaps the 2-dimensional culture technique is having more of a difference on 
the BMP pathway than the other pathways? It is known that the BMP pathway is 
involved in pattern formation (Pearson et al. 2005), so the lack of effects may be due to 
the fact that it only works when localised in the correct position and in cell culture the 
cells are not in a realistic organisation and so the BMP pathway is not effective. 
Little or no effect does not necessarily deem these experimental results 
incorrect; it could infer that the BMP pathway regulated by the release of BMP4 is not 
necessary to adipogenesis at this stage of the process, e16.5. It would be interesting not 
only to look at this pathway at different time points, but also using a different model, 
like that of the organ culture model. BMP may only have an impact if the BMP 
receptors are present in great numbers or if other ligands are not binding to it. A 
different BMP inhibitor, e.g. AMPK could also be investigated in the future. A 
possibility is that endogeneous BMP may be enough to satisfy the BMP receptors and 
therefore any addition is not influencing the development (Macotela et al. 2012). 
 
5.4.3. KGF/KGFR Pathway 
Like that found in the transgenic mice where the level of expression determined 
the degree of hair follicle loss and epidermal thickness, KGF seems to work in a 
concentration-dependent manner, which has been previously been suggested as the 
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theory behind its effect on hair follicle morphogenesis (Botchkarev et al. 1999; 
Richardson et al. 2009). As well as this, the effects of KGF were concentration-
dependent when using 3T3-L1 cells and rat primary preadipocytes (Zhang et al. 2010). 
Some of the spheres were larger with the higher concentration, which links in with KGF 
previously being found to be involved in proliferation (Zhang et al. 2010). In vitro, 
KGF is significantly more able to generate proliferation of keratinocytes than EGF or 
TGFα (Guo et al. 1993). KGF may not be acting alone but also with TGFα. EDU was 
used to understand the proliferative activity in the KGF spheres to see if when 
keratinocytes are eliminated, proliferation still occurs in the fibroblasts. While usually 
there is limited cell proliferation in 3D sphere culture, the cells induced with KGF were 
found to proliferate (Section 5.3.3.1). However, there was also some proliferation 
detected in the control spheres without KGF. The spheres were not treated with a pulse 
of EDU till after a couple of days because the spheres had not formed, however there 
may have been an initial burst of proliferation when KGF was first supplied. If this is 
the case, the EDU did not measure this, but instead its proliferation at a later stage. In 
order to establish if this is the case, a method of measuring the proliferation rate at the 
beginning of KGF treatment should be used. This may be difficult in the spheres 
considering they don’t aggregate till after 48 hours or often longer. This could 
potentially be tested in the organ culture method, or by separating the dermis from the 
epidermis and culturing solely the dermis in one piece, rather than the whole skin or 
needing to dissociate the dermal cells. Cell proliferation may be that KGF triggers 
preadipocyte cells to multiply so more adipocytes are produced. It could be useful to 
track the cells that proliferate and determine if they all become adipocytes, because not 
all the cells in the dermis become adipocytes. 
In contrast to the EGF/EGFR pathway, those treatments that produced more 
adipocytes also thrived in 2-dimensional culture. While KGF and EGF roles are more so 
understood in relation to their roles in epidermal development, it has been suggested 
that mesenchymal development is influenced by this, e.g. through the hair follicles, so 
as described in terms of the EGF/EGFR pathway they may be having indirect effects on 
adipogenesis in the lower dermis of the skin. KGF knockout mice clearly show that it is 
important in hair follicle formation (Guo et al. 1996). As KGF inhibits follicle 
development, using it to block early follicle development in organ culture, could be 
useful to prevent the follicles influence the study of adipogenesis. A preliminary 
experiment showed it is possible to inhibit follicle growth around e13.5. This might 
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now be a useful method to look at how much adipose tissue develops in culture after the 
follicles have been eliminated. It may also be useful to clarify the distribution of the 
FGFR2 receptors; are they present on adipocytes or mesenchymal cells as well as 
keratinocytes or is this how the regulation is mediated through epithelial cells? It has 
previously been found that the FGFR2b isoform (KGFR) is found on epithelial cells 
while FGFR2c is found on mesenchymal cells (Orr-Urtreger et al. 1993; Eswarakumar 
and Schlessinger 2005). This has been thought to allow an interaction between the 
epithelial and mesenchymal tissue layers during development (Eswarakumar and 
Schlessinger 2005). This would further support the idea that responses to KGF may be 
mediated through the epithelium rather than directly affecting the dermis. 
KGF (FGF7) is not the only FGF that could be involved in adipogenesis. If you 
impact KGF activity this may be influencing the expression and effects of other growth 
factors and interacting signalling pathways. Western blotting could be used to look at 
the levels of different growth factors after KGF treatment and it would also be useful to 
observe endogenous levels of KGF already present.  
 
5.4.4. In Conclusion 
There are many general observations, which apply to all the pathways. For 
example, it has been noticed that often the adipocytes are found in clusters and are not 
evenly distributed throughout the cultured cells. As the adipocytes in vivo form a layer, 
this could be put down to cell-to-cell signalling either to trigger each other’s 
development or for them to group together. Having been dissociated before being put 
into culture the cells might be reorganizing into a general upper and lower dermis 
distribution. 
While this chapter has shown some interesting results, they are by no means 
conclusive. Not only have they provided more insight into potential avenues that need 
to be explored, they have also posed questions over what is already known. For 
example, the clear increase in adipocyte development when treated with an EGF 
inhibitor compared with little or no development when treated with EGF. This is a 
surprising result, but one that should not be ignored. Like that found in chapter 4 
whereby the cells seem to develop into adipocytes a lot earlier than previously expected, 
it is appropriate to not only investigate gene expression much earlier, around e13/13.5 
but also at the influence these signalling pathways may be having earlier as well. Are 
their effects limited to a certain time point? Do they act differently earlier in 
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development? Not only this, but whether these signalling pathways act in the same way 
in a different model e.g. the organ culture model. E14.5 spheres were capable of 
producing fat. It has already been shown by Wojciechowicz (2012) in relation to the 
EGF/EGFR pathway, though are the effects similar with different pathways with this 
organ culture model?. It may be that the fact that the epidermis and developing hair 
follicles are present and capable of influencing the results is what is determining how 
the signalling pathways act. The activator and inhibitor treatments are unspecific as both 
the epidermis and dermis receive the signals. On the other hand, the organization of the 
cells in the cell culture model, which are less realistic than that of the dermal cells in the 
organ culture model may be the reason for the way these cells respond to the signalling 
pathways. The organ culture model showed that the effects of EGF were limited to 
certain time-points, i.e. beyond e18/19 the treatments had no effect on adipose tissue 
development (Wojciechowicz 2012). Perhaps there is a degree of inhibition of 
adipogenesis in the skin, which is unable to occur when the cells are dissociated and 
disorganized in the cell culture model. The development of a successful model, 
however, is fundamental to the study of adipogenesis and useful for the functional study 
of genes so to better understand the pathways involved in dermal adipose tissue 
development. It could be concluded from the development and use of this cell culture 
model that a number of different types of model should be used in conjunction with 
each other to build up a better picture of the control adipogenesis. 
The results of the inhibition and activation using receptor ligands may not 
actually depend on the level of endogenous ligands supplemented, but in actual fact the 
number of receptors present and capable of receiving these growth factors. How much 
of the growth factor supplied is used by the cells? 
While only three different pathways were used in this project, it is important to 
be aware that there are many other signalling pathways implicated in adipogenesis e.g. 
the Wnt pathway (Christodoulides et al. 2008). As well as looking at their individual 
roles, how they interact is an interesting factor (Kanazawa et al. 2005; Christodoulides 
et al. 2008). It seems the pathways can influence each other to generate an overall 
effect, thus combining different growth factor inhibitor and activator treatments may be 
an insightful experiment to develop our understanding of this process of adipocyte 
formation and how the pathways impact each other. 
 Background research into these pathways shows that their roles in hair follicle 
formation are better characterized and it is less clearly defined whether and what roles 
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these pathways might have in adipogenesis. Guo et al. (1993) did however show that 
there was suppression of both hair follicles and adipogenesis alongside each other when 
targeted expression of human KGF cDNA in mice was used. This suggests that there is 
a degree of interaction between these two processes, which is increasingly becoming the 
consensus (Jahoda et al. 2003; Schmidt and Horsley 2013). 	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CHAPTER 6: 
Closing Discussion and Further  
Experiments 
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 Many signalling pathways and factors regulate the process of adipogenesis. 
Extracellular signals trigger transcriptional cascades to occur. Not only this, but the 
cells interact with each other to organise the tissues. Development is therefore a very 
complex process. While there is a great deal still to understand about adipogenesis, in 
particular, the dermal adipose layer, this project focused on particular aspects of the 
process and developing a suitable model to study adipogenesis earlier than e17. It is 
easier to study the later stages of differentiation when morphological changes have 
started to occur, but what induces and regulates the commitment to the adipocyte 
lineage step is more difficult to investigate. Microarrays previously conducted started at 
embryonic day 17 and examined the lower dermis. However, this project showed that 
adipocytes can form from cells taken as early as embryonic day 14.5 and previously 
adipocytes formed in the kidney capsule from cells taken from e14 (Wojciechowicz et 
al. 2013). The cells are already committed, or perhaps all dermal cells are capable of 
becoming adipocytes and those in the upper dermis require a negative signal. With the 
production of upper dermis microarrays and the genes flagged up strongly in these, 
future work can aim to investigate this hypothesis of a negative signal on adipogenesis.  
What triggers the difference between the upper and lower dermis? Is it a signal 
from the dermis or epidermis or even the epithelial part of the follicle. Simply, to 
investigate adipocyte development, it is necessary to find out what signals are directly 
influential. It is important to consider that other cell types may be involved in the 
development, e.g. hair follicles and blood vessels as well as their process of 
development may be implicated in adipogenesis (Hausman et al. 1981). 
 This project removed the epidermis to observe what occurs in the dermis 
independently. Adipocytes successful formed from the dermal cells and were influenced 
by growth factors, e.g. EGF and KGF. Next, it would be interesting to investigate how 
the epithelial and mesenchymal components influence each other. Dermis, taken from a 
non-fat producing mouse could be recombined with a wild-type epidermis and wild-
type dermis recombined with a non-fat producing mouse epidermis and observed to see 
which one produces adipocyte development. This should be tried at different ages to 
show when the dermis becomes committed. Literature research was conducted to find a 
mouse model that does not produce fat tissue in the skin to provide the tissue for this 
experiment. Elbe-Bürger and colleagues (2002) found that overexpression of 
Interleukin-4 (IL-4) causes loss of the dermal adipose tissue. This IL-4 transgenic 
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mouse could be used in a recombinant experiment. When Interleukin-7 (IL-7) is 
overexpressed, adipose tissue is also reduced (Lucas et al. 2012). 
 Cells are thought to be committed to the adipocyte lineage earlier than e16.5, 
according to this project (Chapters 4 and 5) The upper and lower dermis may be being 
establishing at the time of hair follicle formation. However what markers can be used to 
follow this? Perhaps microarrays can now be conducted earlier than e17.  
 Adipocytes only form in the lower dermis. Originally this project aimed not only 
to separate the dermis from the epidermis and look at solely dermal effects, but also 
what signals a difference between the upper and lower dermis. However, creating the 
cell-culture model was a time-consuming process.  FABP4 labelling of the lower dermis 
has suggested that it has already separated from the upper dermis by e16/e17 
(Wojciechowicz et al. 2013), though it may be that differences develop even earlier in 
association with hair follicle initiation. A potential way to investigate this is by a 
recombination type experiment. The dermis is flipped so that the lower dermis interacts 
with the epidermis and the upper dermis becomes the lower dermis, to see what effect 
this has on which cells turn into fat in the dermis. This may also enable a better 
understanding of the timings at which the lower dermal cells become committed. There 
is however, a muscle layer (panniculus carnosus) which could prevent this experiment 
from being successful, thus this may need to be taken out of the equation first. Using a 
transgenic mouse without this muscle layer so only the dermis is in contact with the 
epidermis and not muscle tissue.  
There is an obstacle in terms of hair follicle formation and the influence it has on 
adipogenesis. Are the signals indirect to the preadipocytes? The hair follicle specific 
signals could be separated out. Blocking pathways may be blocking follicles at an early 
stage, and this could be influencing adipogenesis and not the signals directly. With 
follicles, later stages are better because the signals for formation have already been 
received, which is why e16.5 was investigated. Another potential experiment could be 
conducted with a mouse model that does not develop follicles to prove if there is 
follicular involvement. Or an early blocking agent of hair follicle formation, e.g. KGF 
could be used in organ culture. For example, KGF could be supplied at e13.5 to block 
follicle formation before looking at dermal adipose tissue development. However, it 
may be difficult for the skin to continue to grow and survive after this treatment: the 
presence of the hair follicles may be necessary to accurately observe the functions of 
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different growth factors and signalling pathways in adipogenesis. Either way, it could 
provide a useful insight.  
While increasing progress is being made, there is still extensive research that 
needs to be done to understand the adipose organ, both its origins and processes of 
development. Knowledge of the timing and localization of many events would be 
greatly improved with the availability of markers specific to MSCs and preadipocytes 
(Gesta et al. 2007). Microarray data and antibody labelling of those found to be 
upregulated might help to find suitable markers. Use FACs and CD36 to separate the 
upper and lower dermis and evaluate if signalling occurs between the upper and lower 
dermis to prevent all the cells differentiating. It was often found in this project that in 
the spheres, clusters of cells differentiated into adipocytes, so potentially there is a 
degree of cell-to-cell signalling. To investigate if all the cells are capable of 
differentiating or if cells are early committed, adipogenic medium can be applied to all 
the cells to see if they all differentiate.  
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Appendix I 
 
Working Solutions and Reagents for Tissue Staining 
 
For Immunofluorescence, Oil Red O and H&E staining 
 
Phosphate buffered saline (PBS) 
- 40g NaCl 
- 9.03g Na2HPO4.2H2O 
- 1.45g KH2PO4 
- 1g KCL 
Adjust pH to 7.4 and stir to dissolve in 1 litre distilled H20 
 
Calcium formal solution 
- 20g paraformaldehyde or 50ml of 37% formaldehyde solution 
- 5g calcium chloride (Sigma) 
- 450ml distilled water. 
 
Mowiol (when not using Vectashield) 
- 6g glycerol, 
- 2.4g mowiol (mowiol 4-88) 
- 6ml H20 
- 12ml 0.2M Tris (ph 6.8) 
Stir overnight , centrifuge and add supernatant to DABCO (1.4-diazobicylo-(2.2.2.)-
octane) to a concentration of 2.5%.  
 
4% Paraformaldehyde 
- Add 4g paraformaldehyde (Sigma) to 100ml PBS and heat to 50°C.  
- Stir until transparent. 
 
0.5% Triton X 
- 0.5ml TritonX (Sigma) and make up to 100ml with PBS 
- Further dilute for 0.1% 
 
Oil Red O stock solution 
- Add 300mg oil red O powder (Sigma) to 100ml 99% isopropanol (Sigma). 
- Dissolve before use. 
 
Oil Red O working solution 
- Add 3 parts oil red O stock solution to 2 parts distilled water.  
- Leave to settle for a few minutes and then filter 2-3 times until the red solution is 
transparent. 
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Appendix II 
 
Working Solutions and Reagents for Chapter 3 
 
Mouse on Mouse Kit (FMK-2207; Vector Labs Inc) 
 
Mouse Ig Blocking Reagent 
- 2 drops of stock solution 
- 2.5ml PBS 
 
Diluent 
- 600µl Protein Concentrate 
- 7.5ml PBS 
 
Biotinylated Anti-mouse IgG Reagent 
- 10µ stock solution 
- 2.5ml of prepared Diluent 
 
Fluorescein Avidin DCS 
- 40µl stock solution 
- 2.5ml PBS 
-  
 
For Inducing Adipogenesis in 3T3 F442A cells 
 
3T3 cell medium 
- DMEM (4.5g/1 D-glucose) (Gibco) 
- 10% foetal bovine serum (Sigma) 
- 2mM L-glutamine 
- Antibiotics: Fungizone, 2µg/ml (Sigma), Penicillin, 100units/ml and Streptomycin, 
100µg/ml (Gibco) 
 
Differentiation medium 
- 1µg/ml insulin (Sigma) 
- 0.5mM IBMX 
- 0.25mM dexamethasone 
- Add Insulin, IBMX and dexamethasone to the 3T3 cell medium 
 
Insulin medium 
- 3T3 cell medium 
- 1µg/ml insulin 
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Appendix III (A) 
 
Working Solutions and Reagents for Chapters 4 and 5 
 
For Organ and Cell Culture Model set ups 
 
5% Agar Plates 
- For approx. 4 petri dishes, add 10grams of agar (Sigma) to 200ml distilled water. 
- Heat in a microwave with the lid loosed for 2 minutes, stirring frequently. 
- Leave to cool then pour into the petri dishes. 
- When set, store upside-down in the fridge. 
 
Collagen coated filters 
- Coat Nucleopore filters (Whatman) with rat-tail collagen type 1 (Sigma) for 40 
seconds on each side.  
- Adhere them to a petri dish lid and place under UV light overnight for sterility 
 
DNase I stock solution 
- 1 mg/ml DNase I (Stock): 0.01 g DNase I (Roche) 
- 10 ml DPBS (Gibco) 
- Mix slowly. 
 
Collagenase II/DNase I working solution 
- 3900 units of collagenase II (Worthington)  
- 100µg of 1mg/ml DNase I in 15ml of MEM-minimal essential medium (Sigma) 
with antibiotics: 2µg/ml fungizone and 100U/ml penicillin and 100µg/ml 
streptomycin (Gibco) 
 
Earle’s Solution 
Two solutions (A and B) were mixed in equal quantities and sterile filtered. 
Solution A Solution B 
NaCl 6.8g NaHCO3 1g 
KCl 0.4g dH20 150ml 
Nah2PO4 0.14g  
Glucose 1g  
dH20 950ml  
*These quantities make 1x, though for solutions A and B, using 95ml and 15ml of distilled 
water respectively can make a 10x solution which can be diluted prior to use. 
 
6% Pancreatin 
- Add 6g pancreatin (Sigma) to 100ml sterile Earles (1x) and leave stirring overnight 
at 4°C 
- Aliquots (500 ml) kept in -20°C. Filter before use. 
 
5% Trypsin 
- Add 5 g trypsin (BD) to 100ml sterile Earle’s (1x) solution.  
- Aliquots (1ml) kept in -20°C. Filter before use. 
 
Before use to create single cell suspension, 6% Pancreatin, 5% Trypsin and 1x Earle’s 
solution were mixed in a 1:1:2 ratio respectively. 
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Appendix III (B) 
 
Working Solutions and Reagents for Chapters 4 and 5 
 
Activation and Inhibition Factors 
- EGF (Sigma) 100ng/ml, dissolved in DMSO 
- AG1478 (Calbiochem) was bought in solution dissolved in DMSO at 10mM 
- BMP4 (Calbiochem) 
- DMH1 (Calbiochem) was dissolved in DMSO at 16.6mg/ml in a water bath 
overnight and then further diluted in sterile PBS at 190µg/ml. 
- KGF (Peprotech) was dissolved in 0.1% BSA (Sigma) in sterile PBS 
 
EDU Reaction Cocktail (Click.-IT® EDU Imaging Kit, Invitrogen, Alexa Fluor 
kit) 
- 86µl Reaction (RX) buffer (1x RX buffer in deionised water) 
- 4µl CuSO4 
- 0.24µl Alexa Fluor 488 Azide 
- 10µl RX buffer additive (1X RX buffer additive in deionised water) 
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Appendix IV 
 
Calculations for Cell Culture 
 
Calculating cell numbers 
 
A cell pellet was resuspended in 1ml of media.  
10µl was pipetted under the coverslip adhered to a haemocytometer.  
Under a microscope, the number of cells in 10 squares was counted (or 5 squares and 
multiplied by 2).  
This was multiplied by 10,000 to get the number of cells in the 1ml. 
 
 
 
 
 
 
 
